[{"i":"NCT00478465","u":"https://clinicaltrials.gov/study/NCT00478465","t":"","x":"valganciclovir","c":"antiviral","p":"ME/CFS","d":"RCT-placebo","b":1,"n":30,"y":2007,"r":"mixed","s":"Valganciclovir (n=30): responder analysis favoured VGCV (7.4x more likely responder, P=0.029); immune changes; small subset trial","v":1,"st":[1]},{"i":"PMID:11340544","u":"https://doi.org/10.1086/320530","t":"","x":"antiviral therapy","c":"antiviral","p":"ME/CFS","d":"RCT-placebo","b":0,"n":0,"y":2001,"r":"not-assessable","s":"Small RCT of antiviral therapy (2001); no abstract available","v":0,"st":[]},{"i":"PMID:18019402","u":"https://pubmed.ncbi.nlm.nih.gov/18019402/","t":"","x":"valacyclovir","c":"antiviral","p":"ME/CFS","d":"RCT-placebo","b":1,"n":0,"y":2007,"r":"positive","s":"Valacyclovir in EBV-subset CFS, 36-month follow-up: energy index and cardiac measures improved","v":1,"st":[1]},{"i":"PMID:24445302","u":"https://pubmed.ncbi.nlm.nih.gov/24445302/","t":"","x":"valacyclovir","c":"antiviral","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2014,"r":"positive","s":"Valacyclovir in adolescents with chronic fatigue/depression, case series: fatigue and vigour improved; uncontrolled","v":1,"st":[1]},{"i":"PMID:2849717","u":"https://doi.org/10.1056/nejm198812293192602","t":"","x":"acyclovir","c":"antiviral","p":"ME/CFS","d":"crossover","b":1,"n":27,"y":1988,"r":"null","s":"Acyclovir vs placebo (n=27, crossover): similar improvement on drug and placebo; ineffective","v":1,"st":[1]},{"i":"PMID:35102619","u":"https://doi.org/10.1111/1348-0421.12966","t":"","x":"valganciclovir + valacyclovir","c":"antiviral","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2022,"r":"positive","s":"Valaciclovir vs valganciclovir vs artesunate in ME/CFS with HHV-6/7 reactivation: artesunate cleared virus most often; viral PCR endpoint","v":1,"st":[1]},{"i":"PMID:29543914","u":"https://doi.org/10.1371/journal.pone.0193672","t":"","x":"immunoadsorption","c":"apheresis/immunoadsorption","p":"ME/CFS","d":"single-arm","b":0,"n":10,"y":2018,"r":"positive","s":"Immunoadsorption for beta2-AR antibodies, open pilot (n=10): antibodies fell; clinical improvement in most","v":1,"st":[1,4]},{"i":"PMID:32751659","u":"https://doi.org/10.3390/jcm9082443","t":"","x":"immunoadsorption","c":"apheresis/immunoadsorption","p":"ME/CFS","d":"single-arm","b":0,"n":5,"y":2020,"r":"positive","s":"Repeat immunoadsorption (n=5): 4 of 5 improved for 6-12 months","v":1,"st":[1,4]},{"i":"PMID:40507564","u":"https://doi.org/10.3390/jcm14113802","t":"","x":"immunoadsorption/apheresis + immunoglobulin (IVIG/SCIG)","c":"apheresis/immunoadsorption","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2025,"r":"feasibility-only","s":"Plasmapheresis + IVIG in autoantibody-positive ME/CFS, pilot: autoantibody levels associated with QoL; efficacy not tested","v":1,"st":[1,4]},{"i":"NCT00598585","u":"https://clinicaltrials.gov/study/NCT00598585","t":"","x":"PDE5 inhibitor","c":"autonomic/vasoactive","p":"ME/CFS","d":"RCT-placebo","b":1,"n":12,"y":2002,"r":"positive","s":"Sildenafil vs placebo (n=12): Fatigue Impact Scale fell 32.6 vs 1.5 points at 6 weeks (p<0.05); very small","v":1,"st":[4,5]},{"i":"NCT00977171","u":"https://clinicaltrials.gov/study/NCT00977171","t":"CFS201","x":"droxidopa","c":"autonomic/vasoactive","p":"ME/CFS","d":"single-arm","b":0,"n":3,"y":2010,"r":"not-assessable","s":"Droxidopa open-label, terminated after 3 participants; no interpretable efficacy result","v":0,"st":[3,4]},{"i":"NCT01040429","u":"https://clinicaltrials.gov/study/NCT01040429","t":"NorCAPITAL","x":"clonidine","c":"autonomic/vasoactive","p":"ME/CFS","d":"RCT-placebo","b":1,"n":120,"y":2010,"r":"negative/harm","s":"NorCAPITAL clonidine (n=120 adolescents): lowered sympathetic activity and inflammation but reduced physical activity (primary steps/day); judged not clinically useful","v":1,"st":[8]},{"i":"NCT01507701","u":"https://clinicaltrials.gov/study/NCT01507701","t":"","x":"clonidine","c":"autonomic/vasoactive","p":"ME/CFS","d":"single-arm","b":0,"n":5,"y":2010,"r":"unreported-after-completion","s":"Primary completion 2010-03; no results posted or published abstract found","v":0,"st":[8]},{"i":"NCT02854683","u":"https://clinicaltrials.gov/study/NCT02854683","t":"","x":"IV saline/fluids","c":"autonomic/vasoactive","p":"ME/CFS","d":"crossover","b":0,"n":45,"y":2016,"r":"unreported-after-completion","s":"Primary completion 2021-12; no results posted or published abstract found","v":0,"st":[3]},{"i":"NCT03674541","u":"https://clinicaltrials.gov/study/NCT03674541","t":"","x":"pyridostigmine","c":"autonomic/vasoactive","p":"ME/CFS","d":"RCT-placebo","b":1,"n":45,"y":2020,"r":"positive","s":"Pyridostigmine single dose (n=45): peak VO2 rose after pyridostigmine vs fell after placebo, via higher cardiac output","v":1,"st":[3,5]},{"i":"NCT04740736","u":"https://clinicaltrials.gov/study/NCT04740736","t":"","x":"IV saline/fluids","c":"autonomic/vasoactive","p":"ME/CFS","d":"RCT-placebo","b":1,"n":106,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2025-07-11; no results posted or published abstract found","v":0,"st":[3]},{"i":"NCT05664711","u":"https://clinicaltrials.gov/study/NCT05664711","t":"SGB_ME","x":"stellate ganglion/sympathetic block","c":"autonomic/vasoactive","p":"ME/CFS","d":"single-arm","b":0,"n":10,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-12-21; no results posted or published abstract found","v":0,"st":[8]},{"i":"PMID:11150109","u":"https://doi.org/10.1001/jama.285.1.52","t":"","x":"fludrocortisone","c":"autonomic/vasoactive","p":"ME/CFS","d":"RCT-placebo","b":1,"n":100,"y":2001,"r":"null","s":"Fludrocortisone vs placebo for neurally mediated hypotension (n=100): no more effective than placebo","v":1,"st":[3]},{"i":"PMID:35056360","u":"https://doi.org/10.3390/medicina58010051","t":"","x":"compression stockings","c":"autonomic/vasoactive","p":"ME/CFS","d":"crossover","b":0,"n":16,"y":2021,"r":"positive","s":"Compression stockings during tilt, crossover (n=~16): smaller drop in cardiac output and cerebral blood flow; acute physiology only","v":1,"st":[3]},{"i":"PMID:40761644","u":"https://doi.org/10.3389/fneur.2025.1601599","t":"","x":"intravenous saline","c":"autonomic/vasoactive","p":"ME/CFS","d":"single-arm","b":0,"n":20,"y":2025,"r":"positive","s":"Intermittent IV saline in dysautonomic ME/CFS, case series (n=~20): health benefits reported; uncontrolled","v":1,"st":[3]},{"i":"PMID:9570178","u":"https://doi.org/10.1001/archinte.158.8.908","t":"","x":"fludrocortisone","c":"autonomic/vasoactive","p":"ME/CFS","d":"crossover","b":1,"n":25,"y":1998,"r":"null","s":"Fludrocortisone vs placebo, crossover (n=20): no symptom or function improvement","v":1,"st":[3]},{"i":"CHICTR-INR-17010694","u":"https://doi.org/10.1159/000528827","t":"","x":"exercise/rehabilitation + sleep treatment","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2023,"r":"positive","s":"Yijinjing qigong vs CBT education: better MFI-20 and sleep","v":1,"st":[8]},{"i":"CHICTR2000032577","u":"https://doi.org/10.1371/journal.pone.0278415","t":"","x":"Tai Chi","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2022,"r":"positive","s":"Tai Chi pilot with fMRI: FS-14 fatigue fell in CFS patients; uncontrolled","v":1,"st":[]},{"i":"CHICTR2200061229","u":"https://doi.org/10.2196/53347","t":"","x":"exercise/rehabilitation + sleep treatment","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":0,"y":2024,"r":"pending","s":"Nine-Turn qigong RCT protocol (ChiCTR2200061229)","v":0,"st":[8]},{"i":"CHICTR2400082268","u":"https://doi.org/10.3389/fnins.2026.1910307","t":"","x":"Tai Chi","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2026,"r":"positive","s":"Tai Chi vs health education 12 wk with fMRI: greater fatigue improvement","v":1,"st":[]},{"i":"ISRCTN16025168","u":"https://www.isrctn.com/ISRCTN16025168","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"unclear","b":0,"n":210,"y":2026,"r":"pending","s":"Registry record only; no results read","v":0,"st":[2]},{"i":"ISRCTN16045700","u":"https://www.isrctn.com/ISRCTN16045700","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-unspecified","b":0,"n":20,"y":2017,"r":"unreported-after-completion","s":"Registry record only; no results read","v":0,"st":[2]},{"i":"ISRCTN18020851","u":"https://doi.org/10.3310/vlrw6701","t":"","x":"CBT/psychological therapy + pacing/energy management","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":1,"n":240,"y":2024,"r":"mixed","s":"FITNET-NHS: remote CBT vs activity management in paediatric ME/CFS (n=~240): better physical function and school attendance at 6 months; limited sustained effect, not cost-effective","v":1,"st":[2,6]},{"i":"ISRCTN21288417","u":"https://www.isrctn.com/ISRCTN21288417","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-unspecified","b":0,"n":0,"y":1999,"r":"unreported-after-completion","s":"Registry record only; no results read; outputs listed on registry","v":0,"st":[2]},{"i":"ISRCTN22975026","u":"https://doi.org/10.1016/s0140-6736(16)32589-2","t":"","x":"graded exercise therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":211,"y":2017,"r":"positive","s":"GETSET: guided graded exercise self-help + SMC vs SMC (n=211): lower fatigue at 12 weeks; smaller effect on disability","v":1,"st":[]},{"i":"ISRCTN23962803","u":"https://doi.org/10.1007/s00431-024-05458-x","t":"","x":"graded exercise therapy + pacing/energy management","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":241,"y":2024,"r":"null","s":"MAGENTA: GET vs activity management in paediatric ME/CFS: no evidence GET more effective; little improvement in either arm","v":1,"st":[6]},{"i":"ISRCTN27293439","u":"https://doi.org/10.1192/bjp.bp.108.051292","t":"","x":"guided self-help CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":171,"y":2008,"r":"positive","s":"Guided self-instruction CBT vs wait list (n=171): less fatigue and disability, mainly in less severe patients","v":1,"st":[2]},{"i":"ISRCTN31632033","u":"https://www.isrctn.com/ISRCTN31632033","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-unspecified","b":0,"n":130,"y":2006,"r":"unreported-after-completion","s":"Registry record only; no results read","v":0,"st":[2]},{"i":"ISRCTN37461058","u":"https://www.isrctn.com/ISRCTN37461058","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-unspecified","b":0,"n":153,"y":2000,"r":"unreported-after-completion","s":"Registry record only; no results read; outputs listed on registry","v":0,"st":[2]},{"i":"ISRCTN54285094","u":"https://doi.org/10.1016/s0140-6736(11)60096-2","t":"","x":"CBT/psychological therapy + pacing/energy management","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":641,"y":2011,"r":"mixed","s":"PACE: APT, CBT, GET vs specialist medical care (n=641): CBT and GET moderately improved fatigue and function vs SMC; APT no benefit. Outcome changes and effect sizes contested in later reanalyses (not from this abstract)","v":1,"st":[2,6]},{"i":"ISRCTN70763996","u":"https://doi.org/10.1007/s12529-014-9432-4","t":"","x":"self-regulation physical activity programme","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":91,"y":2015,"r":"positive","s":"4-STEPS self-regulation activity programme vs control in unexplained chronic fatigue (n=91): less fatigue (g=0.51)","v":1,"st":[]},{"i":"ISRCTN72645894","u":"https://doi.org/10.1186/s40814-020-00595-0","t":"","x":"early intervention (CBT-based)","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":44,"y":2020,"r":"feasibility-only","s":"Early primary-care intervention to prevent CFS, feasibility RCT (n=44): recruitment not feasible","v":1,"st":[2]},{"i":"ISRCTN81456207","u":"https://doi.org/10.1186/1745-6215-14-415","t":"","x":"Lightning Process","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":56,"y":2013,"r":"feasibility-only","s":"SMILE feasibility: Lightning Process + specialist care vs specialist care in children (n=56): RCT feasible and acceptable","v":1,"st":[2,8]},{"i":"NCT00468013","u":"https://clinicaltrials.gov/study/NCT00468013","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"crossover","b":1,"n":60,"y":2007,"r":"unreported-after-completion","s":"Primary completion 2010-03; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT00540254","u":"https://clinicaltrials.gov/study/NCT00540254","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":1,"n":24,"y":2007,"r":"unreported-after-completion","s":"Primary completion 2010-07; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT00860236","u":"https://clinicaltrials.gov/study/NCT00860236","t":"GIFF","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":40,"y":2009,"r":"unreported-after-completion","s":"Primary completion 2010-06; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT00893438","u":"https://clinicaltrials.gov/study/NCT00893438","t":"FitNet","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":135,"y":2008,"r":"positive","s":"FITNET (n=135): full school attendance 75% vs 16% (RR 4.8) and absence of severe fatigue 85% vs 27% vs usual care at 6 months","v":1,"st":[2]},{"i":"NCT00920777","u":"https://clinicaltrials.gov/study/NCT00920777","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":234,"y":2009,"r":"unreported-after-completion","s":"Primary completion 2014-07; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT00997451","u":"https://clinicaltrials.gov/study/NCT00997451","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":107,"y":2009,"r":"positive","s":"Fatigue self-management (n=107, unexplained chronic fatigue/CFS): reduced fatigue impact vs attention control (d=0.46) and usual care (d=0.40)","v":1,"st":[2]},{"i":"NCT01046370","u":"https://clinicaltrials.gov/study/NCT01046370","t":"","x":"brain-retraining programme","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":57,"y":2009,"r":"positive","s":"Amygdala retraining (44 randomised, 21 completers): better physical health, energy and fatigue scores than standard care; heavy attrition","v":1,"st":[2,8]},{"i":"NCT01318356","u":"https://clinicaltrials.gov/study/NCT01318356","t":"Qure","x":"CBT/psychological therapy + antibiotic","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-placebo","b":1,"n":155,"y":2011,"r":"mixed","s":"Qure: doxycycline or CBT vs placebo in Q-fever fatigue syndrome (n=155): posted CIS fatigue CBT 31.6, doxycycline 40.8, placebo 37.8; no between-group statistics posted; CBT numerically lowest, doxycycline no better than placebo","v":1,"st":[1,2]},{"i":"NCT01512342","u":"https://clinicaltrials.gov/study/NCT01512342","t":"","x":"pacing/energy management","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":1,"n":33,"y":2011,"r":"positive","s":"Activity pacing self-management (n=33): COPM satisfaction ES 0.74 and CIS fatigue reduced vs control","v":1,"st":[6]},{"i":"NCT01650636","u":"https://clinicaltrials.gov/study/NCT01650636","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":1,"n":300,"y":2010,"r":"mixed","s":"Video CBSM vs health information: medium-large benefits only in high-PEM subgroup, none in low-PEM","v":1,"st":[2]},{"i":"NCT01765725","u":"https://clinicaltrials.gov/study/NCT01765725","t":"","x":"Patient education program","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":146,"y":2011,"r":"unreported-after-completion","s":"Primary completion 2016-12; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT01806246","u":"https://clinicaltrials.gov/study/NCT01806246","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":13,"y":2013,"r":"unreported-after-completion","s":"Primary completion 2015-09; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT01873482","u":"https://clinicaltrials.gov/study/NCT01873482","t":"","x":"Movement to rhythm","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":17,"y":2014,"r":"unreported-after-completion","s":"Primary completion 2014-05; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT02156128","u":"https://clinicaltrials.gov/study/NCT02156128","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":54,"y":2013,"r":"unreported-after-completion","s":"Primary completion 2015-03; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT02336126","u":"https://clinicaltrials.gov/study/NCT02336126","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":8,"y":2014,"r":"unreported-after-completion","s":"Primary completion 2015-01; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT02499302","u":"https://clinicaltrials.gov/study/NCT02499302","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":50,"y":2015,"r":"feasibility-only","s":"CBT + music therapy after EBV (n=43): feasible; efficacy not tested","v":1,"st":[]},{"i":"NCT02541890","u":"https://clinicaltrials.gov/study/NCT02541890","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":175,"y":2015,"r":"unreported-after-completion","s":"Primary completion 2017-07; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT03496961","u":"https://clinicaltrials.gov/study/NCT03496961","t":"YNJZFCFS","x":"CBT/psychological therapy + herbal/TCM","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-placebo","b":1,"n":135,"y":2018,"r":"null","s":"Nine-turn qigong vs CBT: both groups improved (MFI-20, PSQI, HADS); no between-group difference","v":1,"st":[2]},{"i":"NCT03562325","u":"https://clinicaltrials.gov/study/NCT03562325","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":40,"y":2012,"r":"unreported-after-completion","s":"Primary completion 2017-10-31; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT04151693","u":"https://clinicaltrials.gov/study/NCT04151693","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":1,"n":80,"y":2019,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT04177459","u":"https://clinicaltrials.gov/study/NCT04177459","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":3,"y":2019,"r":"unreported-after-completion","s":"Primary completion 2020-04-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04532827","u":"https://clinicaltrials.gov/study/NCT04532827","t":"DigiPimo","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":105,"y":2020,"r":"unreported-after-completion","s":"Primary completion 2023-07-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04593225","u":"https://clinicaltrials.gov/study/NCT04593225","t":"SFCAMINA","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":480,"y":2020,"r":"positive","s":"FATIGUEWALK online programme + TAU vs TAU: fatigue improved (d 0.25-0.73)","v":1,"st":[]},{"i":"NCT04870476","u":"https://clinicaltrials.gov/study/NCT04870476","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2021,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[2]},{"i":"NCT05168124","u":"https://clinicaltrials.gov/study/NCT05168124","t":"","x":"Acceptance Commitment Therapy for chronic fatigue; Micro breaks in everyday life for chronic fatigue","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":90,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05236465","u":"https://clinicaltrials.gov/study/NCT05236465","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":100,"y":2022,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT05525598","u":"https://clinicaltrials.gov/study/NCT05525598","t":"OneSTEP","x":"graded exercise therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":166,"y":2022,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05899595","u":"https://clinicaltrials.gov/study/NCT05899595","t":"OFF2HEALTH","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":101,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06341751","u":"https://clinicaltrials.gov/study/NCT06341751","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":18,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-01-15; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT06786832","u":"https://clinicaltrials.gov/study/NCT06786832","t":"iFAS","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":190,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT07242573","u":"https://clinicaltrials.gov/study/NCT07242573","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":75,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07363655","u":"https://clinicaltrials.gov/study/NCT07363655","t":"","x":"CBT/psychological therapy + pacing/energy management","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":13,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-02-23; no results posted or published abstract found","v":0,"st":[2,6]},{"i":"NTR4013","u":"https://doi.org/10.1192/bjp.2017.22","t":"","x":"internet CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":240,"y":2018,"r":"positive","s":"Web-based CBT (two feedback formats) vs wait list (n=240): fatigue reduced in both iCBT arms","v":1,"st":[2]},{"i":"NTR4809","u":"https://doi.org/10.2196/11276","t":"","x":"internet CBT stepped care","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":360,"y":2019,"r":"null","s":"Stepped care with internet CBT vs face-to-face CBT (n=~360): noninferior; less therapist time","v":1,"st":[2]},{"i":"PMID:11179154","u":"https://doi.org/10.1136/bmj.322.7283.387","t":"","x":"graded exercise therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":148,"y":2001,"r":"positive","s":"Education to encourage graded exercise vs standard care (n=148): 69% vs 6% satisfactory physical functioning","v":1,"st":[]},{"i":"PMID:11244392","u":"https://doi.org/10.1159/000056234","t":"","x":"group therapy","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2001,"r":"positive","s":"Short-term group therapy: patients reported improved well-being and coping; qualitative","v":1,"st":[]},{"i":"PMID:11265953","u":"https://doi.org/10.1016/s0140-6736(00)04198-2","t":"","x":"CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":278,"y":2001,"r":"positive","s":"CBT vs support groups vs natural course (n=278): CBT better for fatigue and functional impairment at 14 months","v":1,"st":[2]},{"i":"PMID:11271868","u":"https://pubmed.ncbi.nlm.nih.gov/11271868/","t":"","x":"counselling vs CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":160,"y":2001,"r":"null","s":"Counselling vs CBT in primary-care chronic fatigue (n=160, 28% CFS): equivalent; no inactive control","v":1,"st":[2]},{"i":"PMID:11600166","u":"https://doi.org/10.1016/s0163-8343(01)00154-2","t":"","x":"CBT","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2001,"r":"positive","s":"CBT in general hospital outpatients, uncontrolled: improved function and return to work in many; some remain disabled","v":1,"st":[2]},{"i":"PMID:12324640","u":"https://doi.org/10.1093/qjmed/95.10.677","t":"","x":"polynutrient supplement","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-placebo","b":1,"n":53,"y":2002,"r":"null","s":"Polynutrient supplement vs placebo (n=53): no difference in fatigue or activity","v":1,"st":[]},{"i":"PMID:15115421","u":"https://doi.org/10.5694/j.1326-5377.2004.tb06019.x","t":"","x":"graded exercise therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":30,"y":2004,"r":"positive","s":"Graded exercise vs control (n=~30): improved work capacity, depression and Stroop performance","v":1,"st":[]},{"i":"PMID:15585538","u":"https://doi.org/10.1136/bmj.38301.587106.63","t":"","x":"CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":71,"y":2005,"r":"positive","s":"CBT vs waiting list in adolescents (n=71): less fatigue, better function and school attendance","v":1,"st":[2]},{"i":"PMID:15723894","u":"https://doi.org/10.1177/1359105305049774","t":"","x":"graded exercise therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":49,"y":2005,"r":"positive","s":"Graded exercise vs standard care (n=49): more improved and less fatigued; effect mediated by less symptom focusing","v":1,"st":[]},{"i":"PMID:15781925","u":"https://doi.org/10.1136/adc.2003.046649","t":"","x":"behavioural approaches","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2005,"r":"not-assessable","s":"Feasibility study of two treatment approaches in adolescents (2005); no abstract","v":0,"st":[]},{"i":"PMID:15947511","u":"https://doi.org/10.1159/000085145","t":"","x":"group CBT","c":"behavioural/rehab","p":"ME/CFS","d":"open-label","b":0,"n":0,"y":2005,"r":"mixed","s":"Group CBT vs waiting list, non-randomised: moderate effect on fatigue; functional impairment worse than expected","v":1,"st":[2]},{"i":"PMID:17014748","u":"https://doi.org/10.3310/hta10370","t":"","x":"group CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":0,"y":2006,"r":"positive","s":"Group CBT vs standard care: fatigue, mood and fitness improved; primary normal-range target not met","v":1,"st":[2]},{"i":"PMID:18955297","u":"https://doi.org/10.1093/ecam/nem088","t":"","x":"qigong","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2009,"r":"positive","s":"Qigong uncontrolled pilot: sleep, pain and mobility improved over 3-6 months","v":1,"st":[]},{"i":"PMID:19576714","u":"https://doi.org/10.1016/j.pec.2009.05.015","t":"","x":"multi-component coping programme","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":44,"y":2009,"r":"positive","s":"Multi-component coping programme vs wait list (n=~44): fatigue, self-efficacy and anxiety improved at 6 months","v":1,"st":[]},{"i":"PMID:19891804","u":"https://doi.org/10.1017/s003329170999153x","t":"","x":"family-focused CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":63,"y":2010,"r":"null","s":"Family-focused CBT vs psycho-education in adolescents (n=63): similar at 6 and 12 months; faster school return with CBT","v":1,"st":[2]},{"i":"PMID:19902489","u":"https://doi.org/10.1002/jclp.20648","t":"","x":"buddy social support","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":0,"y":2010,"r":"mixed","s":"Student buddy social support vs control: less fatigue and more vitality; physical function unchanged","v":1,"st":[]},{"i":"PMID:19912315","u":"https://doi.org/10.1111/j.1365-2362.2009.02225.x","t":"","x":"home orthostatic training","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-placebo","b":1,"n":38,"y":2010,"r":"feasibility-only","s":"Home orthostatic (tilt) training vs sham (n=38): feasible; less standing BP drop at 4 weeks","v":1,"st":[]},{"i":"PMID:20104421","u":"https://doi.org/10.1682/jrrd.2009.01.0007","t":"","x":"CBT/psychological therapy + pacing/energy management","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":7,"y":2009,"r":"positive","s":"Pacing self-management case series (n=7): modest symptom and function improvement; uncontrolled","v":1,"st":[2,6]},{"i":"PMID:20418251","u":"https://doi.org/10.1136/bmj.c1777","t":"","x":"pragmatic rehabilitation / supportive listening","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":296,"y":2010,"r":"null","s":"FINE trial: nurse-led pragmatic rehabilitation or supportive listening vs GP care (n=296): small short-term fatigue gain, not significant at 70 weeks; listening ineffective","v":1,"st":[]},{"i":"PMID:20605858","u":"https://doi.org/10.1177/0269215510371429","t":"","x":"graded exercise therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":1,"n":22,"y":2010,"r":"mixed","s":"Aerobic vs resistance training in adolescents (n=~22): no between-group difference; both improved from baseline","v":1,"st":[]},{"i":"PMID:20684894","u":"https://doi.org/10.1016/j.apmr.2010.04.020","t":"","x":"pain physiology education","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":1,"n":48,"y":2010,"r":"mixed","s":"Pain physiology education vs pacing education (n=48): better pain understanding and less rumination; no fatigue outcome","v":1,"st":[2]},{"i":"PMID:20873907","u":"https://doi.org/10.1037/a0020052","t":"","x":"stepped care (self-instruction then CBT)","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":169,"y":2010,"r":"null","s":"Stepped care vs CBT care as usual (n=169, noninferiority): equivalent outcomes, less therapist time","v":1,"st":[2]},{"i":"PMID:21197347","u":"https://doi.org/10.2147/jmdh.s5220","t":"","x":"MBSR","c":"behavioural/rehab","p":"ME/CFS","d":"open-label","b":0,"n":76,"y":2009,"r":"positive","s":"Mindfulness-based stress reduction vs wait list in women with MCS/CFS/FM (n=76): lower psychological distress; fatigue not primary","v":1,"st":[2]},{"i":"PMID:21234629","u":"https://doi.org/10.1007/s10067-010-1677-y","t":"","x":"CBT/psychological therapy + graded exercise therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":120,"y":2011,"r":"negative/harm","s":"Group CBT + graded exercise vs usual care (n=120): no HRQoL benefit at 12 months; worse SF-36 physical function and pain in intervention group","v":1,"st":[2]},{"i":"PMID:21414452","u":"https://doi.org/10.1016/j.jpsychores.2010.11.010","t":"","x":"cognitive behavioural stress management","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":69,"y":2011,"r":"positive","s":"Cognitive behavioural stress management vs psychoeducation pilot (n=69): better stress, mood, QoL and CFS symptom severity","v":1,"st":[2]},{"i":"PMID:21929831","u":"https://doi.org/10.1017/s1352465811000543","t":"","x":"CBT (telephone)","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":1,"n":80,"y":2012,"r":"positive","s":"Telephone vs face-to-face CBT (n=80): both improved fatigue and function; no inactive control","v":1,"st":[2]},{"i":"PMID:21983916","u":"https://doi.org/10.1002/cpp.793","t":"","x":"mindfulness-based cognitive therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":18,"y":2013,"r":"positive","s":"Mindfulness-based cognitive therapy after CBT, pilot vs wait list (n=~18): less fatigue","v":1,"st":[2]},{"i":"PMID:22354999","u":"https://doi.org/10.1017/s0033291712000232","t":"","x":"guided self-help CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":123,"y":2012,"r":"mixed","s":"Guided self-instruction vs wait list in a mental health centre (n=123): fatigue fell more; physical and social function unchanged","v":1,"st":[2]},{"i":"PMID:22370004","u":"https://doi.org/10.1017/s0033291712000256","t":"","x":"CBT/psychological therapy + graded exercise therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":300,"y":2012,"r":"null","s":"Counselling or graded exercise vs usual care in primary-care chronic fatigue (n=~300): no significant difference in fatigue","v":1,"st":[2]},{"i":"PMID:22459729","u":"https://doi.org/10.1016/j.brat.2012.02.014","t":"","x":"telephone guided self-help CBT","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2012,"r":"positive","s":"Telephone-guided self-help in adolescents, non-randomised cohort: fatigue fell (d=0.79), school attendance rose","v":1,"st":[2]},{"i":"PMID:22736201","u":"https://doi.org/10.1007/s12160-012-9381-6","t":"","x":"qigong","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":64,"y":2012,"r":"positive","s":"Qigong vs wait list (n=64): less fatigue, better mental functioning, higher telomerase activity","v":1,"st":[]},{"i":"PMID:23166120","u":"https://doi.org/10.1136/bmjopen-2012-001079","t":"","x":"CBT/psychological therapy + diet","c":"behavioural/rehab","p":"ME/CFS","d":"open-label","b":0,"n":0,"y":2012,"r":"positive","s":"Nutritional, psychological or combined therapy, non-randomised: all groups improved; no control","v":1,"st":[2]},{"i":"PMID:23272986","u":"https://doi.org/10.1016/j.jpsychores.2012.09.006","t":"","x":"mindfulness therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":119,"y":2013,"r":"null","s":"Mindfulness therapy vs enhanced usual care in functional somatic syndromes (n=119): no different over time","v":1,"st":[2]},{"i":"PMID:23983785","u":"https://doi.org/10.1155/2013/485341","t":"","x":"qigong","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":137,"y":2013,"r":"positive","s":"Qigong vs wait list in CFS-like illness (n=137): total and physical fatigue and depression improved","v":1,"st":[]},{"i":"PMID:25214803","u":"https://doi.org/10.2147/prbm.s63193","t":"","x":"online symptom management","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2014,"r":"mixed","s":"Online symptom management programme pilot: changes in locus of control and sleep, not overall symptoms","v":1,"st":[]},{"i":"PMID:25581161","u":"https://doi.org/10.3109/11038128.2014.985608","t":"","x":"group self-management programme","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2015,"r":"feasibility-only","s":"Group self-management programme development pilot: feasible after modifications","v":1,"st":[2]},{"i":"PMID:26035692","u":"https://doi.org/10.2340/16501977-1976","t":"","x":"cognitive rehabilitation + exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":30,"y":2015,"r":"positive","s":"Computerised working-memory training vs control pilot (n=~30): better working memory and attention","v":1,"st":[2]},{"i":"PMID:26138726","u":"https://doi.org/10.1186/s12888-015-0515-9","t":"","x":"CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":0,"y":2015,"r":"pending","s":"Neural mechanisms of CBT RCT (Dutch NTR); protocol only","v":0,"st":[2]},{"i":"PMID:26306716","u":"https://doi.org/10.1111/joim.12402","t":"","x":"exercise/rehabilitation + CBT/psychological therapy","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":122,"y":2016,"r":"positive","s":"Multidisciplinary rehabilitation vs CBT (n=122): less fatigue at 52 weeks with rehabilitation","v":1,"st":[2]},{"i":"PMID:26402868","u":"https://doi.org/10.1159/000438867","t":"","x":"group CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":204,"y":2015,"r":"positive","s":"Group CBT vs wait list (n=204): large improvements in fatigue (ES 1.1) and impairment","v":1,"st":[2]},{"i":"PMID:26672998","u":"https://doi.org/10.1177/0269215515621362","t":"","x":"group self-management programme","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":137,"y":2017,"r":"null","s":"Group self-management programme vs usual care (n=137): no sustained effect; fatigue briefly favoured control","v":1,"st":[2]},{"i":"PMID:26950098","u":"https://doi.org/10.1037/ccp0000085","t":"","x":"guided self-help CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":100,"y":2016,"r":"positive","s":"Guided self-instruction vs wait list in idiopathic chronic fatigue (n=100): less fatigue (d=0.68) and impairment","v":1,"st":[2]},{"i":"PMID:27285346","u":"https://pubmed.ncbi.nlm.nih.gov/27285346/","t":"","x":"exercise reconditioning programme","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":33,"y":2016,"r":"positive","s":"Reconditioning exercise vs control: better strength and balance; low relapse risk","v":1,"st":[]},{"i":"PMID:27521652","u":"https://doi.org/10.1016/j.jpsychores.2016.07.009","t":"","x":"interdisciplinary group programme (ACT-based)","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2016,"r":"positive","s":"Interdisciplinary group programme, uncontrolled: better QoL and psychological flexibility; fatigue fell at follow-up","v":1,"st":[2]},{"i":"PMID:28107891","u":"https://doi.org/10.1016/j.jpsychores.2016.12.004","t":"","x":"cognitive behavioural stress management","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2017,"r":"mixed","s":"Telephone vs live group CBSM: both reduced stress; only live group improved PEM and physical symptoms","v":1,"st":[2]},{"i":"PMID:28270860","u":"https://doi.org/10.1186/s13030-017-0090-z","t":"","x":"recumbent isometric yoga","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":15,"y":2017,"r":"feasibility-only","s":"Recumbent isometric yoga for severe ME/CFS pilot (n=~15): feasible; fatigue scores fell","v":1,"st":[]},{"i":"PMID:28473005","u":"https://doi.org/10.1017/s135246581700025x","t":"","x":"guided self-help CBT","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2017,"r":"mixed","s":"Guided self-help while awaiting CBT, cohort: physical function improved; fatigue did not","v":1,"st":[2]},{"i":"PMID:28830024","u":"https://doi.org/10.1016/j.psychres.2017.08.035","t":"","x":"cognitive rehabilitation + exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"open-label","b":0,"n":0,"y":2017,"r":"positive","s":"Cognitive remediation (CET) added to CBT/GET vs CBT/GET alone, non-randomised: better subjective and objective cognition","v":1,"st":[2]},{"i":"PMID:29923110","u":"https://doi.org/10.1007/s00421-018-3913-0","t":"","x":"aquatic exercise","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":11,"y":2018,"r":"positive","s":"Aquatic exercise 5 weeks, uncontrolled (n=~11): 6MWT +61 m and less fatigue","v":1,"st":[]},{"i":"PMID:31574792","u":"https://doi.org/10.1097/md.0000000000016720","t":"","x":"group CBT","c":"behavioural/rehab","p":"ME/CFS","d":"open-label","b":0,"n":0,"y":2019,"r":"positive","s":"Group CBT vs wait list in routine service: physical fatigue d=0.52, mental fatigue d=0.22","v":1,"st":[2]},{"i":"PMID:31607352","u":"https://doi.org/10.1016/bs.irn.2019.08.002","t":"","x":"qigong","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":0,"y":2019,"r":"positive","s":"Two qigong RCTs summary: improved fatigue, sleep and adiponectin; dose-response","v":1,"st":[]},{"i":"PMID:34880007","u":"https://doi.org/10.1136/bmjopen-2020-045398","t":"","x":"activity pacing framework","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":107,"y":2021,"r":"feasibility-only","s":"Activity pacing framework in chronic pain/fatigue rehab (n=107): feasible; pacing ability improved","v":1,"st":[6]},{"i":"PMID:35206569","u":"https://doi.org/10.3390/ijerph19042377","t":"","x":"aerobic exercise","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2022,"r":"positive","s":"Aerobic exercise in adolescents with chronic fatigue: fatigue and oxidative markers improved; metabolomic focus","v":1,"st":[]},{"i":"PMID:39717828","u":"https://doi.org/10.3389/fphys.2024.1441076","t":"","x":"multicomponent education + activity","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":158,"y":2024,"r":"positive","s":"SYNCHRONIZE+ in FM with/without CFS: more physical activity and function at 3 months","v":1,"st":[]},{"i":"PMID:40186656","u":"https://doi.org/10.1007/s00421-025-05759-5","t":"","x":"aquatic exercise (self-paced)","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":0,"y":2025,"r":"positive","s":"Self-paced aquatic exercise 6 months vs control in ME/CFS: better walk distance, sit-to-stand and fatigue without worsening symptoms","v":1,"st":[]},{"i":"PMID:40724680","u":"https://doi.org/10.3390/healthcare13141654","t":"","x":"forest bathing","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2025,"r":"positive","s":"Single forest-bathing session in FM/CFS: short-term mood and anxiety gains; small fatigue effect","v":1,"st":[2]},{"i":"PMID:41752730","u":"https://doi.org/10.3390/medicina62020331","t":"","x":"pacing education","c":"behavioural/rehab","p":"ME/CFS","d":"single-arm","b":0,"n":13,"y":2026,"r":"feasibility-only","s":"Short-term pacing intervention pilot in Portugal (n=13): feasible and acceptable","v":1,"st":[6]},{"i":"PMID:42772658","u":"https://doi.org/10.1016/j.amjmed.2026.09.013","t":"","x":"integrated multidisciplinary care","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":182,"y":2026,"r":"null","s":"Integrated multidisciplinary care model vs usual care, open-label (n=182): no improvement in SF-36 physical function at 12 months","v":1,"st":[]},{"i":"PMID:8148435","u":"https://doi.org/10.1093/clinids/18.supplement_1.s105","t":"","x":"CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":0,"y":1994,"r":"mixed","s":"CBT in CFS vs depression vs untreated CFS controls: reductions in depression and fatigue-related cognitions in treated CFS; small nonrandomised","v":1,"st":[2]},{"i":"PMID:8430715","u":"https://doi.org/10.1016/0002-9343(93)90183-p","t":"","x":"dialysable leukocyte extract + CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-placebo","b":1,"n":90,"y":1993,"r":"null","s":"Dialysable leukocyte extract and/or CBT, factorial placebo-controlled (n=90): no specific benefit","v":1,"st":[2]},{"i":"PMID:8555852","u":"https://doi.org/10.1136/bmj.312.7022.22","t":"","x":"CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":60,"y":1996,"r":"positive","s":"CBT added to medical care vs medical care alone (n=60): 73% vs 27% satisfactory outcome","v":1,"st":[2]},{"i":"PMID:9054791","u":"https://doi.org/10.1176/ajp.154.3.408","t":"","x":"CBT","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":60,"y":1997,"r":"positive","s":"CBT vs relaxation (n=60): 70% vs 19% good outcome among completers at 6-month follow-up","v":1,"st":[2]},{"i":"PMID:9180065","u":"https://doi.org/10.1136/bmj.314.7095.1647","t":"","x":"graded exercise therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-active","b":0,"n":66,"y":1997,"r":"positive","s":"Graded aerobic exercise vs flexibility (n=66): 17/33 vs 9/33 better (ITT); fatigue and function improved","v":1,"st":[]},{"i":"UMIN000009646","u":"https://doi.org/10.1186/s13030-014-0027-8","t":"","x":"isometric yoga","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":30,"y":2014,"r":"positive","s":"Isometric yoga add-on vs usual care (n=30): Chalder fatigue fell in yoga group only","v":1,"st":[]},{"i":"UMIN000023472","u":"https://doi.org/10.1186/s13030-025-00339-7","t":"","x":"recumbent isometric yoga","c":"behavioural/rehab","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":30,"y":2025,"r":"positive","s":"Recumbent isometric yoga vs usual care (n=~30, incl. bedbound): better performance status and Chalder fatigue","v":1,"st":[]},{"i":"DRKS00005445","u":"https://doi.org/10.1016/j.jpsychores.2016.11.014","t":"","x":"biofeedback + graded exercise therapy","c":"device/neuromodulation","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2017,"r":"positive","s":"HRV biofeedback vs graded exercise, pilot: both reduced fatigue; HRV-BF also mental QoL and depression","v":1,"st":[8]},{"i":"ISRCTN15931869","u":"https://www.isrctn.com/ISRCTN15931869","t":"","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"ME/CFS","d":"RCT-unspecified","b":0,"n":40,"y":2024,"r":"pending","s":"Registry record only; no results read","v":0,"st":[7,8]},{"i":"ISRCTN42784463","u":"https://www.isrctn.com/ISRCTN42784463","t":"tDCS in CFS","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"ME/CFS","d":"RCT-unspecified","b":0,"n":93,"y":2024,"r":"pending","s":"Registry record only; no results read","v":0,"st":[2]},{"i":"JRCT1042240065","u":"https://doi.org/10.31083/jin25488","t":"","x":"rTMS","c":"device/neuromodulation","p":"ME/CFS","d":"single-arm","b":0,"n":160,"y":2025,"r":"positive","s":"rTMS for static/kinetic disequilibrium in ME: disequilibrium alleviated; uncontrolled","v":1,"st":[2]},{"i":"NCT03502044","u":"https://clinicaltrials.gov/study/NCT03502044","t":"","x":"Inactive Kinetic Oscillation Stimulation (KOS); Active Kinetic Oscillation Stimulation (KOS)","c":"device/neuromodulation","p":"ME/CFS","d":"RCT-placebo","b":1,"n":200,"y":2018,"r":"unreported-after-completion","s":"Primary completion 2019-12-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05397626","u":"https://clinicaltrials.gov/study/NCT05397626","t":"","x":"biofeedback + molecular hydrogen","c":"device/neuromodulation","p":"ME/CFS","d":"RCT-active","b":1,"n":39,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-05-23; no results posted or published abstract found","v":0,"st":[5,6,8]},{"i":"NCT05791812","u":"https://clinicaltrials.gov/study/NCT05791812","t":"ACTIVATE","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"ME/CFS","d":"single-arm","b":0,"n":20,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06145867","u":"https://clinicaltrials.gov/study/NCT06145867","t":"LightMEup","x":"photobiomodulation","c":"device/neuromodulation","p":"ME/CFS","d":"single-arm","b":0,"n":10,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-08-01; no results posted or published abstract found","v":0,"st":[5]},{"i":"NCT06170645","u":"https://clinicaltrials.gov/study/NCT06170645","t":"PAF-tVNS","x":"vagus nerve stimulation + exercise/rehabilitation","c":"device/neuromodulation","p":"ME/CFS","d":"RCT-placebo","b":1,"n":60,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[7,8]},{"i":"NCT06635928","u":"https://clinicaltrials.gov/study/NCT06635928","t":"BLTME","x":"Bright light therapy","c":"device/neuromodulation","p":"ME/CFS","d":"crossover","b":0,"n":36,"y":2021,"r":"null","s":"Bright light therapy vs wait list, crossover (n=36, ME/CFS): primary fatigue not improved; possible attention benefit","v":1,"st":[]},{"i":"NCT07546539","u":"https://clinicaltrials.gov/study/NCT07546539","t":"","x":"photobiomodulation","c":"device/neuromodulation","p":"ME/CFS","d":"RCT-placebo","b":1,"n":40,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[5]},{"i":"NCT07573709","u":"https://clinicaltrials.gov/study/NCT07573709","t":"FibFatDCS","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"ME/CFS","d":"RCT-active","b":0,"n":20,"y":2025,"r":"unreported-after-completion","s":"Primary completion 2025-05-01; no results posted or published abstract found","v":0,"st":[2]},{"i":"PMID:29354991","u":"https://doi.org/10.13703/j.0255-2930.2017.12.006","t":"","x":"transcutaneous electrical acupoint stimulation","c":"device/neuromodulation","p":"ME/CFS","d":"RCT-placebo","b":0,"n":0,"y":2017,"r":"positive","s":"Transcutaneous electrical acupoint stimulation vs sham: FSS fell more; low quality","v":1,"st":[]},{"i":"PMID:31483181","u":"https://doi.org/10.1080/00207454.2019.1663189","t":"","x":"rTMS","c":"device/neuromodulation","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2020,"r":"positive","s":"rTMS in ME inpatients, uncontrolled: fatigue VAS fell regardless of baseline severity","v":1,"st":[2]},{"i":"2022-000281-18","u":"https://doi.org/10.3389/fmed.2025.1607353","t":"","x":"daratumumab","c":"immunomodulator","p":"ME/CFS","d":"single-arm","b":0,"n":10,"y":2025,"r":"positive","s":"Daratumumab (anti-CD38) pilot (n=10): 6 of 10 improved markedly with IgG fall; uncontrolled","v":1,"st":[1]},{"i":"2024-520094-13-00","u":"https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-520094-13-00","t":"KTS-11-2024","x":"daratumumab","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":66,"y":2025,"r":"pending","s":"Registry record only (EU CTIS); results first received: No","v":0,"st":[1]},{"i":"NCT00215800","u":"https://clinicaltrials.gov/study/NCT00215800","t":"","x":"rintatolimod","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":0,"y":1998,"r":"positive","s":"AMP-516 (n=234): rintatolimod improved treadmill exercise tolerance vs placebo and reduced concomitant drug use; effect modest","v":1,"st":[1,7]},{"i":"NCT00848692","u":"https://clinicaltrials.gov/study/NCT00848692","t":"KTS-1-2008","x":"rituximab","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":30,"y":2008,"r":"mixed","s":"Rituximab (n=30): primary endpoint (fatigue at 3 months) negative; delayed responses at 2-7 months in rituximab arm","v":1,"st":[1]},{"i":"NCT01156909","u":"https://clinicaltrials.gov/study/NCT01156909","t":"","x":"rituximab","c":"immunomodulator","p":"ME/CFS","d":"single-arm","b":0,"n":29,"y":2010,"r":"positive","s":"Rituximab maintenance, open-label (n=29): 18 of 29 had major/moderate fatigue responses; no control group","v":1,"st":[1]},{"i":"NCT01156922","u":"https://clinicaltrials.gov/study/NCT01156922","t":"","x":"rituximab","c":"immunomodulator","p":"ME/CFS","d":"single-arm","b":0,"n":8,"y":2010,"r":"unreported-after-completion","s":"Primary completion 2016-04; no results posted or published abstract found","v":0,"st":[1]},{"i":"NCT01730495","u":"https://clinicaltrials.gov/study/NCT01730495","t":"","x":"anti-TNF","c":"immunomodulator","p":"ME/CFS","d":"single-arm","b":0,"n":4,"y":2012,"r":"unreported-after-completion","s":"Primary completion 2014-08; no results posted or published abstract found","v":0,"st":[6,7]},{"i":"NCT02108210","u":"https://clinicaltrials.gov/study/NCT02108210","t":"CiCFS","x":"anakinra","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":50,"y":2014,"r":"null","s":"Anakinra 4 weeks (n=50): no difference in CIS-fatigue vs placebo (MD 1.5, 95% CI -4.1 to 7.2)","v":1,"st":[6,7]},{"i":"NCT02229942","u":"https://clinicaltrials.gov/study/NCT02229942","t":"RituxME","x":"rituximab","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":151,"y":2014,"r":"null","s":"RituxME (n=151): response 26% rituximab vs 35% placebo (P=0.22); no difference in fatigue over 24 months","v":1,"st":[1]},{"i":"NCT02444091","u":"https://clinicaltrials.gov/study/NCT02444091","t":"CycloME","x":"cyclophosphamide","c":"immunomodulator","p":"ME/CFS","d":"single-arm","b":0,"n":40,"y":2015,"r":"positive","s":"IV cyclophosphamide, open-label (n=40): 55% fatigue responders; uncontrolled","v":1,"st":[1]},{"i":"NCT02955420","u":"https://clinicaltrials.gov/study/NCT02955420","t":"","x":"BC007 (rovunaptabin)","c":"immunomodulator","p":"ME/CFS","d":"single-arm","b":1,"n":74,"y":2016,"r":"unreported-after-completion","s":"Primary completion 2018-04; no results posted or published abstract found","v":0,"st":[1,4]},{"i":"NCT02965768","u":"https://clinicaltrials.gov/study/NCT02965768","t":"","x":"low-dose naltrexone","c":"immunomodulator","p":"ME/CFS","d":"crossover","b":1,"n":0,"y":2016,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[6,7]},{"i":"NCT06952413","u":"https://clinicaltrials.gov/study/NCT06952413","t":"","x":"rituximab","c":"immunomodulator","p":"ME/CFS","d":"crossover","b":1,"n":30,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"NCT07285473","u":"https://clinicaltrials.gov/study/NCT07285473","t":"","x":"low-dose naltrexone","c":"immunomodulator","p":"ME/CFS","d":"single-arm","b":0,"n":75,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[6,7]},{"i":"PMID:10700309","u":"https://doi.org/10.1016/s1090-3801(98)90006-4","t":"","x":"staphylococcus toxoid","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":0,"n":0,"y":1998,"r":"positive","s":"Staphylococcus toxoid vaccine vs placebo in FM/CFS: global impression improved; long-term follow-up 50% back to work","v":1,"st":[1]},{"i":"PMID:12413434","u":"https://doi.org/10.1016/s1090-3801(02)00044-7","t":"","x":"staphylococcus toxoid","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":0,"n":98,"y":2002,"r":"positive","s":"Staphylococcus toxoid injections vs placebo in FM/CFS (n=98): 65% vs 18% responders; relapse on withdrawal","v":1,"st":[1]},{"i":"PMID:14527077","u":"https://doi.org/10.7556/jaoa.2003.103.9.423","t":"","x":"topical nasal corticosteroid","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":0,"y":2003,"r":"null","s":"Nasal corticosteroid vs placebo in CFS with rhinitis: no improvement in fatigue","v":1,"st":[6,7]},{"i":"PMID:2146875","u":"https://doi.org/10.1016/0002-9343(90)90173-b","t":"","x":"IV immunoglobulin","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":49,"y":1990,"r":"positive","s":"IV immunoglobulin vs placebo (n=49): 43% vs 12% responders at 3 months","v":1,"st":[1]},{"i":"PMID:2239975","u":"https://doi.org/10.1016/0002-9343(90)90172-a","t":"","x":"IV immunoglobulin","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":30,"y":1990,"r":"null","s":"IV immunoglobulin G vs placebo (n=28): no therapeutic benefit","v":1,"st":[1]},{"i":"PMID:37255930","u":"https://doi.org/10.1093/oxfimm/iqad003","t":"","x":"neuro-immune combination therapy","c":"immunomodulator","p":"ME/CFS","d":"single-arm","b":0,"n":20,"y":2023,"r":"positive","s":"Open-label pilot targeting neuro-immune interface (low-dose combination, n=~20): ~30% symptom score reduction at 8 weeks","v":1,"st":[]},{"i":"PMID:38910072","u":"https://doi.org/10.1016/j.clinthera.2024.05.010","t":"","x":"subcutaneous immunoglobulin","c":"immunomodulator","p":"ME/CFS","d":"single-arm","b":0,"n":17,"y":2024,"r":"positive","s":"Low-dose subcutaneous immunoglobulin case series: symptoms, QoL and work ability improved; uncontrolled","v":1,"st":[1]},{"i":"PMID:41121328","u":"https://doi.org/10.1186/s12967-025-07213-8","t":"","x":"sirolimus (rapamycin)","c":"immunomodulator","p":"ME/CFS","d":"single-arm","b":0,"n":86,"y":2025,"r":"positive","s":"Low-dose rapamycin 6 mg/week open-label (n=~86, 70 completed): 74% improved in fatigue, PEM and OI; uncontrolled","v":1,"st":[1,6]},{"i":"PMID:8148460","u":"https://doi.org/10.1093/clinids/18.supplement_1.s88","t":"","x":"rintatolimod","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":92,"y":1994,"r":"positive","s":"Rintatolimod (poly(I).poly(C12U)) vs placebo (n=92): better Karnofsky score, treadmill work, ADL and cognition at 24 wk","v":1,"st":[1,7]},{"i":"PMID:8354926","u":"https://doi.org/10.1093/infdis/168.3.791","t":"","x":"interferon-alpha","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":0,"n":0,"y":1993,"r":"not-assessable","s":"Interferon-alpha in CFS; no abstract available","v":0,"st":[1]},{"i":"PMID:8675231","u":"https://doi.org/10.3109/08820139609059298","t":"","x":"interferon-alpha","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":26,"y":1996,"r":"mixed","s":"Alpha-interferon 12 wk in subgroups (n=~26): QoL improved only in subgroup with isolated NK dysfunction","v":1,"st":[1]},{"i":"PMID:8993764","u":"https://doi.org/10.1007/bf02628663","t":"","x":"transfer factor","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":0,"n":20,"y":1996,"r":"positive","s":"Oral transfer factor pilot, placebo-controlled (n=20): improvement in 12/20; group results not separated","v":1,"st":[]},{"i":"PMID:9201655","u":"https://doi.org/10.1016/s0022-3956(96)00047-7","t":"","x":"IV immunoglobulin","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":71,"y":1997,"r":"mixed","s":"IV gammaglobulin vs placebo in adolescents (n=70): functional improvement at 6 months in both groups; between-group difference reported for IVIG","v":1,"st":[1]},{"i":"PMID:9236484","u":"https://doi.org/10.1016/s0002-9343(97)90045-0","t":"","x":"IV immunoglobulin","c":"immunomodulator","p":"ME/CFS","d":"RCT-placebo","b":1,"n":99,"y":1997,"r":"null","s":"IV immunoglobulin, three doses vs placebo (n=99): no specific benefit at any dose","v":1,"st":[1]},{"i":"NCT01108549","u":"https://clinicaltrials.gov/study/NCT01108549","t":"","x":"D-ribose","c":"metabolic/mitochondrial","p":"ME/CFS","d":"single-arm","b":0,"n":257,"y":2009,"r":"unreported-after-completion","s":"Primary completion 2009-09; no results posted or published abstract found","v":0,"st":[5,6]},{"i":"NCT01471652","u":"https://clinicaltrials.gov/study/NCT01471652","t":"CFS:M","x":"coenzyme Q10 + exercise/rehabilitation","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":0,"y":2012,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[5,6]},{"i":"NCT02063126","u":"https://clinicaltrials.gov/study/NCT02063126","t":"ReConnect","x":"coenzyme Q10","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":80,"y":2013,"r":"positive","s":"CoQ10+NADH (n=80): lower max HR on cycle test and lower fatigue perception vs placebo at 8 weeks","v":1,"st":[5,6]},{"i":"NCT02213679","u":"https://clinicaltrials.gov/study/NCT02213679","t":"","x":"creatine/GAA","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":20,"y":2014,"r":"unreported-after-completion","s":"Primary completion 2015-06; no results posted or published abstract found","v":0,"st":[5,6]},{"i":"NCT02374112","u":"https://clinicaltrials.gov/study/NCT02374112","t":"CREFAS","x":"creatine/GAA","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":60,"y":2016,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT03186027","u":"https://clinicaltrials.gov/study/NCT03186027","t":"CONNeCT","x":"coenzyme Q10 + vitamins/minerals","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":282,"y":2017,"r":"mixed","s":"CoQ10 200 mg + NADH 20 mg vs placebo for 12 weeks (n=207 analysed): within-group falls in cognitive fatigue and FIS-40 and better SF-36 and sleep on active; abstract reports within-group changes, not clear between-group superiority","v":1,"st":[5,6]},{"i":"NCT05013606","u":"https://clinicaltrials.gov/study/NCT05013606","t":"H2CFS","x":"molecular hydrogen","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":23,"y":2019,"r":"unreported-after-completion","s":"Primary completion 2021-04-01; no results posted or published abstract found","v":0,"st":[5,6]},{"i":"NCT05128292","u":"https://clinicaltrials.gov/study/NCT05128292","t":"CoSeME","x":"coenzyme Q10","c":"metabolic/mitochondrial","p":"ME/CFS","d":"single-arm","b":0,"n":42,"y":2018,"r":"unreported-after-completion","s":"Primary completion 2018-09-01; no results posted or published abstract found","v":0,"st":[5,6]},{"i":"NCT05273372","u":"https://clinicaltrials.gov/study/NCT05273372","t":"","x":"oxaloacetate","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":82,"y":2022,"r":"positive","s":"RESTORE ME oxaloacetate (n=82): fatigue down >25% vs ~10% in controls (p=0.0039)","v":1,"st":[5,6]},{"i":"NCT06227273","u":"https://clinicaltrials.gov/study/NCT06227273","t":"","x":"molecular hydrogen","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":50,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-11-01; no results posted or published abstract found","v":0,"st":[5,6]},{"i":"NCT07009691","u":"https://clinicaltrials.gov/study/NCT07009691","t":"","x":"molecular hydrogen","c":"metabolic/mitochondrial","p":"ME/CFS","d":"single-arm","b":0,"n":50,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT07753122","u":"https://clinicaltrials.gov/study/NCT07753122","t":"ME/CFS","x":"molecular hydrogen","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":80,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"PMID:10071523","u":"https://doi.org/10.1016/s1081-1206(10)62595-1","t":"","x":"NADH","c":"metabolic/mitochondrial","p":"ME/CFS","d":"crossover","b":1,"n":26,"y":1999,"r":"positive","s":"Oral NADH vs placebo, crossover (n=26): 31% vs 8% responders","v":1,"st":[5,6]},{"i":"PMID:15039515","u":"https://doi.org/10.1097/01.psy.0000116249.60477.e9","t":"","x":"acetyl-L-carnitine / propionyl-L-carnitine","c":"metabolic/mitochondrial","p":"ME/CFS","d":"open-label","b":0,"n":90,"y":2004,"r":"positive","s":"Acetylcarnitine, propionylcarnitine or both, open-label randomised (n=90): fatigue and attention improved with single agents","v":1,"st":[5,6]},{"i":"PMID:15377055","u":"https://pubmed.ncbi.nlm.nih.gov/15377055/","t":"","x":"NADH","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-active","b":0,"n":31,"y":2004,"r":"mixed","s":"NADH vs conventional therapy (n=31): large symptom drop in first 3 months, similar later","v":1,"st":[5,6]},{"i":"PMID:17109576","u":"https://doi.org/10.1089/acm.2006.12.857","t":"","x":"D-ribose","c":"metabolic/mitochondrial","p":"ME/CFS","d":"single-arm","b":0,"n":41,"y":2006,"r":"positive","s":"D-ribose open-label pilot in CFS/FM (n=41): energy, sleep and well-being improved; uncontrolled","v":1,"st":[5,6]},{"i":"PMID:20447621","u":"https://doi.org/10.1016/j.rce.2009.09.015","t":"","x":"NADH","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":86,"y":2010,"r":"null","s":"Oral NADH vs placebo (n=86, Spain): no difference in most outcomes incl. global function; lower anxiety and max heart rate only","v":1,"st":[5,6]},{"i":"PMID:26840330","u":"https://doi.org/10.3390/nu8020072","t":"","x":"guanidinoacetic acid","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":21,"y":2016,"r":"mixed","s":"Guanidinoacetic acid vs placebo in women (n=~21): better creatine metabolism and work capacity; no effect on fatigue or soreness","v":1,"st":[5,6]},{"i":"PMID:27125909","u":"https://doi.org/10.1002/biof.1293","t":"","x":"ubiquinol (CoQ10)","c":"metabolic/mitochondrial","p":"ME/CFS","d":"RCT-placebo","b":1,"n":43,"y":2016,"r":"positive","s":"Ubiquinol-10 vs placebo (n=43, 31 completed): improved several symptoms, autonomic and cognitive function","v":1,"st":[5,6]},{"i":"PMID:29602463","u":"https://doi.org/10.1016/j.mehy.2018.03.002","t":"","x":"sodium dichloroacetate","c":"metabolic/mitochondrial","p":"ME/CFS","d":"single-arm","b":0,"n":22,"y":2018,"r":"mixed","s":"Sodium dichloroacetate open-label (n=22): 10 improved substantially, 12 no benefit","v":1,"st":[]},{"i":"PMID:37929512","u":"https://doi.org/10.4103/2045-9912.385441","t":"","x":"hydrogen gas inhalation","c":"metabolic/mitochondrial","p":"ME/CFS","d":"single-arm","b":0,"n":4,"y":2024,"r":"not-assessable","s":"Hydrogen gas inhalation, four case reports; no abstract","v":0,"st":[5,6]},{"i":"PMID:39408275","u":"https://doi.org/10.3390/nu16193308","t":"","x":"creatine","c":"metabolic/mitochondrial","p":"ME/CFS","d":"single-arm","b":0,"n":11,"y":2024,"r":"positive","s":"Creatine 6 weeks open-label MRS study (n=11): brain creatine up, less fatigue, faster Stroop, better grip","v":1,"st":[5,6]},{"i":"NCT03691987","u":"https://clinicaltrials.gov/study/NCT03691987","t":"","x":"microbiome therapy","c":"microbiome","p":"ME/CFS","d":"RCT-placebo","b":1,"n":80,"y":2019,"r":"unreported-after-completion","s":"Comeback FMT trial: only protocol published","v":0,"st":[1,7]},{"i":"NCT04158427","u":"https://clinicaltrials.gov/study/NCT04158427","t":"","x":"microbiome therapy","c":"microbiome","p":"ME/CFS","d":"RCT-placebo","b":1,"n":13,"y":2020,"r":"null","s":"FMT pilot (n=13): no improvement in symptoms or HRQoL vs placebo","v":1,"st":[1,7]},{"i":"NCT04741841","u":"https://clinicaltrials.gov/study/NCT04741841","t":"","x":"microbiome therapy","c":"microbiome","p":"ME/CFS","d":"RCT-placebo","b":1,"n":74,"y":2020,"r":"unreported-after-completion","s":"Primary completion 2021-03-30; no results posted or published abstract found","v":0,"st":[1,7]},{"i":"NCT06211062","u":"https://clinicaltrials.gov/study/NCT06211062","t":"","x":"microbiome therapy","c":"microbiome","p":"ME/CFS","d":"RCT-placebo","b":1,"n":100,"y":2022,"r":"pending","s":"No results yet","v":0,"st":[1,7]},{"i":"PMID:19338686","u":"https://doi.org/10.1186/1757-4749-1-6","t":"","x":"Lactobacillus casei Shirota probiotic","c":"microbiome","p":"ME/CFS","d":"RCT-placebo","b":0,"n":39,"y":2009,"r":"mixed","s":"Lactobacillus casei Shirota vs placebo (n=39): anxiety reduced; fatigue not primary","v":1,"st":[1,7]},{"i":"PMID:41515290","u":"https://doi.org/10.3390/nu18010174","t":"","x":"multi-strain probiotic","c":"microbiome","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2026,"r":"positive","s":"Multi-strain probiotic (CDS22) in CFS with IBS: symptom remission with tryptophan metabolism shift; small","v":1,"st":[1,7]},{"i":"ACTRN12614001077651","u":"https://doi.org/10.1186/s12967-018-1392-z","t":"","x":"antibiotic + CBT/psychological therapy","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":44,"y":2018,"r":"mixed","s":"Open-label erythromycin + probiotic for gut dysbiosis (n=~44): microbial shifts associated with some symptom changes","v":1,"st":[1,2]},{"i":"CHICTR1800017590","u":"https://doi.org/10.1016/j.ctcp.2020.101210","t":"","x":"cupping","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":96,"y":2020,"r":"positive","s":"Cupping, single-blind RCT of pressures and session numbers (n=~96): fatigue improved; no sham","v":1,"st":[]},{"i":"CHICTR2000041000","u":"https://doi.org/10.1186/s12967-023-04250-z","t":"","x":"moxibustion","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2023,"r":"positive","s":"Long-snake moxibustion 60 vs 30 min, dose-effect RCT: longer sessions better; no inactive control","v":1,"st":[]},{"i":"CHICTR2200056530","u":"https://doi.org/10.1016/j.ctim.2026.103353","t":"","x":"abdominal massage (Nine Turn method)","c":"other","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":0,"y":2023,"r":"positive","s":"Nine Turn abdominal massage vs control: MFI-20 fell; GI symptoms and microbiota changed","v":1,"st":[]},{"i":"ISRCTN02536681","u":"https://doi.org/10.4088/jcp.08m04719whi","t":"","x":"ondansetron","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":67,"y":2010,"r":"null","s":"Ondansetron vs placebo (n=67): no benefit for fatigue or function","v":1,"st":[2]},{"i":"ISRCTN31455243","u":"https://www.isrctn.com/ISRCTN31455243","t":"","x":"Healthcare Evaluation and Assessment of Patients with Chronic Fatigue Syndrome (","c":"other","p":"ME/CFS","d":"RCT-unspecified","b":0,"n":60,"y":2000,"r":"unreported-after-completion","s":"Registry record only; no results read; outputs listed on registry","v":0,"st":[]},{"i":"ISRCTN58998320","u":"https://www.isrctn.com/ISRCTN58998320","t":"","x":"A novel online program for fatigue; a feasibility study","c":"other","p":"ME/CFS","d":"RCT-unspecified","b":0,"n":200,"y":2019,"r":"unreported-after-completion","s":"Registry record only; no results read","v":0,"st":[]},{"i":"ISRCTN74088209","u":"https://www.isrctn.com/ISRCTN74088209","t":"ReMEdi","x":"ReMEdi","c":"other","p":"ME/CFS","d":"unclear","b":0,"n":25,"y":2025,"r":"pending","s":"Registry record only; no results read","v":0,"st":[]},{"i":"KCT0000508","u":"https://doi.org/10.1186/s13063-015-0857-0","t":"","x":"acupuncture","c":"other","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":150,"y":2015,"r":"positive","s":"Acupuncture (body or sa-am) + usual care vs usual care (n=150): FSS lower at 5 weeks in one arm; non-blinded","v":1,"st":[]},{"i":"NCT00375973","u":"https://clinicaltrials.gov/study/NCT00375973","t":"CFS","x":"antidepressant","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":60,"y":2006,"r":"null","s":"Duloxetine (n=60): primary MFI general fatigue not improved vs placebo (P=0.23); some secondary measures improved","v":1,"st":[2]},{"i":"NCT00498485","u":"https://clinicaltrials.gov/study/NCT00498485","t":"","x":"sleep treatment","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":17,"y":2007,"r":"mixed","s":"Sodium oxybate (Xyrem) vs placebo for sleep in CFS (terminated, n=17): posted global change p<0.04 on tiny sample; sleep outcome not posted","v":1,"st":[8]},{"i":"NCT01071044","u":"https://clinicaltrials.gov/study/NCT01071044","t":"","x":"stimulant","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":26,"y":2009,"r":"positive","s":"Lisdexamfetamine vs placebo (n=26): BRIEF-A executive function improved (21.4 vs 3.4, p=0.005); also less fatigue in published paper","v":1,"st":[2]},{"i":"NCT01368718","u":"https://clinicaltrials.gov/study/NCT01368718","t":"","x":"sleep treatment","c":"other","p":"ME/CFS","d":"crossover","b":1,"n":5,"y":2012,"r":"unreported-after-completion","s":"Primary completion 2015-12; no results posted or published abstract found","v":0,"st":[8]},{"i":"NCT01534130","u":"https://clinicaltrials.gov/study/NCT01534130","t":"","x":"acupuncture/manual therapy","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":72,"y":2011,"r":"unreported-after-completion","s":"Primary completion 2012-08; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT01584934","u":"https://clinicaltrials.gov/study/NCT01584934","t":"","x":"sleep treatment","c":"other","p":"ME/CFS","d":"crossover","b":1,"n":0,"y":2013,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[8]},{"i":"NCT01742013","u":"https://clinicaltrials.gov/study/NCT01742013","t":"","x":"GCJBP Laennec Inj.","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":78,"y":2013,"r":"unreported-after-completion","s":"Primary completion 2013-08; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT01793415","u":"https://clinicaltrials.gov/study/NCT01793415","t":"","x":"IodoCarb (r)","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":40,"y":2013,"r":"unreported-after-completion","s":"Primary completion 2013-12; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT01907711","u":"https://clinicaltrials.gov/study/NCT01907711","t":"AV/AS","x":"acupuncture/manual therapy","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":60,"y":2013,"r":"unreported-after-completion","s":"Primary completion 2014-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT01966276","u":"https://clinicaltrials.gov/study/NCT01966276","t":"","x":"stimulant","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":134,"y":2013,"r":"unreported-after-completion","s":"Primary completion 2014-12; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT02055898","u":"https://clinicaltrials.gov/study/NCT02055898","t":"SAFFE","x":"sleep treatment","c":"other","p":"ME/CFS","d":"crossover","b":1,"n":13,"y":2014,"r":"mixed","s":"SAFFE: sodium oxybate vs placebo, crossover (n=13): increased slow-wave sleep activity; daytime function not in primary outcome","v":1,"st":[8]},{"i":"NCT02082730","u":"https://clinicaltrials.gov/study/NCT02082730","t":"ASARM","x":"sleep treatment + CBT/psychological therapy","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":20,"y":2013,"r":"unreported-after-completion","s":"Primary completion 2014-08-01; no results posted or published abstract found","v":0,"st":[2,8]},{"i":"NCT02924831","u":"https://clinicaltrials.gov/study/NCT02924831","t":"","x":"acupuncture/manual therapy","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":210,"y":2016,"r":"mixed","s":"Acupuncture vs moxibustion (active comparison): different short- vs long-term HRV effects; no placebo arm","v":1,"st":[]},{"i":"NCT02964533","u":"https://clinicaltrials.gov/study/NCT02964533","t":"","x":"acupuncture/manual therapy","c":"other","p":"ME/CFS","d":"RCT-active","b":1,"n":70,"y":2016,"r":"unreported-after-completion","s":"Primary completion 2017-02; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT03000777","u":"https://clinicaltrials.gov/study/NCT03000777","t":"MELATOZINC","x":"sleep treatment","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":60,"y":2016,"r":"positive","s":"Melatonin+zinc (n=60): fatigue (FIS-40) and SF-36 physical component improved vs placebo at 16 weeks","v":1,"st":[8]},{"i":"NCT03613129","u":"https://clinicaltrials.gov/study/NCT03613129","t":"InTiME","x":"CT38","c":"other","p":"ME/CFS","d":"open-label","b":0,"n":14,"y":2018,"r":"positive","s":"CT38 (CRFR2 agonist) single dose, open-label (n=17): sustained symptom improvement reported; uncontrolled","v":1,"st":[]},{"i":"NCT04174300","u":"https://clinicaltrials.gov/study/NCT04174300","t":"","x":"acupuncture/manual therapy","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":40,"y":2019,"r":"unreported-after-completion","s":"Primary completion 2020-03-10; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04301609","u":"https://clinicaltrials.gov/study/NCT04301609","t":"","x":"sleep treatment","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":67,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-12-30; no results posted or published abstract found","v":0,"st":[8]},{"i":"NCT04622293","u":"https://clinicaltrials.gov/study/NCT04622293","t":"","x":"stimulant","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":44,"y":2021,"r":"positive","s":"Solriamfetol (n=44): fatigue (FSI) better than placebo at week 8 (p=0.039) but not week 6; small trial","v":1,"st":[2]},{"i":"NCT05454683","u":"https://clinicaltrials.gov/study/NCT05454683","t":"MelatoZincME","x":"sleep treatment + magnesium","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":106,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2024-09-30; no results posted or published abstract found","v":0,"st":[8]},{"i":"NCT07317401","u":"https://clinicaltrials.gov/study/NCT07317401","t":"REenergizeME","x":"Intermittent hypoxia-hyperoxia treatment (IHHT)","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":104,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07621068","u":"https://clinicaltrials.gov/study/NCT07621068","t":"HBOT-ME/CFS","x":"hyperbaric oxygen","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":74,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"PMID:10336228","u":"https://doi.org/10.1046/j.1440-1614.1999.00532.x","t":"","x":"nefazodone","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":10,"y":1999,"r":"positive","s":"Nefazodone open-label (n=10): 80% some fatigue improvement; uncontrolled","v":1,"st":[2]},{"i":"PMID:10990148","u":"https://doi.org/10.1016/s1096-6374(98)80037-3","t":"","x":"growth hormone","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":20,"y":1998,"r":"null","s":"Growth hormone vs placebo then open-label (n=20): no QoL improvement","v":1,"st":[2]},{"i":"PMID:11028837","u":"https://doi.org/10.1080/030097400750001851-1","t":"","x":"5-HT3 antagonists (tropisetron, ondansetron)","c":"other","p":"ME/CFS","d":"single-arm","b":1,"n":20,"y":2000,"r":"positive","s":"Tropisetron or ondansetron open-label (n=20): preliminary improvement reported","v":1,"st":[2]},{"i":"PMID:11030484","u":"https://doi.org/10.4088/jcp.v61n0909","t":"","x":"moclobemide","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":90,"y":2000,"r":"mixed","s":"Moclobemide vs placebo (n=90): 51% vs 33% improved, not significant (OR 2.16, CI 0.9-5.1); more vigour","v":1,"st":[2]},{"i":"PMID:12423324","u":"https://doi.org/10.1046/j.1365-2362.2002.01058.x","t":"","x":"melatonin / phototherapy","c":"other","p":"ME/CFS","d":"crossover","b":0,"n":42,"y":2002,"r":"null","s":"Melatonin and bright-light therapy vs placebo (n=42, crossover): no symptomatic improvement","v":1,"st":[8]},{"i":"PMID:12515836","u":"https://doi.org/10.1176/appi.psy.44.1.38","t":"","x":"dexamphetamine","c":"other","p":"ME/CFS","d":"RCT-placebo","b":0,"n":20,"y":2003,"r":"positive","s":"Dexamphetamine vs placebo pilot (n=20): FSS improved (9/10 vs 4/10)","v":1,"st":[2]},{"i":"PMID:12829200","u":"https://doi.org/10.1016/s0002-9343(03)00182-7","t":"","x":"hydrocortisone + fludrocortisone","c":"other","p":"ME/CFS","d":"crossover","b":1,"n":100,"y":2003,"r":"null","s":"Hydrocortisone + fludrocortisone vs placebo, crossover (n=100): no improvement in fatigue or well-being","v":1,"st":[2,3]},{"i":"PMID:12927008","u":"https://doi.org/10.4088/jcp.v64n0811","t":"","x":"citalopram","c":"other","p":"ME/CFS","d":"RCT-placebo","b":0,"n":0,"y":2003,"r":"mixed","s":"Citalopram for idiopathic chronic fatigue: some fatigue improvement in subgroups; overall comparison not significant","v":1,"st":[2]},{"i":"PMID:1450297","u":"https://doi.org/10.1016/0006-3223(92)90087-g","t":"","x":"bupropion","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":9,"y":1992,"r":"positive","s":"Bupropion in fluoxetine-resistant CFS, open-label (n=~9): depression scores improved","v":1,"st":[2]},{"i":"PMID:14692441","u":"https://pubmed.ncbi.nlm.nih.gov/14692441/","t":"","x":"granisetron","c":"other","p":"ME/CFS","d":"single-arm","b":1,"n":10,"y":2003,"r":"positive","s":"Granisetron open-label pilot (n=10): less fatigue and impairment; no change in activity","v":1,"st":[2]},{"i":"PMID:15016577","u":"https://doi.org/10.1016/s0022-3999(03)00377-5","t":"","x":"homeopathy","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":103,"y":2004,"r":"mixed","s":"Individualised homeopathy vs placebo (n=103): better on MFI general fatigue, not other scales; weak, equivocal","v":1,"st":[]},{"i":"PMID:15353532","u":"https://doi.org/10.1001/jama.292.10.1195","t":"","x":"galantamine","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":434,"y":2004,"r":"null","s":"Galantamine (3 doses) vs placebo (n=434): no benefit on any outcome","v":1,"st":[2]},{"i":"PMID:16136935","u":"https://pubmed.ncbi.nlm.nih.gov/16136935/","t":"","x":"acupuncture + Chinese patent medicines","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2005,"r":"not-assessable","s":"Acupuncture and Chinese patent drugs (2005); no abstract","v":0,"st":[]},{"i":"PMID:16248250","u":"https://pubmed.ncbi.nlm.nih.gov/16248250/","t":"","x":"electroacupuncture","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2005,"r":"positive","s":"Electroacupuncture on back-shu points: FAI and SCL-90 fell; low quality","v":1,"st":[]},{"i":"PMID:16272188","u":"https://doi.org/10.1177/0269881105056531","t":"","x":"modafinil","c":"other","p":"ME/CFS","d":"crossover","b":1,"n":14,"y":2005,"r":"null","s":"Modafinil 200 and 400 mg vs placebo, crossover (n=14): no effect on fatigue or QoL; mixed cognitive effects","v":1,"st":[2]},{"i":"PMID:16318125","u":"https://pubmed.ncbi.nlm.nih.gov/16318125/","t":"","x":"electroacupuncture","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2005,"r":"positive","s":"Electroacupuncture, uncontrolled: FAI scores fell; low quality","v":1,"st":[]},{"i":"PMID:16415546","u":"https://doi.org/10.2169/internalmedicine.44.1258","t":"","x":"minocycline / doxycycline","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":58,"y":2005,"r":"null","s":"Antibiotics (minocycline or doxycycline) in C. burnetii-positive CFS (n=4) and Q-fever fatigue: no significant symptom change in CFS group","v":1,"st":[1]},{"i":"PMID:16420393","u":"https://doi.org/10.1111/j.1468-1331.2006.01132.x","t":"","x":"melatonin","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":29,"y":2006,"r":"positive","s":"Melatonin open-label in CFS with late DLMO (n=29): fatigue, concentration and activity improved; uncontrolled","v":1,"st":[8]},{"i":"PMID:16443425","u":"https://doi.org/10.1016/j.amjmed.2005.07.047","t":"","x":"methylphenidate","c":"other","p":"ME/CFS","d":"crossover","b":1,"n":60,"y":2006,"r":"positive","s":"Methylphenidate 10 mg bid vs placebo, crossover (n=60): less fatigue and better concentration in a minority","v":1,"st":[2]},{"i":"PMID:16809351","u":"https://doi.org/10.1093/qjmed/hcl063","t":"","x":"BioBran MGN-3","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":71,"y":2006,"r":"null","s":"BioBran MGN-3 (NK cell stimulant) vs placebo (n=71): no difference; both groups improved","v":1,"st":[2]},{"i":"PMID:16871471","u":"https://doi.org/10.1055/s-2006-946706","t":"","x":"bupropion","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":1,"y":2006,"r":"positive","s":"Bupropion augmentation of paroxetine, single case: rapid relief","v":1,"st":[2]},{"i":"PMID:17078435","u":"https://pubmed.ncbi.nlm.nih.gov/17078435/","t":"","x":"electroacupuncture + auricular plaster","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":32,"y":2006,"r":"positive","s":"Electroacupuncture + auricular plaster vs Western drugs (n=32): 94% vs 75% \"effective rate\"; low quality","v":1,"st":[]},{"i":"PMID:17710799","u":"https://pubmed.ncbi.nlm.nih.gov/17710799/","t":"","x":"acupuncture/manual therapy + CBT/psychological therapy","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":310,"y":2007,"r":"positive","s":"Acupuncture + moxibustion + psychological approach, case series (n=310): 89% \"clinically cured\"; uncontrolled, low quality","v":1,"st":[2]},{"i":"PMID:17804135","u":"https://doi.org/10.1016/j.pnpbp.2007.07.019","t":"","x":"escitalopram","c":"other","p":"ME/CFS","d":"single-arm","b":1,"n":0,"y":2008,"r":"positive","s":"Escitalopram open-label in CFS with major depression: fatigue, PEM, sleep and cognition scores fell; uncontrolled","v":1,"st":[2]},{"i":"PMID:17997936","u":"https://doi.org/10.3736/jcim20070606","t":"","x":"acupuncture","c":"other","p":"ME/CFS","d":"RCT-active","b":1,"n":0,"y":2007,"r":"positive","s":"Acupuncture vs control in Hong Kong: larger fatigue and QoL improvements","v":1,"st":[]},{"i":"PMID:18085145","u":"https://pubmed.ncbi.nlm.nih.gov/18085145/","t":"","x":"acupressure + massage","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":85,"y":2007,"r":"positive","s":"Acupressure + massage, uncontrolled (n=85): 92% \"effective\"; low quality","v":1,"st":[]},{"i":"PMID:18277062","u":"https://doi.org/10.1159/000116609","t":"","x":"distant healing","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":409,"y":2008,"r":"null","s":"EUHEALS distant healing vs no healing, partially blinded (n=409): no effect on mental or physical health","v":1,"st":[]},{"i":"PMID:18310583","u":"https://doi.org/10.1192/bjp.bp.106.031815","t":"","x":"CBT / mirtazapine","c":"other","p":"ME/CFS","d":"RCT-placebo","b":0,"n":140,"y":2008,"r":"positive","s":"Computerised CBT vs mirtazapine vs placebo in chronic fatigue/neurasthenia (n=~140): CCBT then mirtazapine sequence best","v":1,"st":[2]},{"i":"PMID:18630535","u":"https://pubmed.ncbi.nlm.nih.gov/18630535/","t":"","x":"cupping","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":97,"y":2008,"r":"positive","s":"Multiple cupping vs acupuncture (n=~97): 98% vs 80% \"effective rate\"; low quality","v":1,"st":[]},{"i":"PMID:19078357","u":"https://doi.org/10.1097/00124743-199904000-00004","t":"","x":"DHEA","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":23,"y":1999,"r":"positive","s":"DHEA open-label pilot: reduced pain, fatigue and cognitive complaints; uncontrolled","v":1,"st":[2]},{"i":"PMID:1912132","u":"https://doi.org/10.1016/0006-3223(91)90297-y","t":"","x":"nortriptyline","c":"other","p":"ME/CFS","d":"n-of-1","b":0,"n":1,"y":1991,"r":"not-assessable","s":"Nortriptyline n-of-1 single case; no abstract","v":0,"st":[2]},{"i":"PMID:19226895","u":"https://doi.org/10.1016/s0254-6272(09)60007-8","t":"","x":"abdominal acupuncture","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":40,"y":2008,"r":"positive","s":"Bo's abdominal acupuncture case series (n=40): symptom scores fell; uncontrolled","v":1,"st":[]},{"i":"PMID:19514184","u":"https://doi.org/10.1016/s0254-6272(09)60026-1","t":"","x":"massage","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2009,"r":"positive","s":"Intelligent-turtle massage vs control: better symptom scores; low quality","v":1,"st":[]},{"i":"PMID:19685727","u":"https://pubmed.ncbi.nlm.nih.gov/19685727/","t":"","x":"acupuncture","c":"other","p":"ME/CFS","d":"RCT-placebo","b":0,"n":64,"y":2009,"r":"mixed","s":"Acupuncture at acupoints vs non-acupoints (n=64): both improved; acupoints better only for mental fatigue","v":1,"st":[]},{"i":"PMID:19873911","u":"https://pubmed.ncbi.nlm.nih.gov/19873911/","t":"","x":"acupuncture","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":0,"y":2009,"r":"mixed","s":"Acupuncture vs non-acupoint acupuncture: physical QoL domain improved; other domains unchanged","v":1,"st":[]},{"i":"PMID:20862932","u":"https://pubmed.ncbi.nlm.nih.gov/20862932/","t":"","x":"acupuncture","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2010,"r":"positive","s":"Acupuncture vs Shenmai injection: larger fatigue reduction with acupuncture; low quality","v":1,"st":[]},{"i":"PMID:21112746","u":"https://doi.org/10.1016/j.euroneuro.2010.10.008","t":"","x":"antidepressant + amisulpride","c":"other","p":"ME/CFS","d":"RCT-active","b":1,"n":0,"y":2011,"r":"positive","s":"Amisulpride vs fluoxetine pilot in CFS (2011): amisulpride reported better; low quality","v":1,"st":[2]},{"i":"PMID:21246855","u":"https://pubmed.ncbi.nlm.nih.gov/21246855/","t":"","x":"Tuina massage","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":90,"y":2010,"r":"positive","s":"Tuina vs Taijiquan vs fluoxetine (n=90): Tuina \"effective rate\" 93% vs 80% vs 73%; low quality","v":1,"st":[]},{"i":"PMID:22379791","u":"https://pubmed.ncbi.nlm.nih.gov/22379791/","t":"","x":"acupuncture","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2011,"r":"positive","s":"Back-shu acupuncture vs control: fatigue and some SF-20 domains improved; low quality","v":1,"st":[]},{"i":"PMID:22471128","u":"https://pubmed.ncbi.nlm.nih.gov/22471128/","t":"","x":"acupuncture + cupping","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":72,"y":2012,"r":"positive","s":"Coiling-dragon needling + cupping vs prednisone: 92% vs 71% \"effective rate\"; low quality","v":1,"st":[]},{"i":"PMID:22679716","u":"https://pubmed.ncbi.nlm.nih.gov/22679716/","t":"","x":"Tuina massage","c":"other","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":0,"y":2012,"r":"positive","s":"Tuina vs control: FACIT fatigue improved and muscle mechanics better; low quality","v":1,"st":[]},{"i":"PMID:22757691","u":"https://doi.org/10.1089/acm.2011.0503","t":"","x":"moxibustion","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":45,"y":2013,"r":"positive","s":"Indirect moxibustion vs sham (n=~45, chronic fatigue): lower fatigue NRS and VAS; antioxidant changes","v":1,"st":[]},{"i":"PMID:23682549","u":"https://pubmed.ncbi.nlm.nih.gov/23682549/","t":"","x":"hyperbaric oxygen","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":16,"y":2013,"r":"positive","s":"Hyperbaric oxygen, uncontrolled (n=~16): fatigue and QoL scores improved","v":1,"st":[5,6]},{"i":"PMID:23981369","u":"https://pubmed.ncbi.nlm.nih.gov/23981369/","t":"","x":"acupuncture","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":150,"y":2013,"r":"positive","s":"Acupuncture vs sham (n=~150, single-blind): moderate reductions in physical and mental fatigue","v":1,"st":[]},{"i":"PMID:24617226","u":"https://pubmed.ncbi.nlm.nih.gov/24617226/","t":"","x":"acupuncture/manual therapy + herbal/TCM","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2013,"r":"positive","s":"Time-selective acupuncture vs standard acupuncture: fatigue fell in both, more for mental fatigue; low quality","v":1,"st":[]},{"i":"PMID:24636462","u":"https://doi.org/10.1016/j.euroneuro.2014.02.010","t":"","x":"antidepressant + sleep treatment","c":"other","p":"ME/CFS","d":"open-label","b":0,"n":0,"y":2014,"r":"positive","s":"Agomelatine vs melatonin, open-label sequential: agomelatine reduced fatigue; melatonin did not","v":1,"st":[2,8]},{"i":"PMID:25748743","u":"https://doi.org/10.2169/internalmedicine.54.3042","t":"","x":"Waon thermal therapy","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":10,"y":2015,"r":"positive","s":"Waon (thermal) therapy pilot, uncontrolled (n=~10): fatigue and mood improved","v":1,"st":[]},{"i":"PMID:26056862","u":"https://doi.org/10.1089/acm.2014.0271","t":"","x":"music therapy","c":"other","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":0,"y":2015,"r":"positive","s":"Oriental medicine music therapy vs wait list in idiopathic chronic fatigue: lower FSS and VAS","v":1,"st":[]},{"i":"PMID:26742307","u":"https://doi.org/10.1016/s0254-6272(15)30152-7","t":"","x":"Lixujieyu recipe + music therapy","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2015,"r":"positive","s":"Lixujieyu recipe + five-elements music therapy vs control: fatigue relieved; low quality","v":1,"st":[]},{"i":"PMID:26779319","u":"https://doi.org/10.1016/j.slsci.2015.10.001","t":"","x":"antibiotic + sleep treatment","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":20,"y":2015,"r":"mixed","s":"Short-course antibiotics for gut microbiota imbalance, pilot (n=~20): gut changes not sustained; some sleep and mood gains in responders","v":1,"st":[1,8]},{"i":"PMID:26911970","u":"https://doi.org/10.1248/bpb.b15-00623","t":"","x":"human placental extract","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":0,"y":2016,"r":"mixed","s":"Human placental extract injections vs placebo in chronic fatigue: no overall difference; benefit in CFS subgroup only","v":1,"st":[]},{"i":"PMID:26939325","u":"https://pubmed.ncbi.nlm.nih.gov/26939325/","t":"","x":"moxibustion","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":72,"y":2015,"r":"positive","s":"Moxibustion at BL43 vs acupuncture (n=72): 89% vs 72% \"effective rate\"; low quality","v":1,"st":[]},{"i":"PMID:27886247","u":"https://doi.org/10.1038/srep37846","t":"","x":"acupuncture / moxibustion","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2016,"r":"positive","s":"Acupuncture vs moxibustion, pilot: both reduced fatigue; moxibustion better long-term","v":1,"st":[]},{"i":"PMID:28408193","u":"https://doi.org/10.1016/s2215-0366(17)30126-8","t":"","x":"imipramine","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":138,"y":2017,"r":"positive","s":"STreSS-3: imipramine vs placebo in multiple functional somatic syndromes incl. CFS (n=138): better overall health","v":1,"st":[2]},{"i":"PMID:28721090","u":"https://doi.org/10.2147/jpr.s139466","t":"","x":"lidocaine muscle injections","c":"other","p":"ME/CFS","d":"crossover","b":1,"n":0,"y":2017,"r":"positive","s":"Lidocaine vs saline trigger-point muscle injections, crossover: fatigue fell more after lidocaine (p=0.03)","v":1,"st":[]},{"i":"PMID:29212562","u":"https://doi.org/10.1017/neu.2017.35","t":"","x":"(-)-OSU6162 monoamine stabiliser","c":"other","p":"ME/CFS","d":"crossover","b":0,"n":60,"y":2018,"r":"null","s":"(-)-OSU6162 vs placebo, crossover (n=60): no overall difference; subgroup on antidepressants benefited","v":1,"st":[2]},{"i":"PMID:29231339","u":"https://doi.org/10.13703/j.0255-2930.2017.08.004","t":"","x":"acupoint catgut embedding + moxibustion","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2017,"r":"positive","s":"Acupoint catgut embedding + ginger moxibustion vs acupuncture: lower symptom scores; low quality","v":1,"st":[]},{"i":"PMID:29938480","u":"https://doi.org/10.23736/s0390-5616.18.04384-9","t":"","x":"Robuvit (French oak wood extract)","c":"other","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":0,"y":2018,"r":"positive","s":"Robuvit supplementation vs control: better mood, fatigue and insomnia; low quality","v":1,"st":[8]},{"i":"PMID:30942028","u":"https://doi.org/10.13703/j.0255-2930.2019.02.003","t":"","x":"acupuncture/manual therapy + herbal/TCM","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2019,"r":"positive","s":"Acupuncture (brain-kidney) vs control: fatigue, sleep and IL-6 improved; low quality","v":1,"st":[]},{"i":"PMID:30942029","u":"https://doi.org/10.13703/j.0255-2930.2019.02.004","t":"","x":"acupuncture/manual therapy + herbal/TCM","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":120,"y":2019,"r":"positive","s":"Auricular gold-needle vs auricular pressure vs herbs (n=120): 90% vs 80% vs 83% \"effective rate\"; low quality","v":1,"st":[]},{"i":"PMID:32869588","u":"https://doi.org/10.13703/j.0255-2930.20190722-k0001","t":"","x":"acupuncture/manual therapy + sleep treatment","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2020,"r":"positive","s":"Ginger-separated moxibustion vs control: better SF-36, sleep and depression; low quality","v":1,"st":[8]},{"i":"PMID:33068345","u":"https://doi.org/10.13703/j.0255-2930.20190801-k0006","t":"","x":"scraping (gua sha) + tuina","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":96,"y":2020,"r":"positive","s":"Head-face scraping + tuina vs control (n=96): 92% vs 54% \"effective rate\"; low quality","v":1,"st":[]},{"i":"PMID:33528911","u":"https://doi.org/10.1002/brb3.2040","t":"","x":"(-)-OSU6162 monoamine stabiliser","c":"other","p":"ME/CFS","d":"single-arm","b":1,"n":33,"y":2021,"r":"positive","s":"(-)-OSU6162 open-label (n=33): improved global impression, fatigue and mood; uncontrolled","v":1,"st":[2]},{"i":"PMID:33536023","u":"https://doi.org/10.1186/s12967-021-02721-9","t":"","x":"low-dose aripiprazole","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":101,"y":2021,"r":"not-assessable","s":"Low-dose aripiprazole retrospective review in ME/CFS; no abstract available; result not verified","v":0,"st":[2]},{"i":"PMID:33798308","u":"https://doi.org/10.13703/j.0255-2930.20200210-k0001","t":"","x":"moxibustion","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2021,"r":"positive","s":"Ginger moxibustion vs control: FS-14 fell more; gut flora change; low quality","v":1,"st":[]},{"i":"PMID:35473345","u":"https://doi.org/10.19852/j.cnki.jtcm.20211214.003","t":"","x":"moxibustion + acupuncture","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":90,"y":2022,"r":"positive","s":"Ginger moxibustion + acupuncture vs acupuncture (n=~90): better FSS at 4 weeks","v":1,"st":[]},{"i":"PMID:36397215","u":"https://doi.org/10.13703/j.0255-2930.20220124-k0006","t":"","x":"electroacupuncture","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":0,"y":2022,"r":"positive","s":"Electroacupuncture vs sham EA: lower FS-14 and changed cortical excitability","v":1,"st":[]},{"i":"PMID:37161800","u":"https://doi.org/10.13703/j.0255-2930.20220818-k0001","t":"","x":"moxibustion","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2023,"r":"positive","s":"Bamboo medicinal moxibustion vs acupuncture: lower FS-14 and SPHERE; low quality","v":1,"st":[]},{"i":"PMID:37230457","u":"https://doi.org/10.1016/j.cryobiol.2023.05.003","t":"","x":"whole-body cryotherapy + static stretching","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":32,"y":2023,"r":"positive","s":"Whole-body cryotherapy + stretching, uncontrolled (n=32): fatigue and autonomic symptoms improved; effects held at 1 month in most","v":1,"st":[]},{"i":"PMID:38191162","u":"https://doi.org/10.13703/j.0255-2930.20230307-0002","t":"","x":"acupoint massage","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2024,"r":"positive","s":"Acupoint massage at CV8 vs control: lower FS-14 and PSQI; low quality","v":1,"st":[]},{"i":"PMID:40749563","u":"https://doi.org/10.1016/j.explore.2025.103231","t":"","x":"acupressure","c":"other","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":0,"y":2025,"r":"positive","s":"Acupressure vs control in office workers with CFS: less fatigue and depression","v":1,"st":[]},{"i":"PMID:41247165","u":"https://doi.org/10.5152/pcp.2025.251106","t":"","x":"acupuncture/manual therapy + sleep treatment","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2025,"r":"mixed","s":"Eszopiclone + acupuncture vs eszopiclone in CFS sleep disorder: better PSQI; overall response not significant","v":1,"st":[8]},{"i":"PMID:41507906","u":"https://doi.org/10.1186/s12967-025-07624-7","t":"","x":"Tuina massage","c":"other","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":0,"y":2026,"r":"positive","s":"Tuina + usual care vs usual care: clinically meaningful fatigue improvement, better sleep and anxiety","v":1,"st":[]},{"i":"PMID:41569403","u":"https://doi.org/10.1007/s43440-025-00808-4","t":"","x":"ketamine","c":"other","p":"ME/CFS","d":"crossover","b":1,"n":0,"y":2026,"r":"mixed","s":"Ketamine vs midazolam crossover for fatigue: >20% fatigue drop in ketamine arm but not significant; carryover","v":1,"st":[2]},{"i":"PMID:42434010","u":"https://doi.org/10.3389/fmed.2026.1860390","t":"","x":"moxibustion","c":"other","p":"ME/CFS","d":"RCT-active","b":1,"n":0,"y":2026,"r":"pending","s":"Jianqiao ancient moxibustion RCT protocol","v":0,"st":[]},{"i":"PMID:8561218","u":"https://doi.org/10.1176/ajp.153.2.294a","t":"","x":"venlafaxine","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":1996,"r":"not-assessable","s":"Venlafaxine in CFS (1996); no abstract","v":0,"st":[2]},{"i":"PMID:8568124","u":"https://doi.org/10.1016/s0091-6749(96)70290-7","t":"","x":"terfenadine","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":30,"y":1996,"r":"null","s":"Terfenadine vs placebo (n=30): no benefit","v":1,"st":[]},{"i":"PMID:8622391","u":"https://doi.org/10.1016/s0140-6736(96)91345-8","t":"","x":"fluoxetine","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":107,"y":1996,"r":"null","s":"Fluoxetine 20 mg vs placebo 8 wk (n=107): no benefit on any CFS dimension, including depressed patients","v":1,"st":[2]},{"i":"PMID:8740043","u":"https://doi.org/10.1007/bf02246661","t":"","x":"phenelzine","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":20,"y":1996,"r":"positive","s":"Low-dose phenelzine vs placebo (n=~20): improvement in symptom, mood and function scales; small","v":1,"st":[2]},{"i":"PMID:9018019","u":"https://doi.org/10.1159/000119325","t":"","x":"amantadine + carnitine","c":"other","p":"ME/CFS","d":"RCT-active","b":0,"n":30,"y":1997,"r":"mixed","s":"Amantadine vs L-carnitine, randomised (n=30): amantadine no benefit and poorly tolerated; L-carnitine improved 12/18 parameters","v":1,"st":[2,5,6]},{"i":"PMID:9179634","u":"https://doi.org/10.1097/00004850-199701000-00007","t":"","x":"moclobemide","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":45,"y":1997,"r":"mixed","s":"Moclobemide open-label (n=45): benefit mainly in those with comorbid major depression","v":1,"st":[2]},{"i":"PMID:9597672","u":"https://doi.org/10.1159/000026494","t":"","x":"selegiline","c":"other","p":"ME/CFS","d":"crossover","b":0,"n":25,"y":1998,"r":"positive","s":"Selegiline placebo phase-in, single-blind (n=25): small improvements in vigour, anxiety and sexual relations","v":1,"st":[2]},{"i":"PMID:9757853","u":"https://doi.org/10.1001/jama.280.12.1061","t":"","x":"hydrocortisone","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":70,"y":1998,"r":"mixed","s":"Low-dose hydrocortisone vs placebo (n=70): modest wellness improvement (some p<0.05), but adrenal suppression precludes practical use","v":1,"st":[2]},{"i":"PMID:9822046","u":"https://doi.org/10.1177/000331979804901105","t":"","x":"inopamil / melatonin","c":"other","p":"ME/CFS","d":"single-arm","b":0,"n":4,"y":1998,"r":"mixed","s":"Inopamil vs melatonin pilot (n=4): inopamil reduced night-time hypotension; melatonin worsened it; physiological endpoint only","v":1,"st":[8]},{"i":"PMID:9828987","u":"https://doi.org/10.1192/bjp.172.6.485","t":"","x":"antidepressant + graded exercise therapy","c":"other","p":"ME/CFS","d":"RCT-placebo","b":1,"n":136,"y":1998,"r":"mixed","s":"Fluoxetine and graded exercise, factorial placebo-controlled (n=136): exercise reduced fatigue and improved work capacity; fluoxetine improved depression only","v":1,"st":[2]},{"i":"PMID:9989716","u":"https://doi.org/10.1016/s0140-6736(98)04074-4","t":"","x":"hydrocortisone","c":"other","p":"ME/CFS","d":"crossover","b":0,"n":32,"y":1999,"r":"positive","s":"Low-dose hydrocortisone vs placebo, crossover (n=32): fatigue fell more on hydrocortisone (difference 4.5 points, p=0.009); short term","v":1,"st":[2]},{"i":"ISRCTN07518149","u":"https://www.isrctn.com/ISRCTN07518149","t":"","x":"diet","c":"supplement","p":"ME/CFS","d":"crossover","b":0,"n":5,"y":2011,"r":"unreported-after-completion","s":"Registry record only; no results read; outputs listed on registry","v":0,"st":[]},{"i":"ISRCTN23930966","u":"https://doi.org/10.1016/j.phymed.2024.155636","t":"","x":"Sijunzi decoction (TCM)","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":127,"y":2024,"r":"positive","s":"Sijunzi decoction vs placebo (n=127): larger fatigue improvement with good adherence; gut microbiota changes","v":1,"st":[]},{"i":"ISRCTN59927814","u":"https://doi.org/10.1016/j.numecd.2014.10.007","t":"","x":"vitamin D3","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":50,"y":2015,"r":"null","s":"High-dose vitamin D3 vs placebo (n=50): no change in vascular function or fatigue","v":1,"st":[]},{"i":"KCT0002317","u":"https://doi.org/10.3389/fphar.2019.00991","t":"","x":"Myelophil herbal extract","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":0,"n":100,"y":2019,"r":"null","s":"Myelophil vs placebo (n=~100): no significant overall benefit; subgroup signal","v":1,"st":[]},{"i":"KCT0005613","u":"https://doi.org/10.1016/j.imr.2024.101085","t":"","x":"CAA herbal extract","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"positive","s":"Deer antler + Angelica + Astragalus extract vs placebo in chronic fatigue: lower FSS, MFI and VAS","v":1,"st":[]},{"i":"KCT0007515","u":"https://doi.org/10.1016/j.imr.2024.101025","t":"","x":"Gongjin-Dan / Ssanghwa-Tang herbal medicine","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":103,"y":2024,"r":"mixed","s":"Gongjin-Dan and Ssanghwa-Tang vs placebo in chronic fatigue (n=103): some subscale improvements only","v":1,"st":[]},{"i":"NCT02807649","u":"https://clinicaltrials.gov/study/NCT02807649","t":"GkoCist","x":"herbal/TCM","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":159,"y":2015,"r":"mixed","s":"Cistanche+ginkgo product (n=159): symptom improvement vs placebo but effect size described as trivial","v":1,"st":[]},{"i":"NCT02847845","u":"https://clinicaltrials.gov/study/NCT02847845","t":"","x":"herbal/TCM","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":50,"y":2016,"r":"unreported-after-completion","s":"Primary completion 2017-06; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04381793","u":"https://clinicaltrials.gov/study/NCT04381793","t":"","x":"Recovery Factors","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":43,"y":2019,"r":"unreported-after-completion","s":"Primary completion 2020-07-04; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04435002","u":"https://clinicaltrials.gov/study/NCT04435002","t":"","x":"herbal/TCM","c":"supplement","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":39,"y":2020,"r":"unreported-after-completion","s":"Primary completion 2020-12-09; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04542161","u":"https://clinicaltrials.gov/study/NCT04542161","t":"NAC ME/CFS","x":"N-acetylcysteine","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":95,"y":2020,"r":"pending","s":"No results yet","v":0,"st":[6]},{"i":"NCT04599348","u":"https://clinicaltrials.gov/study/NCT04599348","t":"","x":"herbal/TCM","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":70,"y":2020,"r":"unreported-after-completion","s":"Primary completion 2021-04-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05719493","u":"https://clinicaltrials.gov/study/NCT05719493","t":"SYNCHRONIZE +","x":"diet + exercise/rehabilitation","c":"supplement","p":"ME/CFS","d":"RCT-usual-care","b":1,"n":86,"y":2021,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06245642","u":"https://clinicaltrials.gov/study/NCT06245642","t":"","x":"herbal/TCM","c":"supplement","p":"ME/CFS","d":"RCT-active","b":1,"n":235,"y":2024,"r":"positive","s":"Compound Ciwujia granules vs placebo (TCM, n=235): fatigue scores improved significantly at 6 weeks","v":1,"st":[]},{"i":"NCT07320937","u":"https://clinicaltrials.gov/study/NCT07320937","t":"","x":"herbal/TCM","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":80,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"PMID:10071170","u":"https://doi.org/10.1111/j.1600-0404.1999.tb00667.x","t":"","x":"essential fatty acids","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":0,"n":50,"y":1999,"r":"null","s":"Essential fatty acids (Efamol Marine) vs placebo (n=50): no difference","v":1,"st":[]},{"i":"PMID:10872900","u":"https://doi.org/10.1080/07315724.2000.10718934","t":"","x":"magnesium","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":93,"y":2000,"r":"not-assessable","s":"Magnesium supplementation in chronic fatigue: biochemical outcomes only","v":0,"st":[]},{"i":"PMID:14971626","u":"https://doi.org/10.1017/s0033291703008791","t":"","x":"Siberian ginseng (Eleutherococcus)","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":0,"n":96,"y":2004,"r":"null","s":"Siberian ginseng vs placebo (n=96): no overall efficacy; possible benefit in moderate fatigue","v":1,"st":[]},{"i":"PMID:1672392","u":"https://doi.org/10.1016/0140-6736(91)91371-z","t":"","x":"magnesium sulphate injections","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":32,"y":1991,"r":"positive","s":"IM magnesium sulphate vs placebo (n=32): better energy, mood and pain; 12/15 vs 3/17 felt better","v":1,"st":[]},{"i":"PMID:16889122","u":"https://doi.org/10.1055/s-0031-1296741","t":"","x":"folinic acid","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":58,"y":2006,"r":"positive","s":"Folinic acid open-label (n=58): 81% reported subjective improvement; uncontrolled","v":1,"st":[]},{"i":"PMID:17335116","u":"https://doi.org/10.1002/ptr.2114","t":"","x":"spirulina","c":"supplement","p":"ME/CFS","d":"n-of-1","b":1,"n":4,"y":2007,"r":"null","s":"Spirulina, four n-of-1 trials: no difference from placebo","v":1,"st":[]},{"i":"PMID:17525791","u":"https://doi.org/10.1371/journal.pctr.0020019","t":"","x":"acclydine","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":57,"y":2007,"r":"null","s":"Acclydine vs placebo (n=57): no benefit","v":1,"st":[]},{"i":"PMID:18339054","u":"https://doi.org/10.1111/j.1365-277x.2008.00857.x","t":"","x":"low sugar low yeast diet","c":"supplement","p":"ME/CFS","d":"RCT-active","b":0,"n":52,"y":2008,"r":"null","s":"Low-sugar low-yeast diet vs healthy eating advice (n=52): no difference in fatigue or QoL","v":1,"st":[]},{"i":"PMID:19112401","u":"https://pubmed.ncbi.nlm.nih.gov/19112401/","t":"","x":"NAIOS supplements + leaky gut diet","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":41,"y":2008,"r":"positive","s":"Anti-inflammatory/antioxidant supplements plus leaky-gut diet, uncontrolled (n=41): many improved alongside lower IgA/IgM to LPS","v":1,"st":[]},{"i":"PMID:19398067","u":"https://doi.org/10.1016/j.ctim.2008.11.003","t":"","x":"Myelophil herbal extract","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":60,"y":2009,"r":"positive","s":"Myelophil (Astragalus + Salvia) vs placebo (n=~60, chronic fatigue): fatigue severity fell","v":1,"st":[]},{"i":"PMID:19702080","u":"https://pubmed.ncbi.nlm.nih.gov/19702080/","t":"","x":"Lixu Jieyu recipe (TCM)","c":"supplement","p":"ME/CFS","d":"RCT-active","b":0,"n":75,"y":2009,"r":"positive","s":"Lixu Jieyu herbal recipe vs control (n=75): fatigue and SCL-90 improved; low quality","v":1,"st":[]},{"i":"PMID:21092175","u":"https://doi.org/10.1186/1475-2891-9-55","t":"","x":"high cocoa polyphenol chocolate","c":"supplement","p":"ME/CFS","d":"crossover","b":1,"n":10,"y":2010,"r":"positive","s":"High-polyphenol chocolate vs placebo chocolate, crossover (n=10): Chalder fatigue improved","v":1,"st":[6,7]},{"i":"PMID:24231834","u":"https://pubmed.ncbi.nlm.nih.gov/24231834/","t":"","x":"Robuvit (French oak wood extract)","c":"supplement","p":"ME/CFS","d":"open-label","b":0,"n":91,"y":2014,"r":"positive","s":"Robuvit (French oak extract) registry vs management only (n=91): better fatigue; non-randomised registry","v":1,"st":[]},{"i":"PMID:24419360","u":"https://doi.org/10.12659/msm.889333","t":"","x":"multivitamin-mineral supplement","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2014,"r":"positive","s":"Multivitamin-mineral supplement, uncontrolled: less fatigue, sleep and autonomic symptoms; no QoL change","v":1,"st":[]},{"i":"PMID:25394351","u":"https://pubmed.ncbi.nlm.nih.gov/25394351/","t":"","x":"Robuvit (French oak wood extract)","c":"supplement","p":"ME/CFS","d":"open-label","b":0,"n":0,"y":2015,"r":"positive","s":"Robuvit in CFS with high oxidative stress, registry: more symptom improvement than controls; non-randomised","v":1,"st":[]},{"i":"PMID:2684076","u":"https://doi.org/10.1001/archinte.1989.00390110081017","t":"","x":"liver extract-folic acid-cyanocobalamin injections","c":"supplement","p":"ME/CFS","d":"crossover","b":1,"n":15,"y":1989,"r":"null","s":"Liver extract-folic acid-B12 injections vs placebo, crossover (n=15): no difference","v":1,"st":[]},{"i":"PMID:28219059","u":"https://doi.org/10.1159/000457918","t":"","x":"Rhodiola rosea","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":100,"y":2017,"r":"positive","s":"Rhodiola rosea (WS 1375) open-label (n=~100, prolonged/chronic fatigue): fatigue fell from week 1; uncontrolled","v":1,"st":[]},{"i":"PMID:29354956","u":"https://doi.org/10.13703/j.0255-2930.2017.11.013","t":"","x":"herbal/TCM + acupuncture/manual therapy","c":"supplement","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2017,"r":"positive","s":"Chaihu Longgu Muli decoction + acupuncture vs decoction alone: more fatigue reduction with combination; low quality","v":1,"st":[]},{"i":"PMID:31616305","u":"https://doi.org/10.3389/fphar.2019.01102","t":"","x":"vitamin B12 nasal drops","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":51,"y":2019,"r":"positive","s":"Vitamin B12 nasal drops open-label (n=51): two-thirds reported benefit; steps, physical function and fatigue improved; uncontrolled","v":1,"st":[]},{"i":"PMID:31987248","u":"https://doi.org/10.1016/j.ctim.2019.102246","t":"","x":"Korean red ginseng","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":1,"n":0,"y":2020,"r":"null","s":"Korean red ginseng vs placebo in chronic fatigue: no between-group difference; subgroup signal","v":1,"st":[]},{"i":"PMID:32188192","u":"https://doi.org/10.1016/s0254-6272(18)30046-3","t":"","x":"abdominal tuina","c":"supplement","p":"ME/CFS","d":"RCT-active","b":1,"n":84,"y":2017,"r":"positive","s":"Abdominal tuina vs acupuncture (n=84): better FS-14 and HAMD","v":1,"st":[]},{"i":"PMID:33101925","u":"https://doi.org/10.1016/j.imr.2020.100664","t":"","x":"Sipjeondaebo-tang herbal medicine","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":0,"n":96,"y":2021,"r":"null","s":"Sipjeondaebo-tang vs placebo (n=96): primary response rate not different (35% vs 54%); some secondary scales better","v":1,"st":[]},{"i":"PMID:35056100","u":"https://doi.org/10.3390/ph15010043","t":"","x":"HRG80 red ginseng","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2021,"r":"positive","s":"HRG80 red ginseng open-label in CFS/FM/post-viral fatigue: energy and well-being improved; uncontrolled","v":1,"st":[]},{"i":"PMID:36510244","u":"https://doi.org/10.1186/s13030-022-00255-0","t":"","x":"6-MSITC wasabi extract","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":2022,"r":"positive","s":"Wasabi extract (6-MSITC) open-label: performance status and cognition improved; Chalder fatigue unchanged","v":1,"st":[]},{"i":"PMID:37716119","u":"https://doi.org/10.1016/j.biopha.2023.115453","t":"","x":"polyphenol/omega-3/anti-inflammatory supplement + diet","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":0,"n":78,"y":2023,"r":"positive","s":"Quercetin phytosome 500 mg vs placebo in chronic fatigue (n=78): FIS-40 -10.6 points, better sleep, steps and SPPB","v":1,"st":[6,7]},{"i":"PMID:37960157","u":"https://doi.org/10.3390/nu15214504","t":"","x":"yeast beta-glucan","c":"supplement","p":"ME/CFS","d":"RCT-active","b":1,"n":0,"y":2023,"r":"mixed","s":"Yeast beta-glucan + multivitamins vs multivitamins (36 wk): cognitive fatigue improved vs baseline; between-group effect unclear","v":1,"st":[]},{"i":"PMID:38702173","u":"https://pubmed.ncbi.nlm.nih.gov/38702173/","t":"","x":"Qiye Shen'an Pian + glutathione + B1","c":"supplement","p":"ME/CFS","d":"RCT-active","b":0,"n":0,"y":2024,"r":"positive","s":"Qiye Shen'an Pian + glutathione + vitamin B1 vs control: better fatigue, immune and antioxidant markers; low quality","v":1,"st":[]},{"i":"PMID:39796445","u":"https://doi.org/10.3390/nu17010011","t":"","x":"multicomponent education (diet)","c":"supplement","p":"ME/CFS","d":"RCT-usual-care","b":0,"n":158,"y":2024,"r":"null","s":"SYNCHRONIZE+ in FM/CFS (n=158): improved Mediterranean diet adherence; no symptom outcome","v":1,"st":[]},{"i":"PMID:42487402","u":"https://doi.org/10.4014/jmb.2601.01055","t":"","x":"deer velvet extract","c":"supplement","p":"ME/CFS","d":"RCT-placebo","b":0,"n":0,"y":2026,"r":"positive","s":"Deer velvet extract (YC-1101) vs placebo in chronic fatigue: better FSS and exercise distance","v":1,"st":[]},{"i":"PMID:8939323","u":"https://pubmed.ncbi.nlm.nih.gov/8939323/","t":"","x":"vitamin B12 / nimodipine","c":"supplement","p":"ME/CFS","d":"n-of-1","b":0,"n":2,"y":1996,"r":"mixed","s":"Two n-of-1 trials: high-dose B12 ineffective in one patient; nimodipine effective in another","v":1,"st":[]},{"i":"PMID:9594356","u":"https://doi.org/10.1007/bf02688676","t":"","x":"glyconutrient supplements","c":"supplement","p":"ME/CFS","d":"single-arm","b":0,"n":0,"y":1998,"r":"positive","s":"Open-label glyconutrient + vitamin supplements in FM/CFS: large symptom reduction; uncontrolled","v":1,"st":[]},{"i":"NCT05710770","u":"https://clinicaltrials.gov/study/NCT05710770","t":"","x":"immunoadsorption/apheresis","c":"apheresis/immunoadsorption","p":"both","d":"RCT-placebo","b":1,"n":66,"y":2023,"r":"unreported-after-completion","s":"IA-PACS-CFS: immunoadsorption vs sham in post-COVID ME/CFS (n=66); only protocol published","v":0,"st":[1,4]},{"i":"NCT05954325","u":"https://clinicaltrials.gov/study/NCT05954325","t":"","x":"immunoadsorption/apheresis","c":"apheresis/immunoadsorption","p":"both","d":"RCT-placebo","b":1,"n":63,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-07-31; no results posted or published abstract found","v":0,"st":[1,4]},{"i":"PMID:39759581","u":"https://doi.org/10.1016/j.lanepe.2024.101161","t":"","x":"immunoadsorption","c":"apheresis/immunoadsorption","p":"both","d":"single-arm","b":0,"n":20,"y":2025,"r":"positive","s":"Repeated immunoadsorption in post-COVID ME/CFS with beta2-AR antibodies, open-label (n=~20): SF-36 PF +17.8 points","v":1,"st":[1,4]},{"i":"NCT05697640","u":"https://clinicaltrials.gov/study/NCT05697640","t":"","x":"sGC stimulator","c":"autonomic/vasoactive","p":"both","d":"RCT-placebo","b":1,"n":104,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[4,5]},{"i":"NCT06366724","u":"https://clinicaltrials.gov/study/NCT06366724","t":"LIFT","x":"pyridostigmine + low-dose naltrexone","c":"autonomic/vasoactive","p":"both","d":"RCT-placebo","b":1,"n":160,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[3,5,6,7]},{"i":"NCT06511050","u":"https://clinicaltrials.gov/study/NCT06511050","t":"","x":"anticoagulant/antiplatelet","c":"autonomic/vasoactive","p":"both","d":"open-label","b":0,"n":120,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[4]},{"i":"NCT05130736","u":"https://clinicaltrials.gov/study/NCT05130736","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"both","d":"RCT-active","b":0,"n":80,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-07-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05196529","u":"https://clinicaltrials.gov/study/NCT05196529","t":"Inspire ME","x":"breathing/respiratory training","c":"behavioural/rehab","p":"both","d":"single-arm","b":0,"n":40,"y":2022,"r":"positive","s":"Inspiratory muscle training, single-arm (n=40, ME/CFS and PASC): improved autonomic scores, HRV and 6MWD","v":1,"st":[]},{"i":"NCT05212467","u":"https://clinicaltrials.gov/study/NCT05212467","t":"","x":"brain-retraining programme","c":"behavioural/rehab","p":"both","d":"RCT-placebo","b":1,"n":360,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-12-31; no results posted or published abstract found","v":0,"st":[2,8]},{"i":"NCT05534997","u":"https://clinicaltrials.gov/study/NCT05534997","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"both","d":"RCT-usual-care","b":1,"n":60,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-09-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05973136","u":"https://clinicaltrials.gov/study/NCT05973136","t":"Telecovie","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"both","d":"single-arm","b":0,"n":7,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-08-08; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06933173","u":"https://clinicaltrials.gov/study/NCT06933173","t":"MILES","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"both","d":"crossover","b":1,"n":200,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06978582","u":"https://clinicaltrials.gov/study/NCT06978582","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"both","d":"RCT-usual-care","b":1,"n":147,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07454395","u":"https://clinicaltrials.gov/study/NCT07454395","t":"ME/CFS","x":"Swimming; Cycling","c":"behavioural/rehab","p":"both","d":"crossover","b":0,"n":50,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07523113","u":"https://clinicaltrials.gov/study/NCT07523113","t":"","x":"exercise/rehabilitation + vagus nerve stimulation","c":"behavioural/rehab","p":"both","d":"RCT-active","b":1,"n":30,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[7,8]},{"i":"NCT05608629","u":"https://clinicaltrials.gov/study/NCT05608629","t":"","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"both","d":"single-arm","b":0,"n":17,"y":2022,"r":"positive","s":"Transcutaneous VNS open-label in long COVID (n=17): 8 met treatment-success criterion (matches Natelson preprint)","v":1,"st":[7,8]},{"i":"NCT06585254","u":"https://clinicaltrials.gov/study/NCT06585254","t":"","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"both","d":"RCT-active","b":1,"n":50,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[7,8]},{"i":"NCT06968104","u":"https://clinicaltrials.gov/study/NCT06968104","t":"STIMPACT","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"both","d":"crossover","b":1,"n":48,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[7,8]},{"i":"NCT07874217","u":"https://clinicaltrials.gov/study/NCT07874217","t":"","x":"Cryotherapy","c":"device/neuromodulation","p":"both","d":"single-arm","b":0,"n":40,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT04705831","u":"https://clinicaltrials.gov/study/NCT04705831","t":"","x":"C1-esterase inhibitor","c":"immunomodulator","p":"both","d":"crossover","b":1,"n":40,"y":2021,"r":"mixed","s":"C1 esterase inhibitor crossover, interim (n=36): trends toward improved fatigue, depression and pain","v":1,"st":[1,4]},{"i":"NCT05430152","u":"https://clinicaltrials.gov/study/NCT05430152","t":"","x":"low-dose naltrexone","c":"immunomodulator","p":"both","d":"RCT-placebo","b":1,"n":160,"y":2024,"r":"null","s":"LDN up to 4.5 mg vs placebo for 16 wk (n=160): no difference in fatigue (FSS), pain, symptoms, step count or QoL","v":1,"st":[6,7]},{"i":"NCT05638633","u":"https://clinicaltrials.gov/study/NCT05638633","t":"PreVitaCOV","x":"corticosteroid + vitamins/minerals","c":"immunomodulator","p":"both","d":"RCT-placebo","b":1,"n":321,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2025-01-30; no results posted or published abstract found","v":0,"st":[6,7]},{"i":"NCT07724834","u":"https://clinicaltrials.gov/study/NCT07724834","t":"PIONEER_PAIS","x":"inebilizumab","c":"immunomodulator","p":"both","d":"RCT-placebo","b":1,"n":38,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"PMID:39720104","u":"https://doi.org/10.1016/j.ensci.2024.100537","t":"","x":"minocycline","c":"immunomodulator","p":"both","d":"single-arm","b":0,"n":55,"y":2025,"r":"positive","s":"Oral minocycline open-label in ME incl. long COVID (n=55): 80% of completers improved PS by >=2 points; uncontrolled","v":1,"st":[]},{"i":"NCT05840237","u":"https://clinicaltrials.gov/study/NCT05840237","t":"","x":"oxaloacetate","c":"metabolic/mitochondrial","p":"both","d":"RCT-placebo","b":1,"n":70,"y":2023,"r":"mixed","s":"REGAIN: oxaloacetate vs placebo (n=70): primary CFQ fatigue not different; DSQ fatigue, symptom burden and cognition improved","v":1,"st":[5,6]},{"i":"NCT05939622","u":"https://clinicaltrials.gov/study/NCT05939622","t":"","x":"meldonium/EMHPS","c":"metabolic/mitochondrial","p":"both","d":"RCT-placebo","b":1,"n":30,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-12-20; no results posted or published abstract found","v":0,"st":[5,6]},{"i":"NCT06147050","u":"https://clinicaltrials.gov/study/NCT06147050","t":"REVIVE","x":"metformin","c":"metabolic/mitochondrial","p":"both","d":"RCT-placebo","b":1,"n":16,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-10; no results posted or published abstract found","v":0,"st":[5,6]},{"i":"NCT05167227","u":"https://clinicaltrials.gov/study/NCT05167227","t":"LC&FIRP","x":"Extension for Community Healthcare Outcomes","c":"other","p":"both","d":"RCT-usual-care","b":1,"n":20,"y":2021,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05967052","u":"https://clinicaltrials.gov/study/NCT05967052","t":"POSTCOVID","x":"gabapentinoid + exercise/rehabilitation + CBT/psychological therapy","c":"other","p":"both","d":"RCT-placebo","b":1,"n":23,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-09-11; no results posted or published abstract found","v":0,"st":[2,8]},{"i":"NCT06082518","u":"https://clinicaltrials.gov/study/NCT06082518","t":"PCS-HBOT","x":"hyperbaric oxygen","c":"other","p":"both","d":"RCT-active","b":1,"n":40,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT06128967","u":"https://clinicaltrials.gov/study/NCT06128967","t":"REVIVE","x":"fluvoxamine + metformin","c":"other","p":"both","d":"RCT-placebo","b":1,"n":399,"y":2023,"r":"mixed","s":"Fluvoxamine and metformin vs placebo, adaptive (n=399): fluvoxamine reduced fatigue (day 60 and 90) and improved QoL; metformin no benefit","v":1,"st":[2,5,6]},{"i":"NCT07352254","u":"https://clinicaltrials.gov/study/NCT07352254","t":"ACCESS","x":"online visit","c":"other","p":"both","d":"RCT-usual-care","b":0,"n":100,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07357688","u":"https://clinicaltrials.gov/study/NCT07357688","t":"","x":"acupuncture/manual therapy","c":"other","p":"both","d":"RCT-placebo","b":1,"n":99,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT04947488","u":"https://clinicaltrials.gov/study/NCT04947488","t":"BC","x":"diet","c":"supplement","p":"both","d":"RCT-placebo","b":0,"n":50,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-09-18; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05642923","u":"https://clinicaltrials.gov/study/NCT05642923","t":"","x":"vitamins/minerals","c":"supplement","p":"both","d":"RCT-usual-care","b":1,"n":528,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-06-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06064838","u":"https://clinicaltrials.gov/study/NCT06064838","t":"FLALOC","x":"polyphenol/omega-3/anti-inflammatory supplement","c":"supplement","p":"both","d":"RCT-placebo","b":1,"n":46,"y":2023,"r":"positive","s":"FLALOC: cacao flavonoid extract vs placebo (n=46): improved inflammatory markers, syndecan-1 and fatigue","v":1,"st":[6,7]},{"i":"NCT06739720","u":"https://clinicaltrials.gov/study/NCT06739720","t":"","x":"herbal/TCM + diet","c":"supplement","p":"both","d":"RCT-usual-care","b":0,"n":130,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07745699","u":"https://clinicaltrials.gov/study/NCT07745699","t":"","x":"diet","c":"supplement","p":"both","d":"single-arm","b":0,"n":11,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-06-01; no results posted or published abstract found","v":0,"st":[]},{"i":"PMID:40090177","u":"https://doi.org/10.1016/j.nut.2025.112718","t":"","x":"vitamin D","c":"supplement","p":"both","d":"single-arm","b":0,"n":28,"y":2025,"r":"positive","s":"Vitamin D replacement in ME/CFS after COVID vaccination (n=28): symptomatic relief; uncontrolled","v":1,"st":[]},{"i":"PMID:41683343","u":"https://doi.org/10.3390/nu18030521","t":"","x":"vitamin D","c":"supplement","p":"both","d":"RCT-usual-care","b":0,"n":0,"y":2026,"r":"positive","s":"Vitamin D replacement guidance vs control in post-COVID/post-vaccination ME/CFS: symptom count fell more (-6.7 vs -1.2)","v":1,"st":[]},{"i":"DOI:10.21203/rs.3.rs-1617822/v2","u":"https://doi.org/10.21203/rs.3.rs-1617822/v2","t":"","x":"nirmatrelvir/ritonavir","c":"antiviral","p":"long COVID","d":"single-arm","b":0,"n":3,"y":2022,"r":"mixed","s":"Nirmatrelvir in three long COVID cases: variable outcomes depending on timing","v":1,"st":[1]},{"i":"NCT05576662","u":"https://clinicaltrials.gov/study/NCT05576662","t":"STOP-PASC","x":"nirmatrelvir/ritonavir","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":155,"y":2022,"r":"null","s":"STOP-PASC: nirmatrelvir/ritonavir 15 d vs placebo/r (n=155): safe, no benefit on core symptoms","v":1,"st":[1]},{"i":"NCT05595369","u":"https://clinicaltrials.gov/study/NCT05595369","t":"RECOVER-VITAL","x":"nirmatrelvir/ritonavir","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":951,"y":2023,"r":"null","s":"RECOVER-VITAL: nirmatrelvir/ritonavir 15 or 25 d vs placebo (n=959; cognitive, autonomic, exercise phenotypes): no benefit in any phenotype","v":1,"st":[1]},{"i":"NCT05668091","u":"https://clinicaltrials.gov/study/NCT05668091","t":"","x":"nirmatrelvir/ritonavir","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":100,"y":2023,"r":"null","s":"PAX LC: nirmatrelvir/ritonavir 15 d vs placebo/r (n=100, decentralised): no improvement at day 28","v":1,"st":[1]},{"i":"NCT05823896","u":"https://clinicaltrials.gov/study/NCT05823896","t":"PROLIFIC","x":"nirmatrelvir/ritonavir","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":219,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-11-28; no results posted or published abstract found","v":0,"st":[1]},{"i":"NCT05877508","u":"https://clinicaltrials.gov/study/NCT05877508","t":"outSMART-LC","x":"SARS-CoV-2 monoclonal antibody","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":36,"y":2023,"r":"null","s":"AER002 monoclonal antibody vs placebo (n=36): PROMIS-29 physical 40.9 vs 45.0; published phase 2a negative","v":1,"st":[1]},{"i":"NCT05911906","u":"https://clinicaltrials.gov/study/NCT05911906","t":"ERASE-LC","x":"remdesivir","c":"antiviral","p":"long COVID","d":"single-arm","b":0,"n":73,"y":2024,"r":"feasibility-only","s":"ERASE LC: open-label IV remdesivir 5 d (n=73): feasible and safe; exploratory improvements; uncontrolled","v":1,"st":[1]},{"i":"NCT06161688","u":"https://clinicaltrials.gov/study/NCT06161688","t":"PREVAIL-LC","x":"ensitrelvir","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":40,"y":2024,"r":"null","s":"Ensitrelvir vs placebo (n=40): PROMIS-29 physical 43.6 vs 41.6; no meaningful difference posted","v":1,"st":[1]},{"i":"NCT06316843","u":"https://clinicaltrials.gov/study/NCT06316843","t":"PASC","x":"valacyclovir","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":59,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-10-31; no results posted or published abstract found","v":0,"st":[1]},{"i":"NCT06511063","u":"https://clinicaltrials.gov/study/NCT06511063","t":"","x":"tenofovir/emtricitabine","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":90,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"NCT06766825","u":"https://clinicaltrials.gov/study/NCT06766825","t":"THALASSA","x":"plitidepsin","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":90,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"NCT07021794","u":"https://clinicaltrials.gov/study/NCT07021794","t":"Monoclonal","x":"SARS-CoV-2 monoclonal antibody","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":100,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"NCT07597902","u":"https://clinicaltrials.gov/study/NCT07597902","t":"SHIELD","x":"valacyclovir + nirmatrelvir/ritonavir","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":150,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"NCT07899346","u":"https://clinicaltrials.gov/study/NCT07899346","t":"FLINTLOCK","x":"SARS-CoV-2 monoclonal antibody","c":"antiviral","p":"long COVID","d":"RCT-placebo","b":1,"n":130,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"PMID:41357034","u":"https://doi.org/10.7759/cureus.96246","t":"","x":"pemivibart monoclonal antibody","c":"antiviral","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2025,"r":"positive","s":"Pemivibart monoclonal antibody infusion, case series: improvements in PEM-related fatigue, cognition and dysautonomia","v":1,"st":[1]},{"i":"PMID:41562079","u":"https://doi.org/10.3389/fimmu.2025.1698271","t":"","x":"valacyclovir + nirmatrelvir/ritonavir","c":"antiviral","p":"long COVID","d":"open-label","b":0,"n":24,"y":2025,"r":"positive","s":"IMC-2 (valacyclovir + celecoxib) alone or with Paxlovid, case series (n=24): fatigue improved more with combination","v":1,"st":[1]},{"i":"DOI:10.12688/f1000research.186744.1","u":"https://doi.org/10.12688/f1000research.186744.1","t":"","x":"therapeutic plasma exchange","c":"apheresis/immunoadsorption","p":"long COVID","d":"RCT-placebo","b":1,"n":18,"y":2026,"r":"null","s":"Crossflow membrane plasmapheresis vs sham in long COVID (n=18): fatigue fell in both arms; no between-group difference","v":1,"st":[1,4]},{"i":"NCT05445674","u":"https://clinicaltrials.gov/study/NCT05445674","t":"","x":"immunoadsorption/apheresis","c":"apheresis/immunoadsorption","p":"long COVID","d":"RCT-placebo","b":1,"n":50,"y":2022,"r":"null","s":"Plasma exchange vs sham, 6 sessions (n=50): safe, no difference in any efficacy outcome","v":1,"st":[1,4]},{"i":"NCT05543590","u":"https://clinicaltrials.gov/study/NCT05543590","t":"PLEXCOVIL","x":"immunoadsorption/apheresis","c":"apheresis/immunoadsorption","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2023,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[1,4]},{"i":"NCT05841498","u":"https://clinicaltrials.gov/study/NCT05841498","t":"IAMPOCO","x":"immunoadsorption/apheresis","c":"apheresis/immunoadsorption","p":"long COVID","d":"crossover","b":1,"n":40,"y":2023,"r":"null","s":"Immunoadsorption vs sham, crossover (n=40, Mainz): no difference in symptom severity","v":1,"st":[1,4]},{"i":"NCT07316127","u":"https://clinicaltrials.gov/study/NCT07316127","t":"TURNLongCOVID","x":"immunoadsorption/apheresis","c":"apheresis/immunoadsorption","p":"long COVID","d":"RCT-placebo","b":1,"n":70,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[1,4]},{"i":"PMID:39653042","u":"https://doi.org/10.1055/a-2445-8593","t":"","x":"therapeutic apheresis","c":"apheresis/immunoadsorption","p":"long COVID","d":"single-arm","b":1,"n":0,"y":2024,"r":"positive","s":"Therapeutic apheresis in severe post-COVID, single-centre pilot: clinical improvement associated with autoantibody fall; uncontrolled","v":1,"st":[1,4]},{"i":"DOI:10.21203/rs.3.rs-2697680/v1","u":"https://doi.org/10.21203/rs.3.rs-2697680/v1","t":"","x":"triple anticoagulant therapy","c":"autonomic/vasoactive","p":"long COVID","d":"single-arm","b":0,"n":91,"y":2023,"r":"positive","s":"Triple anticoagulant therapy (clopidogrel, aspirin, apixaban), uncontrolled: most reported improvement; bleeding risk","v":1,"st":[4]},{"i":"DOI:10.21203/rs.3.rs-873830/v1","u":"https://doi.org/10.21203/rs.3.rs-873830/v1","t":"","x":"stellate ganglion block","c":"autonomic/vasoactive","p":"long COVID","d":"single-arm","b":0,"n":3,"y":2021,"r":"positive","s":"Stellate ganglion block, case series (n=3): durable improvement in fatigue, brain fog, smell","v":1,"st":[8]},{"i":"NCT05096884","u":"https://clinicaltrials.gov/study/NCT05096884","t":"PEACE","x":"beta-blocker","c":"autonomic/vasoactive","p":"long COVID","d":"single-arm","b":0,"n":10,"y":2022,"r":"positive","s":"Metoprolol succinate open-label for PASC exertional dyspnoea/tachycardia (n=10, terminated): 6MWT 275 to 339 m; uncontrolled","v":1,"st":[8]},{"i":"NCT05228899","u":"https://clinicaltrials.gov/study/NCT05228899","t":"","x":"IV saline/fluids","c":"autonomic/vasoactive","p":"long COVID","d":"single-arm","b":1,"n":18,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-10-01; no results posted or published abstract found","v":0,"st":[3]},{"i":"NCT05481177","u":"https://clinicaltrials.gov/study/NCT05481177","t":"COVIVA","x":"ivabradine","c":"autonomic/vasoactive","p":"long COVID","d":"RCT-placebo","b":1,"n":250,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-09-01; no results posted or published abstract found","v":0,"st":[8]},{"i":"NCT05513560","u":"https://clinicaltrials.gov/study/NCT05513560","t":"RECLAIM","x":"pentoxifylline","c":"autonomic/vasoactive","p":"long COVID","d":"RCT-placebo","b":1,"n":460,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-03-31; no results posted or published abstract found","v":0,"st":[4]},{"i":"NCT05638620","u":"https://clinicaltrials.gov/study/NCT05638620","t":"DSBLongCOVID","x":"stellate ganglion/sympathetic block","c":"autonomic/vasoactive","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2023,"r":"positive","s":"Dual sympathetic blocks (SGB + lumbar), open-label (n=20, 17 completed): COMPASS-31 -38%, pain -48%; uncontrolled","v":1,"st":[8]},{"i":"NCT06305806","u":"https://clinicaltrials.gov/study/NCT06305806","t":"","x":"ivabradine","c":"autonomic/vasoactive","p":"long COVID","d":"RCT-placebo","b":1,"n":181,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[8]},{"i":"NCT07374562","u":"https://clinicaltrials.gov/study/NCT07374562","t":"STAR-CO","x":"stellate ganglion/sympathetic block","c":"autonomic/vasoactive","p":"long COVID","d":"RCT-placebo","b":1,"n":40,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[8]},{"i":"NCT07468604","u":"https://clinicaltrials.gov/study/NCT07468604","t":"CeASE","x":"stellate ganglion/sympathetic block","c":"autonomic/vasoactive","p":"long COVID","d":"RCT-placebo","b":1,"n":78,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[8]},{"i":"PMID:38240001","u":"https://doi.org/10.1002/jgf2.670","t":"","x":"beta-blockers","c":"autonomic/vasoactive","p":"long COVID","d":"single-arm","b":0,"n":32,"y":2024,"r":"mixed","s":"Post-COVID POTS case series (n=32): some responded to beta-blockers; most improved over time","v":1,"st":[8]},{"i":"PMID:39263197","u":"https://doi.org/10.64719/pb.4500","t":"","x":"stellate ganglion block","c":"autonomic/vasoactive","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2024,"r":"positive","s":"Stellate ganglion block pilot: lower FSS and heart rate after block; uncontrolled","v":1,"st":[8]},{"i":"PMID:40960330","u":"https://doi.org/10.36076/pmcr.2023.7.63","t":"","x":"stellate ganglion block","c":"autonomic/vasoactive","p":"long COVID","d":"single-arm","b":0,"n":2,"y":2023,"r":"positive","s":"Stellate ganglion block (+ rhizotomy), two cases: near-complete sustained relief at 3 months","v":1,"st":[8]},{"i":"ACTRN12621000031864","u":"https://doi.org/10.21203/rs.3.rs-1452186/v1","t":"","x":"group telerehabilitation exercise","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":21,"y":2022,"r":"feasibility-only","s":"Group telerehabilitation feasibility RCT (n=21): feasible and safe","v":1,"st":[]},{"i":"CHICTR2100051901","u":"https://doi.org/10.1186/s13102-025-01317-w","t":"","x":"semi-supervised exercise training","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2025,"r":"mixed","s":"Semi-supervised exercise vs control in post-COVID healthcare workers: better strength and rowing intensity; mood improved within groups only","v":1,"st":[]},{"i":"CTRI/2023/03/050808","u":"https://doi.org/10.1186/s13063-026-09769-2","t":"","x":"adapted physical activity/exercise","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":0,"y":2026,"r":"positive","s":"Hospital physiotherapy vs telerehab vs home programme for long COVID CFS (India): hospital-based best for fatigue and function","v":1,"st":[]},{"i":"DOI:10.1101/2024.07.04.24309908","u":"https://doi.org/10.1101/2024.07.04.24309908","t":"","x":"constraint-induced cognitive therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2024,"r":"positive","s":"Constraint-Induced Cognitive Therapy pilot RCT: less brain fog, better IADL and return to work","v":1,"st":[]},{"i":"DOI:10.1101/2024.11.24.24317856","u":"https://doi.org/10.1101/2024.11.24.24317856","t":"","x":"virtual rehabilitation (exercise)","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":132,"y":2024,"r":"mixed","s":"Virtual rehabilitation vs usual care (n=132): no mobility improvement; better health status; many could not progress exercise","v":1,"st":[]},{"i":"DOI:10.21203/rs.3.rs-463053/v2","u":"https://doi.org/10.21203/rs.3.rs-463053/v2","t":"","x":"exercise + supplemental oxygen","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":3,"y":2021,"r":"positive","s":"Monitored exercise + supplemental oxygen, three cases: ~54% better exercise tolerance","v":1,"st":[]},{"i":"DOI:10.21203/rs.3.rs-4914245/v1","u":"https://doi.org/10.21203/rs.3.rs-4914245/v1","t":"","x":"CBT/psychological therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2024,"r":"positive","s":"Personalised physiotherapy + nutrition counselling pilot RCT: better 1-MST, 6MWT and physical fatigue at 18 weeks","v":1,"st":[2]},{"i":"DRKS00026245","u":"https://doi.org/10.1186/s13102-024-00817-5","t":"","x":"online physical activity programme","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2024,"r":"null","s":"Online-supported physical activity vs control (DRKS): fatigue fell equally in both; no exercise capacity gain","v":1,"st":[]},{"i":"DRKS00029415","u":"https://doi.org/10.1007/s00415-026-13693-5","t":"","x":"multidisciplinary neurological rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":47,"y":2026,"r":"mixed","s":"2-week multidisciplinary neurological rehab (n=47): symptom burden improved; no HRQoL or cognitive change","v":1,"st":[]},{"i":"DRKS00032059","u":"https://doi.org/10.1159/pps/aemag017","t":"","x":"immersive VR + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":100,"y":2026,"r":"null","s":"Immersive VR exercise vs conventional exercise (n=100): not superior on fatigue; fewer symptom worsenings","v":1,"st":[2]},{"i":"DRKS00033562","u":"https://doi.org/10.1016/j.jpsychores.2026.112605","t":"","x":"multimodal inpatient psychotherapy","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":0,"n":120,"y":2026,"r":"mixed","s":"Inpatient psychotherapy vs controls, non-randomised (n=120): better psychological well-being; limited effect on physical symptoms","v":1,"st":[2]},{"i":"DRKS00040598","u":"https://doi.org/10.1186/s40359-026-05149-2","t":"","x":"psychotherapeutic group intervention","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2026,"r":"null","s":"PsyLoCo psychotherapeutic group intervention vs control: no superiority; underpowered","v":1,"st":[2]},{"i":"ISRCTN10665760","u":"https://doi.org/10.1038/s41591-026-04552-x","t":"","x":"integrated care pathway (MRI, digital rehab)","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2026,"r":"null","s":"STIMULATE-ICP cluster RCT: multi-organ MRI and digital rehab no significant fatigue benefit vs usual care","v":1,"st":[]},{"i":"ISRCTN11466448","u":"https://doi.org/10.1136/bmj-2023-076506","t":"","x":"online group rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":585,"y":2024,"r":"positive","s":"REGAIN: online group physical and mental rehab vs usual care (n=585): better HRQoL at 3 and 12 months","v":1,"st":[]},{"i":"ISRCTN11868601","u":"https://www.isrctn.com/ISRCTN11868601","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-unspecified","b":0,"n":94,"y":2022,"r":"unreported-after-completion","s":"Registry record only; no results read; outputs listed on registry","v":0,"st":[2]},{"i":"ISRCTN15068418","u":"https://www.isrctn.com/ISRCTN15068418","t":"SOMA.COV","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-unspecified","b":0,"n":269,"y":2023,"r":"unreported-after-completion","s":"Registry record only; no results read; outputs listed on registry","v":0,"st":[2]},{"i":"ISRCTN16012321","u":"https://www.isrctn.com/ISRCTN16012321","t":"","x":"CBT/psychological therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-unspecified","b":0,"n":40,"y":2022,"r":"unreported-after-completion","s":"Registry record only; no results read","v":0,"st":[2]},{"i":"ISRCTN16033549","u":"https://doi.org/10.1038/s41467-025-64831-y","t":"","x":"digital energy management platform","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":0,"y":2026,"r":"null","s":"Digital platform with activity tracking for energy management vs control: no difference in fatigue","v":1,"st":[6]},{"i":"ISRCTN33340595","u":"https://www.isrctn.com/ISRCTN33340595","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-unspecified","b":0,"n":56,"y":2024,"r":"pending","s":"Registry record only; no results read; outputs listed on registry","v":0,"st":[]},{"i":"ISRCTN36407216","u":"https://www.isrctn.com/ISRCTN36407216","t":"LISTEN","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-unspecified","b":0,"n":554,"y":2022,"r":"unreported-after-completion","s":"Registry record only; no results read; outputs listed on registry","v":0,"st":[2]},{"i":"ISRCTN38746119","u":"https://doi.org/10.1111/hex.70399","t":"","x":"optimal health programme (psychosocial)","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2025,"r":"feasibility-only","s":"Long COVID Optimal Health Programme feasibility RCT: feasible; potential gains","v":1,"st":[]},{"i":"ISRCTN39864861","u":"https://www.isrctn.com/ISRCTN39864861","t":"BEACON","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-unspecified","b":0,"n":1608,"y":2024,"r":"unreported-after-completion","s":"Registry record only; no results read","v":0,"st":[2]},{"i":"ISRCTN91104012","u":"https://doi.org/10.1038/s41598-023-35058-y","t":"","x":"telerehabilitation app","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":100,"y":2023,"r":"mixed","s":"ReCOVery APP telerehab vs usual care (n=100): app use time predicted gains; low adherence; between-group effects limited","v":1,"st":[]},{"i":"NCT02918994","u":"https://clinicaltrials.gov/study/NCT02918994","t":"","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":30,"y":2016,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT04445376","u":"https://clinicaltrials.gov/study/NCT04445376","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":1,"n":20,"y":2020,"r":"unreported-after-completion","s":"Primary completion 2020-09-10; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04632719","u":"https://clinicaltrials.gov/study/NCT04632719","t":"MP-COVID","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":200,"y":2020,"r":"unreported-after-completion","s":"Primary completion 2020-12-29; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04634318","u":"https://clinicaltrials.gov/study/NCT04634318","t":"REHABCOVID","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":23,"y":2020,"r":"null","s":"Home vs hospital pulmonary rehab: 6MWD improved in both; no difference between arms","v":1,"st":[]},{"i":"NCT04644172","u":"https://clinicaltrials.gov/study/NCT04644172","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"crossover","b":1,"n":16,"y":2021,"r":"positive","s":"Constraint-induced cognitive therapy vs TAU (n=16): very large improvements in daily-life cognitive function","v":1,"st":[]},{"i":"NCT04678700","u":"https://clinicaltrials.gov/study/NCT04678700","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":40,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2021-06-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04718506","u":"https://clinicaltrials.gov/study/NCT04718506","t":"RECOVE","x":"exercise/rehabilitation + breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":83,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-02-06; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04742946","u":"https://clinicaltrials.gov/study/NCT04742946","t":"TRCovidA","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":27,"y":2021,"r":"positive","s":"Digital physiotherapy, single-arm (n=32): functional capacity (1-min STS, SPPB) improved","v":1,"st":[]},{"i":"NCT04771598","u":"https://clinicaltrials.gov/study/NCT04771598","t":"","x":"breathing/respiratory training + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":52,"y":2021,"r":"positive","s":"Breathing exercises via telemedicine (n=52): 6MWD +54 m vs +5 m in controls; lung function improved","v":1,"st":[]},{"i":"NCT04794036","u":"https://clinicaltrials.gov/study/NCT04794036","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":50,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-06-13; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04795557","u":"https://clinicaltrials.gov/study/NCT04795557","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":100,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2021-11-11; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04796064","u":"https://clinicaltrials.gov/study/NCT04796064","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":76,"y":2020,"r":"positive","s":"Low- vs high-intensity aerobic training (n=76, post-COVID sarcopenia): low intensity gave larger gains in grip strength and QoL","v":1,"st":[]},{"i":"NCT04811859","u":"https://clinicaltrials.gov/study/NCT04811859","t":"","x":"breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":40,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-01-10; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04836351","u":"https://clinicaltrials.gov/study/NCT04836351","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2023-12-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04841759","u":"https://clinicaltrials.gov/study/NCT04841759","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":1,"n":46,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2021-12-03; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04853966","u":"https://clinicaltrials.gov/study/NCT04853966","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":28,"y":2021,"r":"positive","s":"Physical activity tele-counselling (n=28): improved activity, functional performance and QoL","v":1,"st":[2]},{"i":"NCT04854772","u":"https://clinicaltrials.gov/study/NCT04854772","t":"","x":"Mind Body Syndrome Therapy for Long Covid","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":23,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-08-09; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04898205","u":"https://clinicaltrials.gov/study/NCT04898205","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"crossover","b":1,"n":24,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-01-20; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04900961","u":"https://clinicaltrials.gov/study/NCT04900961","t":"CISCO-21","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":233,"y":2021,"r":"positive","s":"Personalised resistance exercise, 12 weeks: improved exercise capacity, HRQoL and grip strength; PEM not increased","v":1,"st":[]},{"i":"NCT04950725","u":"https://clinicaltrials.gov/study/NCT04950725","t":"","x":"breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":2268,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-12-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04958161","u":"https://clinicaltrials.gov/study/NCT04958161","t":"RECOVERY","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2022,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[]},{"i":"NCT04961333","u":"https://clinicaltrials.gov/study/NCT04961333","t":"COVID-19","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"crossover","b":1,"n":200,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2021-12-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04972864","u":"https://clinicaltrials.gov/study/NCT04972864","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":24,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2021-07-18; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04982042","u":"https://clinicaltrials.gov/study/NCT04982042","t":"COVID19REHAB","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":1,"n":40,"y":2021,"r":"positive","s":"Outpatient pulmonary rehab, single-arm (n=54): 6MWD 429 to 503 m, FSS 4.7 to 3.0","v":1,"st":[]},{"i":"NCT04983394","u":"https://clinicaltrials.gov/study/NCT04983394","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":79,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-02-27; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04996212","u":"https://clinicaltrials.gov/study/NCT04996212","t":"COVIDPERS","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":1,"n":70,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-10-14; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05012826","u":"https://clinicaltrials.gov/study/NCT05012826","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":104,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2023-06-06; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05019963","u":"https://clinicaltrials.gov/study/NCT05019963","t":"ECORT","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":106,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2024-08; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05035628","u":"https://clinicaltrials.gov/study/NCT05035628","t":"COVID-Rehab","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":40,"y":2021,"r":"mixed","s":"COVID-Rehab: 8-week cardiopulmonary rehab vs usual habits (n=40): VO2peak +2.7 mL/kg/min vs control (p=0.003) and lower symptom burden; no cognitive test benefit, less stress and depression","v":1,"st":[]},{"i":"NCT05040893","u":"https://clinicaltrials.gov/study/NCT05040893","t":"POETIC","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":15,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-08-09; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05074771","u":"https://clinicaltrials.gov/study/NCT05074771","t":"RICOMINCIARE","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":31,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-03-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05077241","u":"https://clinicaltrials.gov/study/NCT05077241","t":"","x":"breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":10,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05094622","u":"https://clinicaltrials.gov/study/NCT05094622","t":"POTS-ReCOV","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":30,"y":2022,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05107440","u":"https://clinicaltrials.gov/study/NCT05107440","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":27,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-06-20; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05119608","u":"https://clinicaltrials.gov/study/NCT05119608","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":40,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-09-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05119634","u":"https://clinicaltrials.gov/study/NCT05119634","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":42,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-10-21; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05121688","u":"https://clinicaltrials.gov/study/NCT05121688","t":"TPhysioCovid","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":71,"y":2021,"r":"positive","s":"Telerehabilitation vs wait-and-see (n=71): larger gains in exertion, 6MWT and QoL","v":1,"st":[]},{"i":"NCT05139979","u":"https://clinicaltrials.gov/study/NCT05139979","t":"","x":"breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"crossover","b":0,"n":189,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2024-02-07; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05167266","u":"https://clinicaltrials.gov/study/NCT05167266","t":"COV-COG","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":130,"y":2022,"r":"null","s":"Two psychoeducation programmes (n=130): both improved, no group-by-time difference","v":1,"st":[2]},{"i":"NCT05172102","u":"https://clinicaltrials.gov/study/NCT05172102","t":"Covid-19","x":"breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":40,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2023-03-20; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05172206","u":"https://clinicaltrials.gov/study/NCT05172206","t":"RELOAD","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":132,"y":2022,"r":"positive","s":"RELOAD symptom-based rehab (n=104): SF-12 PCS +2.9 at 3 weeks and +4.2 at 3 months vs control","v":1,"st":[]},{"i":"NCT05196451","u":"https://clinicaltrials.gov/study/NCT05196451","t":"SIPCOV","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":314,"y":2022,"r":"positive","s":"SIPCOV brief outpatient rehab (n=314): effective on primary physical functioning vs usual care","v":1,"st":[2]},{"i":"NCT05204511","u":"https://clinicaltrials.gov/study/NCT05204511","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":66,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-05-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05205460","u":"https://clinicaltrials.gov/study/NCT05205460","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":182,"y":2021,"r":"mixed","s":"Telerehabilitation (n=182): more walking and physical activity, better sleep; VO2peak benefit not reported in abstract","v":1,"st":[]},{"i":"NCT05216549","u":"https://clinicaltrials.gov/study/NCT05216549","t":"postcovidkids","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":75,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-06-05; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05218174","u":"https://clinicaltrials.gov/study/NCT05218174","t":"PASC","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"crossover","b":1,"n":21,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-11-17; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05231395","u":"https://clinicaltrials.gov/study/NCT05231395","t":"","x":"breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":40,"y":2022,"r":"positive","s":"Inspiratory muscle strength training: improved exercise capacity, muscle oxygenation and fatigue","v":1,"st":[]},{"i":"NCT05231408","u":"https://clinicaltrials.gov/study/NCT05231408","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":30,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2024-08-15; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05234281","u":"https://clinicaltrials.gov/study/NCT05234281","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":0,"n":1000,"y":2021,"r":"positive","s":"Micro-choice concentrated group rehab, single-arm (n=241): WSAS function improved","v":1,"st":[]},{"i":"NCT05242094","u":"https://clinicaltrials.gov/study/NCT05242094","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":2000,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2021-02-02; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05244044","u":"https://clinicaltrials.gov/study/NCT05244044","t":"PuRe-COVID","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":76,"y":2022,"r":"positive","s":"PuRe-COVID primary-care pulmonary rehab (n=76): 6MWD +39 m vs control; CIS-fatigue reduced","v":1,"st":[]},{"i":"NCT05254301","u":"https://clinicaltrials.gov/study/NCT05254301","t":"UNLOCK","x":"CBT/psychological therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":65,"y":2022,"r":"unreported-after-completion","s":"Only protocol published","v":0,"st":[2]},{"i":"NCT05279430","u":"https://clinicaltrials.gov/study/NCT05279430","t":"InsCOVID","x":"breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":26,"y":2022,"r":"positive","s":"InsCOVID home IMT (n=26): peak VO2 +4.5 mL/kg/min vs usual care","v":1,"st":[]},{"i":"NCT05289154","u":"https://clinicaltrials.gov/study/NCT05289154","t":"ACUQiG","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":200,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-09-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05298878","u":"https://clinicaltrials.gov/study/NCT05298878","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":132,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-09-22; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05299333","u":"https://clinicaltrials.gov/study/NCT05299333","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":30,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2025-03-07; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05302973","u":"https://clinicaltrials.gov/study/NCT05302973","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":30,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-12-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05317975","u":"https://clinicaltrials.gov/study/NCT05317975","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":13,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2024-02-17; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05323331","u":"https://clinicaltrials.gov/study/NCT05323331","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":60,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-10-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05338749","u":"https://clinicaltrials.gov/study/NCT05338749","t":"PACS-Cog","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":16,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-11-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05360563","u":"https://clinicaltrials.gov/study/NCT05360563","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":94,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-12; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05374668","u":"https://clinicaltrials.gov/study/NCT05374668","t":"Yoga","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":85,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2021-09-22; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05381779","u":"https://clinicaltrials.gov/study/NCT05381779","t":"","x":"breathing/respiratory training + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":60,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2024-06-05; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05398692","u":"https://clinicaltrials.gov/study/NCT05398692","t":"LC Rehab","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":21,"y":2022,"r":"feasibility-only","s":"Pilot aerobic exercise training (n=21, terminated): VO2peak +1.55 mL/kg/min and better QoL/fatigue, no harm to immune markers; uncontrolled","v":1,"st":[]},{"i":"NCT05419219","u":"https://clinicaltrials.gov/study/NCT05419219","t":"TaiChi-DTx","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":200,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-05-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05422924","u":"https://clinicaltrials.gov/study/NCT05422924","t":"BLEND","x":"CBT/psychological therapy + diet","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":45,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-10-31; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05425264","u":"https://clinicaltrials.gov/study/NCT05425264","t":"BOOST","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":80,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05435456","u":"https://clinicaltrials.gov/study/NCT05435456","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":76,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2021-03-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05449379","u":"https://clinicaltrials.gov/study/NCT05449379","t":"","x":"breathing/respiratory training + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":60,"y":2022,"r":"positive","s":"Multi-component rehabilitation (n=60, randomised): functional gains, greatest in those with lower baseline capacity; limited detail in abstract","v":1,"st":[]},{"i":"NCT05453188","u":"https://clinicaltrials.gov/study/NCT05453188","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":0,"n":30,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-07-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05453201","u":"https://clinicaltrials.gov/study/NCT05453201","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":21,"y":2022,"r":"positive","s":"Long COVID coping and recovery psychotherapy, single-arm (n=21): symptom severity improved (p=0.004); disability borderline","v":1,"st":[2]},{"i":"NCT05477199","u":"https://clinicaltrials.gov/study/NCT05477199","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":54,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-09-15; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05494424","u":"https://clinicaltrials.gov/study/NCT05494424","t":"TRAINCOVID","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":135,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05498493","u":"https://clinicaltrials.gov/study/NCT05498493","t":"","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":67,"y":2022,"r":"mixed","s":"Cognitive rehabilitation vs attention control pilot (n=67): objective cognition passed futility only; self-reported cognition improved; no fMRI connectivity change","v":1,"st":[2]},{"i":"NCT05501067","u":"https://clinicaltrials.gov/study/NCT05501067","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":60,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-11-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05507190","u":"https://clinicaltrials.gov/study/NCT05507190","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-06-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05516550","u":"https://clinicaltrials.gov/study/NCT05516550","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":412,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-12; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05516836","u":"https://clinicaltrials.gov/study/NCT05516836","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":62,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-12-20; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05530317","u":"https://clinicaltrials.gov/study/NCT05530317","t":"CARE BEAR-LC","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":0,"n":13,"y":2022,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05532904","u":"https://clinicaltrials.gov/study/NCT05532904","t":"ECHAP-COVID","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":80,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-06-13; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05539950","u":"https://clinicaltrials.gov/study/NCT05539950","t":"COVID-19","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":1,"n":0,"y":2022,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[]},{"i":"NCT05543408","u":"https://clinicaltrials.gov/study/NCT05543408","t":"CON-VIDA","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":40,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-08-02; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05543551","u":"https://clinicaltrials.gov/study/NCT05543551","t":"","x":"breathing/respiratory training + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":42,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-12-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05566379","u":"https://clinicaltrials.gov/study/NCT05566379","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-07-29; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05566483","u":"https://clinicaltrials.gov/study/NCT05566483","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":30,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05571852","u":"https://clinicaltrials.gov/study/NCT05571852","t":"","x":"cognitive rehabilitation + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":73,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-02-28; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05582603","u":"https://clinicaltrials.gov/study/NCT05582603","t":"CCTLongCOVID","x":"exercise/rehabilitation + cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-11-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05597722","u":"https://clinicaltrials.gov/study/NCT05597722","t":"","x":"CBT/psychological therapy + stimulant","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":7,"y":2023,"r":"not-assessable","s":"Cognitive fog trial terminated (n=7); no results values","v":0,"st":[2]},{"i":"NCT05597774","u":"https://clinicaltrials.gov/study/NCT05597774","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":64,"y":2022,"r":"null","s":"Respiratory muscle training + aerobic exercise vs sham RMT + exercise (n=64): no between-group difference in QoL or exercise tolerance","v":1,"st":[]},{"i":"NCT05616806","u":"https://clinicaltrials.gov/study/NCT05616806","t":"LIGHT","x":"iENDURE","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":10,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-07-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05629884","u":"https://clinicaltrials.gov/study/NCT05629884","t":"COPERIA-REHAB","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":56,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-11-14; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05629897","u":"https://clinicaltrials.gov/study/NCT05629897","t":"COPERIA-COG","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":88,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-11; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05630378","u":"https://clinicaltrials.gov/study/NCT05630378","t":"TaPoCo","x":"outpatient clinic with multimodal integrative medicine and naturopathy for post-COVID-19 patients; waiting group","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":42,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-02-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05631171","u":"https://clinicaltrials.gov/study/NCT05631171","t":"COVIDAI","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":58,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-06-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05658536","u":"https://clinicaltrials.gov/study/NCT05658536","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":51,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-01-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05665205","u":"https://clinicaltrials.gov/study/NCT05665205","t":"SARS-CoV-2","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":20,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-01-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05675995","u":"https://clinicaltrials.gov/study/NCT05675995","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":40,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-05-15; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05676008","u":"https://clinicaltrials.gov/study/NCT05676008","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":400,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT05676047","u":"https://clinicaltrials.gov/study/NCT05676047","t":"STAR-C3","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":100,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-01-21; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05697042","u":"https://clinicaltrials.gov/study/NCT05697042","t":"MYS LCOVID-19","x":"CBT/psychological therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":16,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-12-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05705193","u":"https://clinicaltrials.gov/study/NCT05705193","t":"","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":39,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT05722730","u":"https://clinicaltrials.gov/study/NCT05722730","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":60,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-03-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05725538","u":"https://clinicaltrials.gov/study/NCT05725538","t":"COVIDReApp","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":100,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-03-15; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05731570","u":"https://clinicaltrials.gov/study/NCT05731570","t":"","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":78,"y":2023,"r":"positive","s":"Individualised cognitive rehabilitation vs usual care (n=78): greater goal attainment at 3 months, sustained","v":1,"st":[2]},{"i":"NCT05732285","u":"https://clinicaltrials.gov/study/NCT05732285","t":"CoINTEGRATE","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":15,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-09-01; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05739032","u":"https://clinicaltrials.gov/study/NCT05739032","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":50,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-05-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05739552","u":"https://clinicaltrials.gov/study/NCT05739552","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":30,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-07-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05752331","u":"https://clinicaltrials.gov/study/NCT05752331","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":32,"y":2022,"r":"feasibility-only","s":"Personalised health behaviour coaching pilot (n=32): feasible; early signals of better activity and fatigue","v":1,"st":[]},{"i":"NCT05765591","u":"https://clinicaltrials.gov/study/NCT05765591","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":98,"y":2022,"r":"positive","s":"Balneotherapy vs control (n=98): better SF-36 energy/fatigue and pain, sleep and anxiety; some effects lost at 1-month follow-up","v":1,"st":[]},{"i":"NCT05770505","u":"https://clinicaltrials.gov/study/NCT05770505","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":77,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-05-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05792852","u":"https://clinicaltrials.gov/study/NCT05792852","t":"","x":"ENGAGE","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":21,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05799534","u":"https://clinicaltrials.gov/study/NCT05799534","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":400,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-07; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05817032","u":"https://clinicaltrials.gov/study/NCT05817032","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":0,"n":22,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-10; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05831839","u":"https://clinicaltrials.gov/study/NCT05831839","t":"CO-TRAINER","x":"cognitive rehabilitation + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":50,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-09-01; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05846126","u":"https://clinicaltrials.gov/study/NCT05846126","t":"REHABCOVID","x":"immersive VR","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":172,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-12-20; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05848518","u":"https://clinicaltrials.gov/study/NCT05848518","t":"EJerSA-COVID","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":120,"y":2023,"r":"unreported-after-completion","s":"Supervised exercise programmes in older post-COVID patients (n=120); protocol only","v":0,"st":[]},{"i":"NCT05851846","u":"https://clinicaltrials.gov/study/NCT05851846","t":"","x":"brain-retraining programme","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":130,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-05-15; no results posted or published abstract found","v":0,"st":[2,8]},{"i":"NCT05851859","u":"https://clinicaltrials.gov/study/NCT05851859","t":"COCO-Long'Run","x":"exercise/rehabilitation + breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":200,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05855356","u":"https://clinicaltrials.gov/study/NCT05855356","t":"LoCoDiRe-Dys","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":50,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-12-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05866224","u":"https://clinicaltrials.gov/study/NCT05866224","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":130,"y":2021,"r":"mixed","s":"Supervised home telerehabilitation vs control (n=130): better CPET duration and power output; no VO2peak difference","v":1,"st":[]},{"i":"NCT05877534","u":"https://clinicaltrials.gov/study/NCT05877534","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":60,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05880108","u":"https://clinicaltrials.gov/study/NCT05880108","t":"MARVEL","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":150,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05890599","u":"https://clinicaltrials.gov/study/NCT05890599","t":"YoFaPoCo","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":100,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05932797","u":"https://clinicaltrials.gov/study/NCT05932797","t":"MLongCovid","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":60,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-11-18; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05934279","u":"https://clinicaltrials.gov/study/NCT05934279","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":40,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-07-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05956405","u":"https://clinicaltrials.gov/study/NCT05956405","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":120,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-03-31; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05961462","u":"https://clinicaltrials.gov/study/NCT05961462","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":24,"y":2023,"r":"positive","s":"Supervised aerobic training 4 wk vs control (n=24): fewer symptoms and better exercise tolerance; small","v":1,"st":[]},{"i":"NCT05965739","u":"https://clinicaltrials.gov/study/NCT05965739","t":"","x":"cognitive rehabilitation + transcranial stimulation/neurofeedback","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":328,"y":2023,"r":"null","s":"RECOVER-NEURO: BrainHQ, PASC-CoRE cognitive rehab and tDCS vs controls (n=328): no benefit of any intervention on cognition","v":1,"st":[2]},{"i":"NCT06004310","u":"https://clinicaltrials.gov/study/NCT06004310","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":120,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-07-25; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06004362","u":"https://clinicaltrials.gov/study/NCT06004362","t":"","x":"Complementary and Integrative Medicine online intervention, routine care and book; Routine care and book","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":120,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-07; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06016192","u":"https://clinicaltrials.gov/study/NCT06016192","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":139,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-11-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06042751","u":"https://clinicaltrials.gov/study/NCT06042751","t":"TELPOCO","x":"exercise/rehabilitation + CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":195,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06045338","u":"https://clinicaltrials.gov/study/NCT06045338","t":"","x":"Mind Body Intervention #1","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":180,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06063031","u":"https://clinicaltrials.gov/study/NCT06063031","t":"ARACOV-02","x":"exercise/rehabilitation + diet","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":146,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2025-01-15; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06065033","u":"https://clinicaltrials.gov/study/NCT06065033","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":0,"y":2023,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[]},{"i":"NCT06073002","u":"https://clinicaltrials.gov/study/NCT06073002","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06082258","u":"https://clinicaltrials.gov/study/NCT06082258","t":"EMPATY","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":1,"n":0,"y":2024,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[]},{"i":"NCT06085911","u":"https://clinicaltrials.gov/study/NCT06085911","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":60,"y":2023,"r":"null","s":"Tailored individual CBT-based follow-up vs one-day group course (n=60): no difference in HRQoL","v":1,"st":[]},{"i":"NCT06086379","u":"https://clinicaltrials.gov/study/NCT06086379","t":"CCT-COVID","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":70,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06091384","u":"https://clinicaltrials.gov/study/NCT06091384","t":"","x":"breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":40,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-09-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06095297","u":"https://clinicaltrials.gov/study/NCT06095297","t":"","x":"exercise/rehabilitation + vagus nerve stimulation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":30,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[7,8]},{"i":"NCT06124625","u":"https://clinicaltrials.gov/study/NCT06124625","t":"ReLoAd2","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":90,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-09-08; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06128941","u":"https://clinicaltrials.gov/study/NCT06128941","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":60,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-04; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06136871","u":"https://clinicaltrials.gov/study/NCT06136871","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":48,"y":2024,"r":"feasibility-only","s":"Cognitive Orientation (CO-OP) rehab vs inactive control (n=48): recruitment and retention only","v":1,"st":[]},{"i":"NCT06142240","u":"https://clinicaltrials.gov/study/NCT06142240","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":40,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-04-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06142253","u":"https://clinicaltrials.gov/study/NCT06142253","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":50,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06156176","u":"https://clinicaltrials.gov/study/NCT06156176","t":"PREFACER","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":60,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06156202","u":"https://clinicaltrials.gov/study/NCT06156202","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":125,"y":2023,"r":"pending","s":"Multimodal outpatient rehabilitation for PASC (n=125); protocol only","v":0,"st":[]},{"i":"NCT06161740","u":"https://clinicaltrials.gov/study/NCT06161740","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":17,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-09-20; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06165978","u":"https://clinicaltrials.gov/study/NCT06165978","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":162,"y":2024,"r":"feasibility-only","s":"Physical activity coaching pilot (n=162 planned, suspended): feasible, large gains in activity and fatigue; pilot only","v":1,"st":[]},{"i":"NCT06168006","u":"https://clinicaltrials.gov/study/NCT06168006","t":"Recovery","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":60,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06172803","u":"https://clinicaltrials.gov/study/NCT06172803","t":"RESToRE","x":"exercise/rehabilitation + breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":4,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-01-15; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06208696","u":"https://clinicaltrials.gov/study/NCT06208696","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":0,"n":47,"y":2023,"r":"mixed","s":"Chronic disease self-management in Puerto Rico, non-randomised (n=47): counts only; no clear difference","v":1,"st":[2]},{"i":"NCT06211686","u":"https://clinicaltrials.gov/study/NCT06211686","t":"Sarcopenia","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":50,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-12-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06231225","u":"https://clinicaltrials.gov/study/NCT06231225","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":0,"n":100,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-06-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06231238","u":"https://clinicaltrials.gov/study/NCT06231238","t":"BalanceACT","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":196,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06251011","u":"https://clinicaltrials.gov/study/NCT06251011","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":32,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-06-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06251518","u":"https://clinicaltrials.gov/study/NCT06251518","t":"InvidiCO","x":"vimida","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":160,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06315894","u":"https://clinicaltrials.gov/study/NCT06315894","t":"SuperCAP","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":60,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-09-05; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06330376","u":"https://clinicaltrials.gov/study/NCT06330376","t":"","x":"breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":16,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-08-15; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06374446","u":"https://clinicaltrials.gov/study/NCT06374446","t":"","x":"immersive VR","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":56,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-06-15; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT06379737","u":"https://clinicaltrials.gov/study/NCT06379737","t":"MULTI-COVID","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":1,"n":72,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-12-20; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06391489","u":"https://clinicaltrials.gov/study/NCT06391489","t":"","x":"CBT/psychological therapy + cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":10,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06404060","u":"https://clinicaltrials.gov/study/NCT06404060","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":360,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06404073","u":"https://clinicaltrials.gov/study/NCT06404073","t":"","x":"pacing/energy management","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":298,"y":2024,"r":"positive","s":"RECOVER-ENERGIZE structured pacing vs usual care (n=298): PEM frequency (-0.46, CI -0.65 to -0.27) and severity reduced","v":1,"st":[6]},{"i":"NCT06492551","u":"https://clinicaltrials.gov/study/NCT06492551","t":"TRAK-COVID","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":80,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-09-23; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06492577","u":"https://clinicaltrials.gov/study/NCT06492577","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":61,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-10-06; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06492590","u":"https://clinicaltrials.gov/study/NCT06492590","t":"COVIDL/MIQoL","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":74,"y":2025,"r":"unreported-after-completion","s":"Primary completion 2025-09-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06503874","u":"https://clinicaltrials.gov/study/NCT06503874","t":"LongCovAtten","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":58,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06503913","u":"https://clinicaltrials.gov/study/NCT06503913","t":"COMLOC","x":"breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":18,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06568393","u":"https://clinicaltrials.gov/study/NCT06568393","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":176,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-04-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06570239","u":"https://clinicaltrials.gov/study/NCT06570239","t":"COVIDTHERM","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":200,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06614309","u":"https://clinicaltrials.gov/study/NCT06614309","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"crossover","b":0,"n":45,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06658340","u":"https://clinicaltrials.gov/study/NCT06658340","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":34,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-11-14; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT06679218","u":"https://clinicaltrials.gov/study/NCT06679218","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":60,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06726772","u":"https://clinicaltrials.gov/study/NCT06726772","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":50,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2024-01-31; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT06789952","u":"https://clinicaltrials.gov/study/NCT06789952","t":"MBSR-LCP","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":41,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-11-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT06814379","u":"https://clinicaltrials.gov/study/NCT06814379","t":"COVIDATE-02","x":"exercise/rehabilitation + immersive VR","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":54,"y":2025,"r":"unreported-after-completion","s":"Primary completion 2025-07-31; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT06822179","u":"https://clinicaltrials.gov/study/NCT06822179","t":"RESPICARE","x":"CBT/psychological therapy + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":57,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06840873","u":"https://clinicaltrials.gov/study/NCT06840873","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":68,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-06-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06871293","u":"https://clinicaltrials.gov/study/NCT06871293","t":"","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":374,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06928116","u":"https://clinicaltrials.gov/study/NCT06928116","t":"HEAL","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":99,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06952127","u":"https://clinicaltrials.gov/study/NCT06952127","t":"TEPCO","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":22,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-03-29; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06973018","u":"https://clinicaltrials.gov/study/NCT06973018","t":"eRehabCog","x":"cognitive rehabilitation + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":64,"y":2021,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT07013903","u":"https://clinicaltrials.gov/study/NCT07013903","t":"HydroCoVital A","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":50,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07046208","u":"https://clinicaltrials.gov/study/NCT07046208","t":"LongCovidRehab","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":58,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07079787","u":"https://clinicaltrials.gov/study/NCT07079787","t":"TeleRehab DSS","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":30,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07140094","u":"https://clinicaltrials.gov/study/NCT07140094","t":"LONG-CALM","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":400,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT07184398","u":"https://clinicaltrials.gov/study/NCT07184398","t":"","x":"cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":120,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-09-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT07216040","u":"https://clinicaltrials.gov/study/NCT07216040","t":"HOPE-LC","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":25,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT07254377","u":"https://clinicaltrials.gov/study/NCT07254377","t":"START","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":48,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07397910","u":"https://clinicaltrials.gov/study/NCT07397910","t":"NUTRACOVID","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":40,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07530757","u":"https://clinicaltrials.gov/study/NCT07530757","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":100,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT07553897","u":"https://clinicaltrials.gov/study/NCT07553897","t":"","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":120,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2023-11-08; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT07651371","u":"https://clinicaltrials.gov/study/NCT07651371","t":"ReabCovid","x":"exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":74,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2023-12-15; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT07697261","u":"https://clinicaltrials.gov/study/NCT07697261","t":"FALCON","x":"brain-retraining programme + pacing/energy management","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":100,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[2,6,8]},{"i":"NCT07714889","u":"https://clinicaltrials.gov/study/NCT07714889","t":"","x":"CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2026,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[2]},{"i":"NCT07726082","u":"https://clinicaltrials.gov/study/NCT07726082","t":"CHOOSE-POC","x":"Micro-choice-based intervention","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":24,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"PACTR202111640499636","u":"https://doi.org/10.1186/s12984-024-01340-x","t":"","x":"home-based rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2024,"r":"positive","s":"Home-based pulmonary rehab vs control: lower Chalder fatigue, better 6MWT","v":1,"st":[]},{"i":"PACTR202311561948428","u":"https://doi.org/10.1016/j.jesf.2024.04.003","t":"","x":"exercise/rehabilitation + immersive VR","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":0,"y":2024,"r":"positive","s":"Treadmill with vs without VR: both improved fatigue, cognition and sleep; no inactive control","v":1,"st":[2]},{"i":"PMID:35847457","u":"https://doi.org/10.3389/fspor.2022.877188","t":"","x":"adapted physical activity","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":0,"y":2022,"r":"positive","s":"CoviMouv: supervised vs telerehab adapted physical activity pilot: fatigue and VO2max improved in both","v":1,"st":[]},{"i":"PMID:36151435","u":"https://doi.org/10.1007/s11356-022-22949-2","t":"","x":"high-altitude spa rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2023,"r":"positive","s":"Mountain spa rehabilitation pilot: symptoms, lung function and platelet mitochondrial respiration improved; uncontrolled","v":1,"st":[]},{"i":"PMID:36191860","u":"https://doi.org/10.1016/j.rehab.2022.101709","t":"","x":"breathing/respiratory training + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-placebo","b":1,"n":88,"y":2023,"r":"mixed","s":"Home respiratory muscle training vs sham (n=88): quality of life improved, exercise tolerance not","v":1,"st":[]},{"i":"PMID:36429623","u":"https://doi.org/10.3390/ijerph192214905","t":"","x":"online forest bathing","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":0,"n":0,"y":2022,"r":"positive","s":"Online forest bathing vs wait-list period: less anxiety and rumination; better symptom severity","v":1,"st":[]},{"i":"PMID:36476156","u":"https://doi.org/10.1152/japplphysiol.00489.2022","t":"","x":"exercise/rehabilitation + CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":80,"y":2023,"r":"positive","s":"RECOVE: concurrent training ± inspiratory exercise vs WHO self-management (n=80): better fitness, strength and symptom severity","v":1,"st":[2]},{"i":"PMID:36674117","u":"https://doi.org/10.3390/ijerph20021361","t":"","x":"neuro-meditation programme","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2023,"r":"positive","s":"Rebalance neuro-meditation 4 weeks vs control: better cognition, fatigue, pain and mood","v":1,"st":[]},{"i":"PMID:37316403","u":"https://doi.org/10.1016/j.jvoice.2023.04.024","t":"","x":"breathing retraining","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2025,"r":"positive","s":"Breathing retraining case series for dysfunctional breathing: symptoms and function improved","v":1,"st":[]},{"i":"PMID:37492483","u":"https://doi.org/10.1155/2023/7068326","t":"","x":"brain-retraining programme + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":0,"y":2023,"r":"positive","s":"Amygdala and Insula Retraining vs active control in long COVID: larger fatigue reduction and energy gain","v":1,"st":[2,8]},{"i":"PMID:37658773","u":"https://doi.org/10.1093/ptj/pzad118","t":"","x":"exercise/rehabilitation + breathing/respiratory training","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":43,"y":2023,"r":"positive","s":"Functional vs aerobic exercise telerehab (n=43): both improved QoL; functional better for fatigue","v":1,"st":[]},{"i":"PMID:37834888","u":"https://doi.org/10.3390/jcm12196244","t":"","x":"water-based / land-based exercise","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2023,"r":"mixed","s":"Water vs land exercise in children with post-COVID: VO2max improved in both; fatigue unchanged","v":1,"st":[]},{"i":"PMID:38191766","u":"https://doi.org/10.1007/s10072-023-07268-9","t":"","x":"dual-task augmented reality rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":0,"n":0,"y":2024,"r":"mixed","s":"Dual-task augmented-reality rehab vs physiotherapy in long COVID: cognitive gains only in physiotherapy arm; other outcomes no interaction","v":1,"st":[]},{"i":"PMID:38213055","u":"https://pubmed.ncbi.nlm.nih.gov/38213055/","t":"","x":"internet group supportive psychotherapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":0,"y":2023,"r":"null","s":"Internet group supportive psychotherapy vs education: both improved; no between-group difference","v":1,"st":[2]},{"i":"PMID:38330704","u":"https://doi.org/10.1016/j.pec.2024.108180","t":"","x":"lifestyle adjustment programme","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":54,"y":2024,"r":"positive","s":"Lifestyle adjustment programme vs control (n=54): better QoL and symptom severity","v":1,"st":[]},{"i":"PMID:38398284","u":"https://doi.org/10.3390/jcm13040970","t":"","x":"multidisciplinary telerehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":81,"y":2024,"r":"positive","s":"Multidisciplinary telerehab vs wait list: more ICF functions and activities improved","v":1,"st":[]},{"i":"PMID:38398348","u":"https://doi.org/10.3390/jcm13041035","t":"","x":"Nordic walking","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2024,"r":"positive","s":"Nordic walking 12 weeks vs control: less fatigue (MFIS) and better QoL","v":1,"st":[]},{"i":"PMID:38578435","u":"https://doi.org/10.1007/s00406-024-01792-1","t":"","x":"integrative multimodal inpatient programme","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":64,"y":2024,"r":"positive","s":"Integrative inpatient programme, observational (n=64): fatigue fell at discharge and 6 months","v":1,"st":[]},{"i":"PMID:38876631","u":"https://doi.org/10.1016/j.jbmt.2024.02.033","t":"","x":"whole-body vibration exercise","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2024,"r":"not-assessable","s":"Whole-body vibration in post-COVID (functional capacity, QoL); no abstract","v":0,"st":[]},{"i":"PMID:39131859","u":"https://doi.org/10.3389/fpsyg.2024.1441018","t":"","x":"immersive virtual reality multimodal programme","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":0,"n":0,"y":2024,"r":"positive","s":"Immersive VR cognitive + exercise + mindfulness vs control: better global cognition and mental health","v":1,"st":[2]},{"i":"PMID:39198662","u":"https://doi.org/10.1038/s41598-024-71055-5","t":"","x":"tailored exercise for POTS","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2024,"r":"feasibility-only","s":"Individually tailored exercise for post-COVID POTS: feasible; symptom burden improved","v":1,"st":[]},{"i":"PMID:39292241","u":"https://doi.org/10.1007/s00115-024-01732-3","t":"","x":"neurological rehabilitation + CBT","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2024,"r":"positive","s":"Neurologically controlled rehab with CBT in post-COVID, observational: fatigue and sensorimotor instability improved","v":1,"st":[2]},{"i":"PMID:39294767","u":"https://doi.org/10.1186/s13690-024-01354-w","t":"","x":"online multimodal rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":134,"y":2024,"r":"mixed","s":"Online multimodal rehab vs control (n=134): mental-health QoL improved; physical outcomes not reported as different","v":1,"st":[]},{"i":"PMID:39356325","u":"https://doi.org/10.1007/s00406-024-01904-x","t":"","x":"CBT/psychological therapy + cognitive rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"open-label","b":1,"n":0,"y":2024,"r":"positive","s":"Cognitive training + group psychotherapy, non-randomised: cognition improved; feasible","v":1,"st":[2]},{"i":"PMID:39457358","u":"https://doi.org/10.3390/ijerph21101385","t":"","x":"mat Pilates","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2024,"r":"positive","s":"Online vs face-to-face mat Pilates vs control: face-to-face reduced fatigue and improved function","v":1,"st":[]},{"i":"PMID:39559920","u":"https://doi.org/10.1002/jcsm.13628","t":"","x":"intermittent hypoxic-hyperoxic training","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":145,"y":2024,"r":"positive","s":"Intermittent hypoxic-hyperoxic training + inpatient rehab vs rehab (n=145): 6MWD gain 2.8-fold; better symptoms and QoL","v":1,"st":[]},{"i":"PMID:39575513","u":"https://doi.org/10.1093/eurheartj/ehae721","t":"","x":"exercise training","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2025,"r":"not-assessable","s":"EXER-COVID exercise training trial; no abstract","v":0,"st":[]},{"i":"PMID:39663092","u":"https://doi.org/10.1016/j.jbmt.2024.11.037","t":"","x":"exercise/rehabilitation + sleep treatment","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":0,"y":2025,"r":"positive","s":"Pilates vs stretching vs control: better 6MWT, sleep and fatigue","v":1,"st":[8]},{"i":"PMID:39681609","u":"https://doi.org/10.1038/s41598-024-82584-4","t":"","x":"symptom-titrated exercise","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":118,"y":2024,"r":"positive","s":"Symptom-titrated exercise in commercial gyms vs control (n=118): better fatigue, HRQoL and performance","v":1,"st":[]},{"i":"PMID:39709881","u":"https://doi.org/10.1016/j.jpsychores.2024.112021","t":"","x":"multimodal psychosomatic treatment","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2025,"r":"positive","s":"Multimodal psychosomatic inpatient treatment, observational: symptoms reduced from admission to discharge","v":1,"st":[]},{"i":"PMID:39835145","u":"https://doi.org/10.3389/fneur.2024.1486751","t":"","x":"exercise/rehabilitation + CBT/psychological therapy","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":701,"y":2024,"r":"positive","s":"PoCoRe inpatient multidisciplinary rehab, observational (n=701): neuropsychological deficits and fatigue improved","v":1,"st":[2]},{"i":"PMID:40014640","u":"https://doi.org/10.1097/hcr.0000000000000928","t":"","x":"combined aerobic + resistance exercise","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2025,"r":"positive","s":"Combined exercise training vs control: endothelial function (FMD) restored to healthy levels","v":1,"st":[]},{"i":"PMID:40040864","u":"https://doi.org/10.1016/j.bbih.2025.100963","t":"","x":"mindfulness programme","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2025,"r":"mixed","s":"Virtual mindfulness in women with long COVID dysautonomia (n=20): better sleep; no objective dysautonomia change","v":1,"st":[2]},{"i":"PMID:40190996","u":"https://doi.org/10.1097/cpt.0000000000000268","t":"","x":"wearable heart-rate pacing device + education","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":9,"y":2025,"r":"feasibility-only","s":"Wearable devices + education, user testing (n=9): most found it helpful","v":1,"st":[6]},{"i":"PMID:40392877","u":"https://doi.org/10.1371/journal.pone.0312714","t":"","x":"online occupational therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":158,"y":2025,"r":"mixed","s":"Online occupational therapy (interactive vs video vs control, n=158): all groups improved cognition; exploratory efficacy","v":1,"st":[]},{"i":"PMID:40559080","u":"https://doi.org/10.3390/jpm15060217","t":"","x":"non-aerobic strength exercise","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":17,"y":2025,"r":"positive","s":"Non-aerobic plank-based exercise in women, uncontrolled: fatigue and body fat fell","v":1,"st":[]},{"i":"PMID:40943540","u":"https://doi.org/10.3390/ijms26178623","t":"","x":"HIIT ± Triphala","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2025,"r":"mixed","s":"HIIT ± Triphala vs control: HIIT reduced inflammation, oxidative stress and dyspnoea; Triphala no added benefit","v":1,"st":[]},{"i":"PMID:40954621","u":"https://doi.org/10.1016/j.jbmt.2025.06.013","t":"","x":"whole-body vibration exercise","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2025,"r":"not-assessable","s":"Whole-body vibration RCT in long COVID (exercise capacity, strength); no abstract","v":0,"st":[]},{"i":"PMID:41302301","u":"https://doi.org/10.3390/healthcare13222914","t":"","x":"immersive VR + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"RCT-active","b":1,"n":0,"y":2025,"r":"positive","s":"VR video-game exercise vs conventional exercise: greater reduction in pain, fatigue (FSS) and depression","v":1,"st":[2]},{"i":"PMID:41367065","u":"https://doi.org/10.12659/msm.950105","t":"","x":"virtual pet-assisted therapy","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":42,"y":2025,"r":"positive","s":"Virtual pet-assisted therapy, uncontrolled (n=42): small symptom and fatigue reductions","v":1,"st":[]},{"i":"PMID:41442105","u":"https://doi.org/10.1007/s40121-025-01287-z","t":"","x":"self-help lymphatic drainage","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":126,"y":2026,"r":"feasibility-only","s":"Self-help lymphatic drainage in long COVID feasibility RCTs (n=126): feasible; signs of benefit","v":1,"st":[]},{"i":"PMID:41493630","u":"https://doi.org/10.1007/s00431-025-06705-5","t":"","x":"online exercise therapy","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2026,"r":"positive","s":"Individualised online exercise therapy in paediatric long COVID, exploratory RCT: better physical function, QoL and school attendance","v":1,"st":[]},{"i":"PMID:41597495","u":"https://doi.org/10.3390/medicina62010210","t":"","x":"motor control-based exercise","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2026,"r":"positive","s":"Motor-control (core) exercise vs control in women: lower MFIS fatigue","v":1,"st":[]},{"i":"PMID:41598473","u":"https://doi.org/10.3390/jcm15020535","t":"","x":"multidisciplinary rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":115,"y":2026,"r":"positive","s":"Paediatric multidisciplinary rehab, quasi-experimental (n=115): 6MWD, fatigue and QoL improved","v":1,"st":[]},{"i":"PMID:41921919","u":"https://doi.org/10.1016/j.ctim.2026.103367","t":"","x":"yoga","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":1,"n":0,"y":2026,"r":"feasibility-only","s":"Breathe Easy yoga programme pilot RCT: feasible; no pre-post symptom difference (underpowered)","v":1,"st":[]},{"i":"PMID:42041818","u":"https://doi.org/10.3390/brainsci16040410","t":"","x":"cognitive rehabilitation + exercise/rehabilitation","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2026,"r":"positive","s":"LearningRx cognitive training pilot: better workplace self-efficacy and cognition","v":1,"st":[2]},{"i":"PMID:42339247","u":"https://doi.org/10.3389/fcogn.2025.1692578","t":"","x":"vibratory-auditory stimulation","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2025,"r":"positive","s":"Vibratory and auditory treatment device vs no device, 4 weeks: better selective attention and inhibition, higher BDNF","v":1,"st":[2]},{"i":"PMID:42435513","u":"https://doi.org/10.1016/j.jpsychores.2026.112920","t":"","x":"CBT","c":"behavioural/rehab","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2026,"r":"positive","s":"CBT vs wait list pilot RCT: medium fatigue reduction (d=-0.58)","v":1,"st":[2]},{"i":"PMID:42522341","u":"https://pubmed.ncbi.nlm.nih.gov/42522341/","t":"","x":"group cognitive treatment","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":23,"y":2026,"r":"mixed","s":"Group cognitive treatment (n=23): verbal learning improved; other domains unchanged","v":1,"st":[]},{"i":"PMID:42855370","u":"https://doi.org/10.1016/j.jagp.2026.09.002","t":"","x":"digital cognitive intervention","c":"behavioural/rehab","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2026,"r":"positive","s":"Digital cognitive intervention in older adults with PASC-Neuro: better mood, everyday function and some cognition","v":1,"st":[]},{"i":"DOI:10.3310/nihropenres.14236.1","u":"https://doi.org/10.3310/nihropenres.14236.1","t":"","x":"auricular vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":114,"y":2026,"r":"null","s":"PAuSing-pCF: percutaneous auricular VNS vs sham vs placebo (n=114): no difference in fatigue at 8 weeks","v":1,"st":[7,8]},{"i":"DRKS00031294","u":"https://doi.org/10.1186/s12868-025-00989-x","t":"","x":"tDCS","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2026,"r":"null","s":"Repetitive anodal tDCS vs sham for cognitive state fatigue: neurophysiological effects only; no subjective or behavioural benefit","v":1,"st":[2]},{"i":"DRKS00031974","u":"https://doi.org/10.1007/s40120-026-00928-w","t":"","x":"transcutaneous auricular VNS","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":45,"y":2026,"r":"null","s":"taVNS vs sham for long COVID fatigue (n=45): safe and adherent; no superiority over sham","v":1,"st":[7,8]},{"i":"ISRCTN49037874","u":"https://doi.org/10.1371/journal.pone.0271350","t":"","x":"neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2022,"r":"positive","s":"Neurofeedback open-label pilot: less anxiety and depression; non-specific effects possible","v":1,"st":[2]},{"i":"NCT04876417","u":"https://clinicaltrials.gov/study/NCT04876417","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":61,"y":2022,"r":"null","s":"tDCS vs sham for post-COVID fatigue (n=61): posted FAS and FSS not better with active tDCS","v":1,"st":[2]},{"i":"NCT04890483","u":"https://clinicaltrials.gov/study/NCT04890483","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2021,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT04944147","u":"https://clinicaltrials.gov/study/NCT04944147","t":"","x":"transcranial stimulation/neurofeedback + cognitive rehabilitation","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":60,"y":2022,"r":"mixed","s":"Cognitive training +/- tDCS (n=60): cognitive training alone did not improve working memory (primary); training + active tDCS did","v":1,"st":[2]},{"i":"NCT04978571","u":"https://clinicaltrials.gov/study/NCT04978571","t":"","x":"percutaneous electrical nerve-field stimulation, PENFS; percutaneous electrical nerve-field stimulation, PENFS (sham device)","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":125,"y":2021,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05092516","u":"https://clinicaltrials.gov/study/NCT05092516","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":31,"y":2022,"r":"null","s":"Home tDCS vs sham for PASC (n=31): inhibitory control unchanged (0.80 vs 0.79)","v":1,"st":[2]},{"i":"NCT05212831","u":"https://clinicaltrials.gov/study/NCT05212831","t":"RESTORE","x":"Inogen One® G4","c":"device/neuromodulation","p":"long COVID","d":"crossover","b":0,"n":21,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-03-02; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05225220","u":"https://clinicaltrials.gov/study/NCT05225220","t":"","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":25,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-01-06; no results posted or published abstract found","v":0,"st":[7,8]},{"i":"NCT05228665","u":"https://clinicaltrials.gov/study/NCT05228665","t":"HEARTLOC","x":"biofeedback","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":30,"y":2022,"r":"positive","s":"HRV biofeedback, single-arm feasibility (n=13): improved C19-YRS, COMPASS-31 and RMSSD","v":1,"st":[8]},{"i":"NCT05252481","u":"https://clinicaltrials.gov/study/NCT05252481","t":"STIMULATECOVID","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":47,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-06-26; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05289115","u":"https://clinicaltrials.gov/study/NCT05289115","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":30,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-04-14; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05289128","u":"https://clinicaltrials.gov/study/NCT05289128","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":30,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-06-25; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05389592","u":"https://clinicaltrials.gov/study/NCT05389592","t":"PASC","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":60,"y":2022,"r":"positive","s":"tDCS + cognitive training vs sham + CT (n=60): small gains in inhibitory control, processing speed and attention; modest effect sizes","v":1,"st":[2]},{"i":"NCT05445427","u":"https://clinicaltrials.gov/study/NCT05445427","t":"","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-usual-care","b":0,"n":18,"y":2022,"r":"null","s":"Vagus nerve stimulation vs none for post-COVID fatigue (n=18): no difference in functional status (p=0.54)","v":1,"st":[7,8]},{"i":"NCT05589272","u":"https://clinicaltrials.gov/study/NCT05589272","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2023,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[2]},{"i":"NCT05630040","u":"https://clinicaltrials.gov/study/NCT05630040","t":"","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"crossover","b":1,"n":40,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2024-10-03; no results posted or published abstract found","v":0,"st":[7,8]},{"i":"NCT05668039","u":"https://clinicaltrials.gov/study/NCT05668039","t":"EXPECT","x":"EECP","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":32,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-04-01; no results posted or published abstract found","v":0,"st":[4,5]},{"i":"NCT05677932","u":"https://clinicaltrials.gov/study/NCT05677932","t":"","x":"photobiomodulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":12,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-02-28; no results posted or published abstract found","v":0,"st":[5]},{"i":"NCT05679505","u":"https://clinicaltrials.gov/study/NCT05679505","t":"","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"crossover","b":1,"n":40,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-01-01; no results posted or published abstract found","v":0,"st":[7,8]},{"i":"NCT05753202","u":"https://clinicaltrials.gov/study/NCT05753202","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-active","b":1,"n":40,"y":2023,"r":"feasibility-only","s":"tDCS (two targets) + cognitive training (n=40): feasible; both groups improved in fatigue and cognition; no sham arm","v":1,"st":[2]},{"i":"NCT05764070","u":"https://clinicaltrials.gov/study/NCT05764070","t":"","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":44,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-03-09; no results posted or published abstract found","v":0,"st":[7,8]},{"i":"NCT05793736","u":"https://clinicaltrials.gov/study/NCT05793736","t":"","x":"biofeedback","c":"device/neuromodulation","p":"long COVID","d":"open-label","b":1,"n":17,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-10-30; no results posted or published abstract found","v":0,"st":[8]},{"i":"NCT05857124","u":"https://clinicaltrials.gov/study/NCT05857124","t":"","x":"photobiomodulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":36,"y":2023,"r":"mixed","s":"Transcranial-intranasal photobiomodulation (Vielight) vs sham (n=43): primary composite cognition p=0.088 (not significant); gains in under-45s exploratory","v":1,"st":[5]},{"i":"NCT05918965","u":"https://clinicaltrials.gov/study/NCT05918965","t":"Vagus","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-active","b":1,"n":45,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-03-01; no results posted or published abstract found","v":0,"st":[7,8]},{"i":"NCT05922865","u":"https://clinicaltrials.gov/study/NCT05922865","t":"","x":"KNEESUP smart knee assistive device + KNEESUP care APP; Healthy consulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":120,"y":2023,"r":"positive","s":"Exercise telerehabilitation with smart sensor vs active control (n=120): VO2peak +2.1 and gait speed improved; QoL and sleep unchanged","v":1,"st":[]},{"i":"NCT05931497","u":"https://clinicaltrials.gov/study/NCT05931497","t":"","x":"whole body hyperthermia","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":21,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06074848","u":"https://clinicaltrials.gov/study/NCT06074848","t":"tDCS","x":"transcranial stimulation/neurofeedback + exercise/rehabilitation + cognitive rehabilitation","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":48,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-07-01; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT06113679","u":"https://clinicaltrials.gov/study/NCT06113679","t":"EB-PCC-01","x":"RDX-19","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":41,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-05-24; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06178952","u":"https://clinicaltrials.gov/study/NCT06178952","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":102,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06183424","u":"https://clinicaltrials.gov/study/NCT06183424","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"crossover","b":1,"n":50,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06189066","u":"https://clinicaltrials.gov/study/NCT06189066","t":"LOCUS","x":"Splenic Ultrasound","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":15,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-07-24; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06510985","u":"https://clinicaltrials.gov/study/NCT06510985","t":"","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"crossover","b":1,"n":120,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[7,8]},{"i":"NCT06544395","u":"https://clinicaltrials.gov/study/NCT06544395","t":"COVID-19","x":"transcranial stimulation/neurofeedback + acupuncture/manual therapy","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":104,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06586398","u":"https://clinicaltrials.gov/study/NCT06586398","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":10,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06637800","u":"https://clinicaltrials.gov/study/NCT06637800","t":"","x":"Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100)","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2025,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[]},{"i":"NCT06739668","u":"https://clinicaltrials.gov/study/NCT06739668","t":"","x":"Pascal device","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":30,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06928506","u":"https://clinicaltrials.gov/study/NCT06928506","t":"RECLAIM-HiOxSR","x":"Hi-OxSR device; Hi-Ox device","c":"device/neuromodulation","p":"long COVID","d":"RCT-active","b":1,"n":120,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06996314","u":"https://clinicaltrials.gov/study/NCT06996314","t":"","x":"vagus nerve stimulation + breathing/respiratory training","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":100,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[7,8]},{"i":"NCT07005921","u":"https://clinicaltrials.gov/study/NCT07005921","t":"QEEG-NFT","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":40,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT07154199","u":"https://clinicaltrials.gov/study/NCT07154199","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":40,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT07190105","u":"https://clinicaltrials.gov/study/NCT07190105","t":"","x":"vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-usual-care","b":0,"n":546,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[7,8]},{"i":"NCT07278206","u":"https://clinicaltrials.gov/study/NCT07278206","t":"MALIBU","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":66,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT07279272","u":"https://clinicaltrials.gov/study/NCT07279272","t":"HR-QoL","x":"Cold Atmospheric Plasma; Atmospheric Air","c":"device/neuromodulation","p":"long COVID","d":"crossover","b":1,"n":40,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-07-22; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT07312357","u":"https://clinicaltrials.gov/study/NCT07312357","t":"WB-EMS PostCOV","x":"Whole-Body Electromyostimulation Suit","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":30,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07397130","u":"https://clinicaltrials.gov/study/NCT07397130","t":"","x":"biofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-usual-care","b":1,"n":80,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-08-01; no results posted or published abstract found","v":0,"st":[8]},{"i":"NCT07492953","u":"https://clinicaltrials.gov/study/NCT07492953","t":"","x":"EECP","c":"device/neuromodulation","p":"long COVID","d":"open-label","b":0,"n":10,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-06-24; no results posted or published abstract found","v":0,"st":[4,5]},{"i":"NCT07709234","u":"https://clinicaltrials.gov/study/NCT07709234","t":"NEUROSTIM-LC","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT07880171","u":"https://clinicaltrials.gov/study/NCT07880171","t":"","x":"transcranial stimulation/neurofeedback","c":"device/neuromodulation","p":"long COVID","d":"crossover","b":1,"n":40,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"PMID:34924406","u":"https://doi.org/10.3233/rnn-211249","t":"","x":"transcranial alternating current stimulation","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":2,"y":2021,"r":"positive","s":"Non-invasive brain microcurrent stimulation, two cases: cognition and visual field improved","v":1,"st":[2]},{"i":"PMID:36002874","u":"https://doi.org/10.1186/s42234-022-00094-y","t":"","x":"transcutaneous auricular VNS","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2022,"r":"feasibility-only","s":"Home taVNS pilot RCT vs sham: feasible and safe; trends only","v":1,"st":[7,8]},{"i":"PMID:36693536","u":"https://doi.org/10.1016/j.brs.2023.01.1672","t":"","x":"HD-tDCS","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":70,"y":2023,"r":"positive","s":"HD-tDCS (M1) + rehab vs sham + rehab: larger MFIS fatigue reduction (22 vs 10 points)","v":1,"st":[2]},{"i":"PMID:37091591","u":"https://doi.org/10.1093/braincomms/fcad117","t":"","x":"tDCS","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":70,"y":2023,"r":"mixed","s":"tDCS vs sham for post-COVID fatigue (n=~70): physical fatigue improved; cognitive fatigue and QoL did not","v":1,"st":[2]},{"i":"PMID:38179014","u":"https://doi.org/10.1155/2023/6687803","t":"","x":"enhanced external counterpulsation","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":10,"y":2023,"r":"positive","s":"Enhanced external counterpulsation for PASC microvascular angina/fatigue (n=10): 6MWD and fatigue improved; uncontrolled","v":1,"st":[4,5]},{"i":"PMID:38272997","u":"https://doi.org/10.1038/s41598-024-52763-4","t":"","x":"tDCS","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":34,"y":2024,"r":"null","s":"tDCS vs sham for long COVID neuropsychiatric symptoms: no difference in fatigue, mood, QoL or cognition","v":1,"st":[2]},{"i":"PMID:38371381","u":"https://doi.org/10.1016/j.bbih.2024.100736","t":"","x":"rTMS (iTBS)","c":"device/neuromodulation","p":"long COVID","d":"crossover","b":1,"n":4,"y":2024,"r":"mixed","s":"iTBS rTMS vs sham case series (n=4): positive trends only","v":1,"st":[2]},{"i":"PMID:38458016","u":"https://doi.org/10.1016/j.jpsychores.2024.111625","t":"","x":"HRV biofeedback","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2024,"r":"positive","s":"HRV biofeedback open trial: somatic, anxiety, sleep and QoL improved; uncontrolled","v":1,"st":[8]},{"i":"PMID:38756213","u":"https://doi.org/10.3389/fneur.2024.1393371","t":"","x":"transcutaneous vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2024,"r":"positive","s":"tVNS pilot in women: cognitive and other symptoms improved; uncontrolled","v":1,"st":[7,8]},{"i":"PMID:39531278","u":"https://doi.org/10.1097/yct.0000000000001072","t":"","x":"rTMS","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2025,"r":"mixed","s":"rTMS case series: fatigue and depression scores fell; not significant","v":1,"st":[2]},{"i":"PMID:39969545","u":"https://doi.org/10.1007/s00508-025-02501-1","t":"","x":"auricular vagus nerve stimulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-active","b":1,"n":0,"y":2025,"r":"feasibility-only","s":"Transdermal auricular VNS (TENS) at different frequencies in women: feasible; fatigue and dyspnoea fell in all groups; no sham","v":1,"st":[7,8]},{"i":"PMID:40071827","u":"https://doi.org/10.1177/21501319251325639","t":"","x":"wearable EEG neurofeedback device","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2025,"r":"positive","s":"Wearable S-EEG brain-activity device, open-label: cognition, sleep and QoL improved; less stress and anxiety; uncontrolled","v":1,"st":[2]},{"i":"PMID:40097846","u":"https://doi.org/10.1007/s00508-025-02522-w","t":"","x":"pulsed electromagnetic field therapy","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2025,"r":"positive","s":"Pulsed electromagnetic field therapy vs sham pilot: better 6MWT and fatigue (BFI, MFI)","v":1,"st":[]},{"i":"PMID:40426680","u":"https://doi.org/10.3390/brainsci15050510","t":"","x":"superficial neuromodulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2025,"r":"null","s":"Superficial neuromodulation vs control in post-COVID dysautonomia: both improved fatigue; HRV better only in active; likely placebo","v":1,"st":[2]},{"i":"PMID:40806985","u":"https://doi.org/10.3390/jcm14155363","t":"","x":"HRV biofeedback","c":"device/neuromodulation","p":"long COVID","d":"RCT-usual-care","b":0,"n":36,"y":2025,"r":"positive","s":"HRV biofeedback (VR) vs control in long COVID CFS: severe fatigue improved more (p=0.043); feasible","v":1,"st":[8]},{"i":"PMID:41537614","u":"https://doi.org/10.17116/kurort20251020615","t":"","x":"transcranial electrical stimulation","c":"device/neuromodulation","p":"long COVID","d":"RCT-active","b":0,"n":150,"y":2025,"r":"positive","s":"Transcranial electrical stimulation + Cortexin vs Cortexin (n=150, post-COVID): better fatigue and cognition","v":1,"st":[2]},{"i":"PMID:42106490","u":"https://doi.org/10.1038/s41598-026-52582-9","t":"","x":"transcutaneous auricular VNS","c":"device/neuromodulation","p":"long COVID","d":"single-arm","b":1,"n":0,"y":2026,"r":"positive","s":"taVNS open-label: COMPASS-31 fell from 34 to 14; better PTSD and cognitive scores","v":1,"st":[7,8]},{"i":"PMID:42501005","u":"https://doi.org/10.1177/21501319261473073","t":"","x":"non-invasive vagus nerve stimulation (gammaCore)","c":"device/neuromodulation","p":"long COVID","d":"RCT-usual-care","b":0,"n":18,"y":2026,"r":"null","s":"Handheld non-invasive VNS vs control pilot (n=18): improvements not significant","v":1,"st":[7,8]},{"i":"PMID:42846928","u":"https://doi.org/10.1093/braincomms/fcag364","t":"","x":"microtesla magnetic therapy","c":"device/neuromodulation","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2026,"r":"mixed","s":"Microtesla magnetic therapy vs sham pilot: nominal gains on selected cognitive measures and anxiety","v":1,"st":[]},{"i":"2022-001781-35","u":"https://doi.org/10.1101/2024.12.13.24318856","t":"","x":"BC007 (rovunaptabin, aptamer)","c":"immunomodulator","p":"long COVID","d":"crossover","b":1,"n":30,"y":2024,"r":"positive","s":"reCOVer: BC007 (rovunaptabin) vs placebo, crossover (n=30): well tolerated; significant improvement in fatigue and QoL reported","v":1,"st":[1,4]},{"i":"2023-504087-42-00","u":"https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-504087-42-00","t":"THALASA","x":"corticosteroid + plitidepsin","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":260,"y":"","r":"pending","s":"Registry record only (EU CTIS); results first received: No","v":0,"st":[1,6,7]},{"i":"CTRI/2021/11/038234","u":"https://doi.org/10.1001/jamainternmed.2025.5408","t":"","x":"colchicine","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":346,"y":2025,"r":"null","s":"Colchicine vs placebo (n=346, India): no improvement in 6MWT, respiratory function or inflammation at 52 weeks","v":1,"st":[6,7]},{"i":"DOI:10.1101/2023.06.08.23291102","u":"https://doi.org/10.1101/2023.06.08.23291102","t":"","x":"low-dose naltrexone","c":"immunomodulator","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2023,"r":"positive","s":"LDN observational use: fewer symptoms (fatigue, PEM, sleep) and better function","v":1,"st":[6,7]},{"i":"IRCT20090117001556N138","u":"https://doi.org/10.1016/j.jpsychores.2023.111389","t":"","x":"famotidine","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2023,"r":"positive","s":"Famotidine vs placebo: better MMSE, MoCA and depression scores at 6 and 12 weeks","v":1,"st":[6,7]},{"i":"ISRCTN10665760 (paper 2)","u":"https://doi.org/10.1016/s1473-3099(26)00242-2","t":"","x":"colchicine + antihistamine/mast-cell stabiliser","c":"immunomodulator","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2026,"r":"mixed","s":"STIMULATE-ICP drug arms: rivaroxaban, colchicine, famotidine-loratadine vs no drug: small extra fatigue reductions with colchicine and famotidine-loratadine, not sustained","v":1,"st":[6,7]},{"i":"ISRCTN46454974","u":"https://www.isrctn.com/ISRCTN46454974","t":"PHOSP-I","x":"tocilizumab","c":"immunomodulator","p":"long COVID","d":"RCT-unspecified","b":0,"n":152,"y":2024,"r":"pending","s":"Registry record only; no results read","v":0,"st":[6,7]},{"i":"NCT04604704","u":"https://clinicaltrials.gov/study/NCT04604704","t":"","x":"low-dose naltrexone + NADH/NAD+ precursor","c":"immunomodulator","p":"long COVID","d":"single-arm","b":0,"n":36,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2023-01-23; no results posted or published abstract found","v":0,"st":[5,6,7]},{"i":"NCT04909892","u":"https://clinicaltrials.gov/study/NCT04909892","t":"","x":"cell therapy (MSC/cord blood)","c":"immunomodulator","p":"long COVID","d":"RCT-active","b":0,"n":0,"y":2021,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[6]},{"i":"NCT04944121","u":"https://clinicaltrials.gov/study/NCT04944121","t":"","x":"RSLV-132","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":112,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2023-10-31; no results posted or published abstract found","v":0,"st":[1]},{"i":"NCT04992247","u":"https://clinicaltrials.gov/study/NCT04992247","t":"BR","x":"cell therapy (MSC/cord blood)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[6]},{"i":"NCT05116761","u":"https://clinicaltrials.gov/study/NCT05116761","t":"","x":"cell therapy (MSC/cord blood)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[6]},{"i":"NCT05126563","u":"https://clinicaltrials.gov/study/NCT05126563","t":"HBPCOVID02","x":"HB-adMSCs (allogeneic)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":79,"y":2022,"r":"null","s":"Allogeneic adipose MSCs (HB-adMSCs) vs placebo (n=79): no difference in fatigue (p=0.94) or brain fog (p=0.80)","v":1,"st":[]},{"i":"NCT05350774","u":"https://clinicaltrials.gov/study/NCT05350774","t":"","x":"immunoglobulin (IVIG/SCIG)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":45,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"NCT05497089","u":"https://clinicaltrials.gov/study/NCT05497089","t":"","x":"temelimab","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":203,"y":2022,"r":"null","s":"Temelimab (anti-HERV-W Env) vs placebo (n=203): no improvement in fatigue","v":1,"st":[1,7]},{"i":"NCT05592418","u":"https://clinicaltrials.gov/study/NCT05592418","t":"","x":"rintatolimod","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":80,"y":2023,"r":"null","s":"Rintatolimod (Ampligen) vs placebo in post-COVID fatigue (n=80): PROMIS fatigue change identical (difference 0.03, p=0.99)","v":1,"st":[1,7]},{"i":"NCT05633407","u":"https://clinicaltrials.gov/study/NCT05633407","t":"POTS","x":"efgartigimod","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":53,"y":2022,"r":"null","s":"Efgartigimod (FcRn blocker) vs placebo in post-COVID POTS (n=53): COMPASS-31 change -14.4 vs -16.0; no benefit","v":1,"st":[1]},{"i":"NCT05682560","u":"https://clinicaltrials.gov/study/NCT05682560","t":"","x":"cell therapy (MSC/cord blood)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":30,"y":2023,"r":"positive","s":"REGENECYTE cord blood infusions vs placebo (n=30): safe; meaningful and durable fatigue reduction; small, industry-funded","v":1,"st":[6]},{"i":"NCT05719012","u":"https://clinicaltrials.gov/study/NCT05719012","t":"","x":"cell therapy (MSC/cord blood)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2023,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[6]},{"i":"NCT05747534","u":"https://clinicaltrials.gov/study/NCT05747534","t":"","x":"larazotide","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":107,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[1,7]},{"i":"NCT05858515","u":"https://clinicaltrials.gov/study/NCT05858515","t":"REVERSE-LC","x":"JAK inhibitor","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[6,7]},{"i":"NCT05911009","u":"https://clinicaltrials.gov/study/NCT05911009","t":"BLOC","x":"BC007 (rovunaptabin)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":119,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-06-26; no results posted or published abstract found","v":0,"st":[1,4]},{"i":"NCT05918978","u":"https://clinicaltrials.gov/study/NCT05918978","t":"POTS","x":"efgartigimod","c":"immunomodulator","p":"long COVID","d":"single-arm","b":0,"n":33,"y":2023,"r":"not-assessable","s":"Efgartigimod open-label extension (terminated): safety counts only","v":0,"st":[1]},{"i":"NCT05926505","u":"https://clinicaltrials.gov/study/NCT05926505","t":"PRECISION","x":"anakinra","c":"immunomodulator","p":"long COVID","d":"crossover","b":1,"n":182,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[6,7]},{"i":"NCT05946551","u":"https://clinicaltrials.gov/study/NCT05946551","t":"","x":"antihistamine/mast-cell stabiliser","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":5,"y":2024,"r":"feasibility-only","s":"TLC feasibility trial (terminated, n=5): adherence counts only","v":1,"st":[6,7]},{"i":"NCT05986422","u":"https://clinicaltrials.gov/study/NCT05986422","t":"","x":"corticosteroid","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":96,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-03-14; no results posted or published abstract found","v":0,"st":[6,7]},{"i":"NCT06156241","u":"https://clinicaltrials.gov/study/NCT06156241","t":"COVID-19","x":"cell therapy (MSC/cord blood)","c":"immunomodulator","p":"long COVID","d":"open-label","b":0,"n":12,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[6]},{"i":"NCT06305793","u":"https://clinicaltrials.gov/study/NCT06305793","t":"","x":"immunoglobulin (IVIG/SCIG)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":200,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"NCT06492798","u":"https://clinicaltrials.gov/study/NCT06492798","t":"","x":"cell therapy (MSC/cord blood)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":76,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-07-01; no results posted or published abstract found","v":0,"st":[6]},{"i":"NCT06524739","u":"https://clinicaltrials.gov/study/NCT06524739","t":"","x":"immunoglobulin (IVIG/SCIG)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":16,"y":2024,"r":"not-assessable","s":"IgPro20 (SC immunoglobulin) vs placebo in post-COVID POTS (terminated, n=16): 33% off-criteria on drug; placebo value not shown; uninterpretable","v":0,"st":[1]},{"i":"NCT06597396","u":"https://clinicaltrials.gov/study/NCT06597396","t":"CLEAR-LC","x":"JAK inhibitor","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":46,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[6,7]},{"i":"NCT06597682","u":"https://clinicaltrials.gov/study/NCT06597682","t":"RISE","x":"corticosteroid + coenzyme Q10 + montelukast","c":"immunomodulator","p":"long COVID","d":"RCT-active","b":0,"n":632,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[5,6,7]},{"i":"NCT06631287","u":"https://clinicaltrials.gov/study/NCT06631287","t":"REVERSE-LC","x":"JAK inhibitor","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":550,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[6,7]},{"i":"NCT06847191","u":"https://clinicaltrials.gov/study/NCT06847191","t":"ADDRESS-LC","x":"NE3107","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":203,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[6,7]},{"i":"NCT06940765","u":"https://clinicaltrials.gov/study/NCT06940765","t":"","x":"cell therapy (MSC/cord blood)","c":"immunomodulator","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2021,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[6]},{"i":"NCT06960928","u":"https://clinicaltrials.gov/study/NCT06960928","t":"","x":"rapamycin (sirolimus)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":80,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[1,6]},{"i":"NCT06974084","u":"https://clinicaltrials.gov/study/NCT06974084","t":"IMPACT-LC","x":"maraviroc + statin","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":252,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[1,6,7]},{"i":"NCT07108036","u":"https://clinicaltrials.gov/study/NCT07108036","t":"INTERRUPT_LC","x":"N-803 (IL-15 superagonist)","c":"immunomodulator","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"NCT07123727","u":"https://clinicaltrials.gov/study/NCT07123727","t":"","x":"N-803 (IL-15 superagonist)","c":"immunomodulator","p":"long COVID","d":"single-arm","b":0,"n":40,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"NCT07184385","u":"https://clinicaltrials.gov/study/NCT07184385","t":"","x":"cell therapy (MSC/cord blood)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":60,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[6]},{"i":"NCT07388550","u":"https://clinicaltrials.gov/study/NCT07388550","t":"","x":"pembrolizumab","c":"immunomodulator","p":"long COVID","d":"single-arm","b":0,"n":15,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[1]},{"i":"PMID:35814187","u":"https://doi.org/10.1016/j.bbih.2022.100485","t":"","x":"low-dose naltrexone","c":"immunomodulator","p":"long COVID","d":"single-arm","b":0,"n":52,"y":2022,"r":"positive","s":"LDN pre-post study (n=52): improved well-being and fewer symptoms; uncontrolled","v":1,"st":[6,7]},{"i":"PMID:36267491","u":"https://doi.org/10.1007/s40200-022-01138-5","t":"","x":"adalimumab (TNF inhibitor)","c":"immunomodulator","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2022,"r":"positive","s":"Adalimumab case series in post-COVID neuropsychiatric complications: dramatic improvement reported","v":1,"st":[6,7]},{"i":"PMID:36844201","u":"https://doi.org/10.3389/fmed.2023.1122529","t":"","x":"maraviroc + statin","c":"immunomodulator","p":"long COVID","d":"single-arm","b":1,"n":18,"y":2023,"r":"positive","s":"Maraviroc + pravastatin case series (n=18): symptoms and vascular markers fell; uncontrolled","v":1,"st":[1,6,7]},{"i":"PMID:37529714","u":"https://doi.org/10.3389/fcvm.2023.1202696","t":"","x":"antihistamines (H1 + H2)","c":"immunomodulator","p":"long COVID","d":"open-label","b":0,"n":0,"y":2023,"r":"positive","s":"H1+H2 antihistamines vs untreated controls: symptoms resolved in 29% and improved in all treated","v":1,"st":[6,7]},{"i":"PMID:38267326","u":"https://doi.org/10.1016/j.clinthera.2023.12.009","t":"","x":"low-dose naltrexone","c":"immunomodulator","p":"long COVID","d":"open-label","b":0,"n":108,"y":2024,"r":"positive","s":"LDN vs physical therapy in post-COVID clinic, retrospective (n=108): higher hazard of improvement with LDN; observational","v":1,"st":[6,7]},{"i":"PMID:38728385","u":"https://doi.org/10.1093/cid/ciae205","t":"","x":"RSLV-132 (RNase)","c":"immunomodulator","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"null","s":"RNase (RSLV-132) vs placebo in severe PASC fatigue: no difference at day 71; earlier timepoints better","v":1,"st":[1]},{"i":"DOI:10.21203/rs.3.rs-9517130/v1","u":"https://doi.org/10.21203/rs.3.rs-9517130/v1","t":"","x":"metformin","c":"metabolic/mitochondrial","p":"long COVID","d":"n-of-1","b":0,"n":3,"y":2026,"r":"positive","s":"Metformin, three cases with dechallenge/rechallenge: fatigue and cognition improved","v":1,"st":[5,6]},{"i":"KCT0009342","u":"https://doi.org/10.7326/annals-25-04883","t":"","x":"metformin / ursodeoxycholic acid","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":396,"y":2026,"r":"null","s":"Metformin or ursodeoxycholic acid vs placebo 2 weeks (n=396, Korea): no improvement in recovery","v":1,"st":[5,6]},{"i":"NCT04592354","u":"https://clinicaltrials.gov/study/NCT04592354","t":"AEO","x":"oxaloacetate","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":40,"y":2020,"r":"positive","s":"Oxaloacetate, open-label (ME/CFS and long COVID): fatigue fell over 6 weeks; uncontrolled","v":1,"st":[5,6]},{"i":"NCT04809974","u":"https://clinicaltrials.gov/study/NCT04809974","t":"","x":"NADH/NAD+ precursor","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":58,"y":2021,"r":"null","s":"Nicotinamide riboside (n=58): raised NAD+ but no improvement in cognition, fatigue, sleep or mood vs placebo","v":1,"st":[5,6]},{"i":"NCT04960215","u":"https://clinicaltrials.gov/study/NCT04960215","t":"","x":"coenzyme Q10","c":"metabolic/mitochondrial","p":"long COVID","d":"crossover","b":1,"n":121,"y":2023,"r":"null","s":"High-dose CoQ10 500 mg vs placebo, crossover (n=121): no reduction in PCC symptoms","v":1,"st":[5,6]},{"i":"NCT05152849","u":"https://clinicaltrials.gov/study/NCT05152849","t":"","x":"AXA1125","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":41,"y":2021,"r":"mixed","s":"AXA1125 (n=41): primary muscle PCr recovery not improved; fatigue scores improved vs placebo","v":1,"st":[5,6]},{"i":"NCT05178225","u":"https://clinicaltrials.gov/study/NCT05178225","t":"SpaCOVID","x":"coenzyme Q10 + exercise/rehabilitation + anticoagulant/antiplatelet","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":0,"n":51,"y":2021,"r":"positive","s":"Mountain spa rehab + ubiquinol: faster recovery and higher CoQ10 vs spa alone; unblinded","v":1,"st":[4,5,6]},{"i":"NCT05689827","u":"https://clinicaltrials.gov/study/NCT05689827","t":"","x":"meldonium/EMHPS","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":160,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-11-10; no results posted or published abstract found","v":0,"st":[5,6]},{"i":"NCT05703074","u":"https://clinicaltrials.gov/study/NCT05703074","t":"MINIRICO","x":"NADH/NAD+ precursor","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":310,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-09-23; no results posted or published abstract found","v":0,"st":[5,6]},{"i":"NCT06171152","u":"https://clinicaltrials.gov/study/NCT06171152","t":"","x":"GLP-1 agonist","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-active","b":0,"n":30,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[6,7]},{"i":"NCT06721949","u":"https://clinicaltrials.gov/study/NCT06721949","t":"","x":"taurine","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":300,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT06907251","u":"https://clinicaltrials.gov/study/NCT06907251","t":"DALCO","x":"SGLT2 inhibitor","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":192,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT06992414","u":"https://clinicaltrials.gov/study/NCT06992414","t":"","x":"creatine/GAA","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":24,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT07128082","u":"https://clinicaltrials.gov/study/NCT07128082","t":"LOCITT","x":"GLP-1 agonist","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":1000,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[6,7]},{"i":"NCT07280572","u":"https://clinicaltrials.gov/study/NCT07280572","t":"RECLAIM","x":"metformin + colchicine","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-usual-care","b":0,"n":1250,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[5,6,7]},{"i":"NCT07298005","u":"https://clinicaltrials.gov/study/NCT07298005","t":"SON4PEM","x":"sonlicromanol","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":80,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT07682402","u":"https://clinicaltrials.gov/study/NCT07682402","t":"TaurineLCPeds","x":"taurine","c":"metabolic/mitochondrial","p":"long COVID","d":"single-arm","b":0,"n":30,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT07798570","u":"https://clinicaltrials.gov/study/NCT07798570","t":"CICR-NAM-PCS","x":"NADH/NAD+ precursor","c":"metabolic/mitochondrial","p":"long COVID","d":"single-arm","b":0,"n":100,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"PMID:34037351","u":"https://doi.org/10.17116/jnevro202112104125","t":"","x":"Neurox (EMHPS)","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2021,"r":"positive","s":"Neurox (ethylmethylhydroxypyridine succinate) vs control in post-COVID asthenia: VAS and MFI-20 improved only on drug","v":1,"st":[]},{"i":"PMID:34874654","u":"https://doi.org/10.17116/jnevro202112110145","t":"","x":"NADH/NAD+ precursor + exercise/rehabilitation","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2021,"r":"positive","s":"CITADEL: Cytoflavin vs control in post-COVID rehab: anti-asthenic effect and cognitive gains","v":1,"st":[5,6]},{"i":"PMID:37167167","u":"https://doi.org/10.26442/00403660.2022.11.201981","t":"","x":"Brainmax (ethylmethylhydroxypyridine succinate + meldonium)","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2022,"r":"positive","s":"Brainmax vs placebo in post-COVID asthenia: MFI-20 -19.5 vs -3; better sleep","v":1,"st":[5,6]},{"i":"PMID:37970399","u":"https://doi.org/10.1002/fsn3.3597","t":"","x":"creatine","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":12,"y":2023,"r":"mixed","s":"Creatine vs placebo 6 months in post-COVID fatigue (n=12): general fatigue fell vs baseline at 3 months; several symptoms improved at 6 months","v":1,"st":[5,6]},{"i":"PMID:38099612","u":"https://doi.org/10.4103/jpgm.jpgm_650_23","t":"","x":"creatine/GAA + breathing/respiratory training","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"positive","s":"Creatine + breathing exercises vs breathing alone: less respiratory discomfort, higher tissue creatine, longer time to exhaustion","v":1,"st":[5,6]},{"i":"PMID:38684388","u":"https://doi.org/10.3177/jnsv.70.174","t":"","x":"creatine + glucose","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"positive","s":"Creatine-glucose vs placebo 8 weeks: fewer body aches, concentration problems and headache","v":1,"st":[5,6]},{"i":"PMID:38713041","u":"https://doi.org/10.26442/00403660.2024.03.202639","t":"","x":"inhaled nitric oxide + hydrogen","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2024,"r":"positive","s":"Inhaled nitric oxide + molecular hydrogen in post-COVID rehab vs control: less dyspnoea and fatigue; better 6MWT","v":1,"st":[5,6]},{"i":"PMID:38794767","u":"https://doi.org/10.3390/nu16101529","t":"","x":"hydrogen-rich water","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"positive","s":"Hydrogen-rich water vs placebo water 14 days: lower FSS, better 6MWT and sleep; dyspnoea unchanged","v":1,"st":[5,6]},{"i":"PMID:41859790","u":"https://doi.org/10.26442/00403660.2026.03.203537","t":"","x":"inhaled nitric oxide + hydrogen","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-active","b":0,"n":0,"y":2026,"r":"positive","s":"Inhaled NO + H2 vs NO vs control: regression of dyspnoea, cough and fatigue; better QoL and microcirculation","v":1,"st":[5,6]},{"i":"PMID:41958909","u":"https://doi.org/10.3389/fnut.2026.1731306","t":"","x":"creatine","c":"metabolic/mitochondrial","p":"long COVID","d":"RCT-placebo","b":1,"n":67,"y":2026,"r":"positive","s":"Creatine 6 g vs 18 g vs placebo (n=67): 6 g/day improved fatigue and muscle strength","v":1,"st":[5,6]},{"i":"NCT05813899","u":"https://clinicaltrials.gov/study/NCT05813899","t":"","x":"microbiome therapy","c":"microbiome","p":"long COVID","d":"RCT-placebo","b":1,"n":39,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-12-31; no results posted or published abstract found","v":0,"st":[1,7]},{"i":"NCT05975034","u":"https://clinicaltrials.gov/study/NCT05975034","t":"","x":"microbiome therapy","c":"microbiome","p":"long COVID","d":"RCT-placebo","b":1,"n":240,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-12-11; no results posted or published abstract found","v":0,"st":[1,7]},{"i":"NCT06348212","u":"https://clinicaltrials.gov/study/NCT06348212","t":"COVID-19","x":"microbiome therapy","c":"microbiome","p":"long COVID","d":"RCT-placebo","b":1,"n":60,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-08; no results posted or published abstract found","v":0,"st":[1,7]},{"i":"NCT06560554","u":"https://clinicaltrials.gov/study/NCT06560554","t":"","x":"microbiome therapy + diet","c":"microbiome","p":"long COVID","d":"RCT-active","b":1,"n":40,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[1,7]},{"i":"NCT06620406","u":"https://clinicaltrials.gov/study/NCT06620406","t":"","x":"microbiome therapy","c":"microbiome","p":"long COVID","d":"RCT-placebo","b":1,"n":36,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-08-06; no results posted or published abstract found","v":0,"st":[1,7]},{"i":"NCT06643299","u":"https://clinicaltrials.gov/study/NCT06643299","t":"PURE-LC","x":"microbiome therapy","c":"microbiome","p":"long COVID","d":"crossover","b":1,"n":194,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[1,7]},{"i":"PMID:39106427","u":"https://doi.org/10.1212/nxi.0000000000200296","t":"","x":"paraprobiotics","c":"microbiome","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2024,"r":"positive","s":"Paraprobiotics pilot: some neurological symptoms improved alongside immune changes; Class IV","v":1,"st":[1,7]},{"i":"2023-507870-42-00","u":"https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-507870-42-00","t":"RIMOCOVID-1","x":"rimonabant","c":"other","p":"long COVID","d":"unclear","b":0,"n":80,"y":"","r":"pending","s":"Registry record only (EU CTIS); results first received: No","v":0,"st":[2,7]},{"i":"2025-524443-12-00","u":"https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2025-524443-12-00","t":"2025-03997","x":"antidepressant","c":"other","p":"long COVID","d":"RCT-unspecified","b":0,"n":250,"y":2026,"r":"pending","s":"Registry record only (EU CTIS); results first received: No","v":0,"st":[2]},{"i":"CHICTR2300070565","u":"https://doi.org/10.1016/j.rmed.2024.107763","t":"","x":"intermittent hypoxia exposure","c":"other","p":"long COVID","d":"RCT-placebo","b":0,"n":95,"y":2024,"r":"positive","s":"Intermittent hypoxia exposure vs normoxia (n=95): better 6MWD, spirometry, dyspnoea and fatigue","v":1,"st":[]},{"i":"DOI:10.21203/rs.3.rs-10729022/v1","u":"https://doi.org/10.21203/rs.3.rs-10729022/v1","t":"","x":"manual lymphatic drainage","c":"other","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2026,"r":"positive","s":"Head and neck manual lymphatic drainage, single-arm: brain fog, concentration and fatigue fell","v":1,"st":[]},{"i":"DOI:10.21203/rs.3.rs-2063399/v1","u":"https://doi.org/10.21203/rs.3.rs-2063399/v1","t":"","x":"nicotine patch + transcranial stimulation/neurofeedback","c":"other","p":"long COVID","d":"single-arm","b":0,"n":4,"y":2022,"r":"positive","s":"Nicotine patch, case series: rapid symptom improvement to remission; anecdotal","v":1,"st":[2,7]},{"i":"DOI:10.22541/au.168849372.20263077/v1","u":"https://doi.org/10.22541/au.168849372.20263077/v1","t":"","x":"cannabidiol-dominant cannabis medicine","c":"other","p":"long COVID","d":"single-arm","b":0,"n":12,"y":2023,"r":"feasibility-only","s":"CBD-dominant cannabis product, single-arm (n=~12): safe and feasible","v":1,"st":[2]},{"i":"DOI:10.64898/2026.08.19.26360832","u":"https://doi.org/10.64898/2026.08.19.26360832","t":"","x":"injectable repurposed drug (decentralised trial)","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":1058,"y":2026,"r":"not-assessable","s":"Direct-to-participant decentralised placebo-controlled trial of an injectable drug (n=1,058): infrastructure report, efficacy not in abstract","v":0,"st":[]},{"i":"IRCT20210816052203N1","u":"https://doi.org/10.1016/j.jocn.2023.09.005","t":"","x":"donepezil","c":"other","p":"long COVID","d":"RCT-placebo","b":0,"n":0,"y":2023,"r":"null","s":"Donepezil 5 mg vs control for post-COVID memory impairment: no overall memory improvement; some subtests","v":1,"st":[2]},{"i":"ISRCTN11050086","u":"https://www.isrctn.com/ISRCTN11050086","t":"COVI-Care M-V","x":"COVI-Care M-V","c":"other","p":"long COVID","d":"RCT-unspecified","b":0,"n":240,"y":2026,"r":"pending","s":"Registry record only; no results read; outputs listed on registry","v":0,"st":[]},{"i":"ISRCTN11563542","u":"https://www.isrctn.com/ISRCTN11563542","t":"COVID VR","x":"COVID VR","c":"other","p":"long COVID","d":"RCT-unspecified","b":0,"n":6,"y":2021,"r":"unreported-after-completion","s":"Registry record only; no results read","v":0,"st":[]},{"i":"ISRCTN15106165","u":"https://www.isrctn.com/ISRCTN15106165","t":"ACU-POCO","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"RCT-unspecified","b":0,"n":50,"y":2024,"r":"pending","s":"Registry record only; no results read","v":0,"st":[]},{"i":"NCT03554265","u":"https://clinicaltrials.gov/study/NCT03554265","t":"","x":"growth hormone","c":"other","p":"long COVID","d":"open-label","b":0,"n":72,"y":2018,"r":"mixed","s":"Growth hormone in PASC: neurologic symptom scores improved but cognition, body composition and physical performance unchanged","v":1,"st":[2]},{"i":"NCT04647656","u":"https://clinicaltrials.gov/study/NCT04647656","t":"HBOTpCOVID","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":91,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT04652518","u":"https://clinicaltrials.gov/study/NCT04652518","t":"","x":"(deu)pirfenidone","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":177,"y":2020,"r":"null","s":"Deupirfenidone (n=185): 6MWD improved in both arms; no difference vs placebo","v":1,"st":[6]},{"i":"NCT04842448","u":"https://clinicaltrials.gov/study/NCT04842448","t":"HOT-LoCO","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":80,"y":2021,"r":"null","s":"HOT-LoCO (n=80): 10 HBOT sessions no better than sham at short-term endpoint","v":1,"st":[5,6]},{"i":"NCT04871815","u":"https://clinicaltrials.gov/study/NCT04871815","t":"","x":"sodium pyruvate nasal spray","c":"other","p":"long COVID","d":"single-arm","b":0,"n":22,"y":2021,"r":"positive","s":"Sodium pyruvate nasal spray, non-randomised (n=22): lower body ache, headache and cough scores vs untreated; low quality","v":1,"st":[]},{"i":"NCT04904536","u":"https://clinicaltrials.gov/study/NCT04904536","t":"STRONGER","x":"statin","c":"other","p":"long COVID","d":"RCT-usual-care","b":1,"n":190,"y":2022,"r":"pending","s":"No results yet","v":0,"st":[6,7]},{"i":"NCT04905888","u":"https://clinicaltrials.gov/study/NCT04905888","t":"","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2021,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[5,6]},{"i":"NCT04980573","u":"https://clinicaltrials.gov/study/NCT04980573","t":"","x":"Aromatherapy","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":47,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2021-11-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04997395","u":"https://clinicaltrials.gov/study/NCT04997395","t":"","x":"cannabinoid","c":"other","p":"long COVID","d":"single-arm","b":0,"n":12,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-01-06; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05047952","u":"https://clinicaltrials.gov/study/NCT05047952","t":"","x":"vortioxetine","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":149,"y":2021,"r":"mixed","s":"Vortioxetine vs placebo (n=149): DSST cognition change 0.33 vs 0.18, not significant unadjusted; depression and HRQoL improved in paper","v":1,"st":[2]},{"i":"NCT05074888","u":"https://clinicaltrials.gov/study/NCT05074888","t":"","x":"Prospekta","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":676,"y":2021,"r":"positive","s":"Prospekta vs placebo for post-COVID asthenia (n=676): FSS fell 16.5 vs 14.0 (p=0.0016); small absolute difference; industry-sponsored","v":1,"st":[2]},{"i":"NCT05104749","u":"https://clinicaltrials.gov/study/NCT05104749","t":"","x":"homeopathy","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":77,"y":2021,"r":"null","s":"Homeopathy vs placebo (n=77): FAS and SF-36 PCS no better than placebo","v":1,"st":[]},{"i":"NCT05212688","u":"https://clinicaltrials.gov/study/NCT05212688","t":"ACU-COVID","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"crossover","b":0,"n":119,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2024-09-25; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05217771","u":"https://clinicaltrials.gov/study/NCT05217771","t":"WHO","x":"High tone power therapy group","c":"other","p":"long COVID","d":"RCT-active","b":1,"n":56,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-11-20; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05274477","u":"https://clinicaltrials.gov/study/NCT05274477","t":"FamC","x":"fampridine","c":"other","p":"long COVID","d":"crossover","b":1,"n":8,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2024-06-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05467904","u":"https://clinicaltrials.gov/study/NCT05467904","t":"","x":"Xltranplus, Xltran","c":"other","p":"long COVID","d":"single-arm","b":1,"n":0,"y":2024,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[]},{"i":"NCT05618587","u":"https://clinicaltrials.gov/study/NCT05618587","t":"","x":"lithium","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":50,"y":2022,"r":"null","s":"Lithium aspartate 10-15 mg/d vs placebo (n=52): ineffective for fatigue and cognitive dysfunction","v":1,"st":[2]},{"i":"NCT05667077","u":"https://clinicaltrials.gov/study/NCT05667077","t":"","x":"amantadine","c":"other","p":"long COVID","d":"RCT-usual-care","b":0,"n":83,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-12-29; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT05669261","u":"https://clinicaltrials.gov/study/NCT05669261","t":"","x":"Adipose Tissue Harvest; ATCell","c":"other","p":"long COVID","d":"crossover","b":1,"n":20,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-12-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05693064","u":"https://clinicaltrials.gov/study/NCT05693064","t":"","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"single-arm","b":0,"n":40,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05715801","u":"https://clinicaltrials.gov/study/NCT05715801","t":"","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"RCT-active","b":1,"n":80,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-01-31; no results posted or published abstract found","v":0,"st":[5,6]},{"i":"NCT05749757","u":"https://clinicaltrials.gov/study/NCT05749757","t":"","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":84,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-07-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05764538","u":"https://clinicaltrials.gov/study/NCT05764538","t":"","x":"DAOIB","c":"other","p":"long COVID","d":"single-arm","b":0,"n":40,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05787366","u":"https://clinicaltrials.gov/study/NCT05787366","t":"SPACO+","x":"Personalized Multifactorial Intervention (IMP)","c":"other","p":"long COVID","d":"RCT-usual-care","b":0,"n":400,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05795816","u":"https://clinicaltrials.gov/study/NCT05795816","t":"","x":"Testofen; Microcrystalline cellulose","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":150,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-01-30; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05823805","u":"https://clinicaltrials.gov/study/NCT05823805","t":"AFTERMATH","x":"Community Health Worker","c":"other","p":"long COVID","d":"RCT-usual-care","b":1,"n":520,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05874037","u":"https://clinicaltrials.gov/study/NCT05874037","t":"","x":"fluvoxamine","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":137,"y":2023,"r":"positive","s":"Fluvoxamine vs placebo (n=137): total symptom score fell 47.3 vs 31.1 (no p-value posted)","v":1,"st":[2]},{"i":"NCT05890508","u":"https://clinicaltrials.gov/study/NCT05890508","t":"","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":150,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05901337","u":"https://clinicaltrials.gov/study/NCT05901337","t":"","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"RCT-active","b":1,"n":76,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-06-21; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05947617","u":"https://clinicaltrials.gov/study/NCT05947617","t":"","x":"VIX001","c":"other","p":"long COVID","d":"RCT-active","b":0,"n":9,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-04-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05999435","u":"https://clinicaltrials.gov/study/NCT05999435","t":"ESSOR","x":"LAU-7b (fenretinide)","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":272,"y":2023,"r":"null","s":"LAU-7b (fenretinide) vs placebo (n=272): no SF-36 PCS improvement at week 12","v":1,"st":[6,7]},{"i":"NCT06012552","u":"https://clinicaltrials.gov/study/NCT06012552","t":"COVMENT","x":"antidepressant","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":140,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06055244","u":"https://clinicaltrials.gov/study/NCT06055244","t":"AmantadineLC","x":"amantadine","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":64,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06108297","u":"https://clinicaltrials.gov/study/NCT06108297","t":"","x":"lithium","c":"other","p":"long COVID","d":"single-arm","b":0,"n":5,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-03-26; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT06144320","u":"https://clinicaltrials.gov/study/NCT06144320","t":"","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":40,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2023-11; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06204458","u":"https://clinicaltrials.gov/study/NCT06204458","t":"HyPoCo","x":"mild hyperthermia group","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":60,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06234462","u":"https://clinicaltrials.gov/study/NCT06234462","t":"","x":"amantadine + CBT/psychological therapy","c":"other","p":"long COVID","d":"single-arm","b":1,"n":0,"y":2025,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[2]},{"i":"NCT06267300","u":"https://clinicaltrials.gov/study/NCT06267300","t":"","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"crossover","b":0,"n":120,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT06348186","u":"https://clinicaltrials.gov/study/NCT06348186","t":"","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"RCT-active","b":1,"n":30,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2024-04-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06437223","u":"https://clinicaltrials.gov/study/NCT06437223","t":"","x":"tonabersat","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":16,"y":2024,"r":"unreported-after-completion","s":"Primary completion 2025-09-30; no results posted or published abstract found","v":0,"st":[2]},{"i":"NCT06452095","u":"https://clinicaltrials.gov/study/NCT06452095","t":"RECLAIM-HBOT","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":120,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[5,6]},{"i":"NCT06590324","u":"https://clinicaltrials.gov/study/NCT06590324","t":"","x":"apabetalone","c":"other","p":"long COVID","d":"single-arm","b":0,"n":200,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[4,6]},{"i":"NCT06633666","u":"https://clinicaltrials.gov/study/NCT06633666","t":"","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"RCT-usual-care","b":1,"n":160,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06821087","u":"https://clinicaltrials.gov/study/NCT06821087","t":"","x":"ketamine","c":"other","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT06883513","u":"https://clinicaltrials.gov/study/NCT06883513","t":"","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"crossover","b":1,"n":20,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06928272","u":"https://clinicaltrials.gov/study/NCT06928272","t":"","x":"(deu)pirfenidone + JAK inhibitor","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":348,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[6,7]},{"i":"NCT07110714","u":"https://clinicaltrials.gov/study/NCT07110714","t":"HydroCoVitalB","x":"Cold water hydrotherapy","c":"other","p":"long COVID","d":"RCT-usual-care","b":0,"n":30,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07189936","u":"https://clinicaltrials.gov/study/NCT07189936","t":"","x":"To Measure levels of circulating monocyte/ T cell doublets at Baseline; To measure levels of circulating monocyte/ T cell doublets after 28 days of 2 HOBA treatment","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":50,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07285707","u":"https://clinicaltrials.gov/study/NCT07285707","t":"ACUCM-LC","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"single-arm","b":0,"n":10,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07355751","u":"https://clinicaltrials.gov/study/NCT07355751","t":"","x":"acupuncture/manual therapy","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":108,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07359482","u":"https://clinicaltrials.gov/study/NCT07359482","t":"ESPRIT","x":"fluvoxamine","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":160,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"NCT07661862","u":"https://clinicaltrials.gov/study/NCT07661862","t":"","x":"PERCEIVE-Outreach Disease Management Program","c":"other","p":"long COVID","d":"RCT-usual-care","b":1,"n":577,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07694232","u":"https://clinicaltrials.gov/study/NCT07694232","t":"long COVID POD","x":"homeopathy","c":"other","p":"long COVID","d":"RCT-usual-care","b":0,"n":120,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07714213","u":"https://clinicaltrials.gov/study/NCT07714213","t":"PAISE-AriSE","x":"low-dose aripiprazole","c":"other","p":"long COVID","d":"crossover","b":1,"n":138,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[2]},{"i":"PMID:34604980","u":"https://doi.org/10.26355/eurrev_202109_26809","t":"","x":"oxygen-ozone autohaemotherapy","c":"other","p":"long COVID","d":"single-arm","b":0,"n":100,"y":2021,"r":"positive","s":"Oxygen-ozone autohaemotherapy in PASC, uncontrolled (n=100): fatigue fell in 67%; low quality","v":1,"st":[]},{"i":"PMID:34862223","u":"https://doi.org/10.7861/clinmed.2021-0462","t":"","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"single-arm","b":0,"n":10,"y":2021,"r":"positive","s":"Hyperbaric oxygen, uncontrolled (n=10): large improvements in fatigue and cognition after 10 sessions","v":1,"st":[5,6]},{"i":"PMID:35394732","u":"https://doi.org/10.17116/jnevro2022122031126","t":"","x":"Cortexin + Recognan","c":"other","p":"long COVID","d":"open-label","b":0,"n":0,"y":2022,"r":"positive","s":"Cortexin + Recognan neurotropic therapy in young post-COVID patients: asthenia and cognition improved","v":1,"st":[]},{"i":"PMID:35632649","u":"https://doi.org/10.3390/v14050907","t":"","x":"epipharyngeal abrasive therapy","c":"other","p":"long COVID","d":"single-arm","b":0,"n":58,"y":2022,"r":"positive","s":"Epipharyngeal abrasive therapy, uncontrolled (n=58): fatigue, headache and attention improved","v":1,"st":[]},{"i":"PMID:35821512","u":"https://doi.org/10.1038/s41598-022-15565-0","t":"","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":73,"y":2022,"r":"positive","s":"Hyperbaric oxygen vs sham (n=73): better cognition, fatigue, sleep, pain and brain perfusion","v":1,"st":[5,6]},{"i":"PMID:35821795","u":"https://doi.org/10.1089/acu.2021.0086","t":"","x":"acupuncture","c":"other","p":"long COVID","d":"single-arm","b":0,"n":1,"y":2022,"r":"positive","s":"Acupuncture alongside physiotherapy, single case: full recovery; anecdotal","v":1,"st":[]},{"i":"PMID:36036410","u":"https://doi.org/10.17116/jnevro2022122081101","t":"","x":"Anvifen (phenibut)","c":"other","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2022,"r":"positive","s":"Anvifen (phenibut) for post-COVID brain fog, pre-post: anxiety, MoCA and fatigue improved; uncontrolled","v":1,"st":[]},{"i":"PMID:36311877","u":"https://doi.org/10.1007/s11055-022-01307-2","t":"","x":"Cortexin (cortical peptides)","c":"other","p":"long COVID","d":"RCT-active","b":0,"n":0,"y":2022,"r":"positive","s":"Cortexin 10 or 20 mg in post-COVID neurological symptoms: cognitive and asthenic manifestations improved","v":1,"st":[]},{"i":"PMID:37683237","u":"https://doi.org/10.1097/jcp.0000000000001725","t":"","x":"tricyclic antidepressants","c":"other","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2023,"r":"not-assessable","s":"Tricyclic antidepressants for long COVID neuropsychiatric sequelae, case series; no abstract","v":0,"st":[2]},{"i":"PMID:37799621","u":"https://doi.org/10.3831/kpi.2023.26.3.238","t":"","x":"acupuncture/manual therapy + exercise/rehabilitation","c":"other","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2023,"r":"positive","s":"Rehabilitation with vs without acupuncture: more scales improved with acupuncture","v":1,"st":[]},{"i":"PMID:37862966","u":"https://doi.org/10.1016/j.biopha.2023.115723","t":"","x":"CCSA neuroprotective therapy","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2023,"r":"positive","s":"Neuroprotective drug (CCSA) vs placebo in post-COVID asthenia: larger MFI-20 reduction and cognitive gains","v":1,"st":[]},{"i":"PMID:37919310","u":"https://doi.org/10.1038/s41598-023-45072-9","t":"","x":"SSRIs","c":"other","p":"long COVID","d":"single-arm","b":0,"n":95,"y":2023,"r":"positive","s":"SSRIs in 95 post-COVID patients, case series: reported improvement; uncontrolled","v":1,"st":[]},{"i":"PMID:38008074","u":"https://doi.org/10.1159/000535279","t":"","x":"homeopathy","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"positive","s":"Individualised homeopathy vs placebo, single-blind: better post-COVID fatigue scores","v":1,"st":[]},{"i":"PMID:38228731","u":"https://doi.org/10.1038/s41598-024-51904-z","t":"","x":"amantadine","c":"other","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2024,"r":"positive","s":"Amantadine vs no treatment, open-label RCT in post-COVID fatigue: FSS fell markedly more (28 vs 43)","v":1,"st":[2]},{"i":"PMID:38406122","u":"https://doi.org/10.7759/cureus.52935","t":"","x":"amifampridine","c":"other","p":"long COVID","d":"n-of-1","b":1,"n":5,"y":2024,"r":"positive","s":"Amifampridine case collection (n=5) with double-blind discontinuation in 2: less sleep need, better Bell score","v":1,"st":[2]},{"i":"PMID:39018686","u":"https://doi.org/10.1016/j.intimp.2024.112673","t":"","x":"ozone autohaemotherapy","c":"other","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2024,"r":"positive","s":"Major ozone autohaemotherapy + conventional vs conventional pilot: better symptoms, lung function and inflammation","v":1,"st":[]},{"i":"PMID:39089276","u":"https://pubmed.ncbi.nlm.nih.gov/39089276/","t":"","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2024,"r":"positive","s":"Hyperbaric oxygen, observational: ~90% improved; uncontrolled","v":1,"st":[5,6]},{"i":"PMID:39091579","u":"https://doi.org/10.14740/jmc4254","t":"","x":"methylphenidate","c":"other","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2024,"r":"positive","s":"Methylphenidate case series for brain fog: better recall and verbal fluency","v":1,"st":[2]},{"i":"PMID:39321328","u":"https://doi.org/10.1089/jicm.2024.0102","t":"","x":"homeopathy","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2025,"r":"positive","s":"Individualised homeopathy vs placebo: large symptom score differences favouring homeopathy; implausible effect sizes","v":1,"st":[]},{"i":"PMID:39499692","u":"https://doi.org/10.1371/journal.pone.0312735","t":"","x":"supplemental oxygen","c":"other","p":"long COVID","d":"crossover","b":0,"n":0,"y":2024,"r":"mixed","s":"Portable oxygen concentrator vs control, crossover: no overall MoCA difference; period-1 and subscore gains","v":1,"st":[]},{"i":"PMID:39960888","u":"https://doi.org/10.1093/qjmed/hcaf050","t":"","x":"intravenous laser irradiation of blood","c":"other","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2025,"r":"positive","s":"Intravenous laser blood irradiation pilot: MoCA and sleep improved; uncontrolled","v":1,"st":[]},{"i":"PMID:40094666","u":"https://doi.org/10.1001/jamanetworkopen.2025.0728","t":"","x":"cholinesterase inhibitor/memantine + CBT/psychological therapy","c":"other","p":"long COVID","d":"RCT-placebo","b":1,"n":120,"y":2025,"r":"null","s":"Donepezil vs placebo (n=120): no benefit for fatigue or psychological symptoms","v":1,"st":[2]},{"i":"PMID:40336247","u":"https://doi.org/10.1080/02656736.2025.2488792","t":"","x":"whole-body hyperthermia","c":"other","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2025,"r":"positive","s":"Whole-body hyperthermia within multimodal therapy, case series: FACIT-F improved","v":1,"st":[]},{"i":"PMID:40544138","u":"https://doi.org/10.28920/dhm55.2.104-113","t":"","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"RCT-placebo","b":0,"n":0,"y":2025,"r":"null","s":"Normobaric/hyperbaric hyperoxia at different doses vs placebo: no differences in symptoms or cognition","v":1,"st":[5,6]},{"i":"PMID:41767530","u":"https://doi.org/10.3389/fmed.2026.1720578","t":"","x":"ozone autohaemotherapy","c":"other","p":"long COVID","d":"single-arm","b":0,"n":40,"y":2026,"r":"positive","s":"Major ozone autohaemotherapy (n=40), uncontrolled: FACIT and SF-36 improved","v":1,"st":[]},{"i":"PMID:42301972","u":"https://doi.org/10.12968/bjon.2025.0241","t":"","x":"hyperbaric oxygen","c":"other","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2026,"r":"positive","s":"Community hyperbaric oxygen pilot in long COVID: fatigue, breathlessness and QoL improved; attendance difficult; uncontrolled","v":1,"st":[5,6]},{"i":"PMID:42328645","u":"https://doi.org/10.3389/fphar.2026.1807203","t":"","x":"donepezil","c":"other","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2026,"r":"positive","s":"Donepezil in PASC with anti-SITH-1 antibodies: fatigue and depression improved in this subgroup; small, partly preclinical","v":1,"st":[2]},{"i":"PMID:42478179","u":"https://doi.org/10.1080/20565623.2026.2704605","t":"","x":"ozone rectal insufflation","c":"other","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2026,"r":"positive","s":"Rectal ozone insufflation, preliminary: handgrip and SF-12 improved; uncontrolled","v":1,"st":[]},{"i":"2024-511628-16-00","u":"https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-511628-16-00","t":"2023-02978","x":"magnesium","c":"supplement","p":"long COVID","d":"RCT-unspecified","b":0,"n":376,"y":2024,"r":"pending","s":"Registry record only (EU CTIS); results first received: No","v":0,"st":[]},{"i":"2024-517199-39-00","u":"https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-517199-39-00","t":"D.01.02.3.03","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":400,"y":2025,"r":"pending","s":"Registry record only (EU CTIS); results first received: No","v":0,"st":[]},{"i":"DOI:10.1101/2022.10.04.22280680","u":"https://doi.org/10.1101/2022.10.04.22280680","t":"","x":"elderberry extract","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":0,"n":0,"y":2022,"r":"positive","s":"Elderberry extract (Immunodaat) vs control, 30 days: fewer physical and mental symptoms, better QoL","v":1,"st":[]},{"i":"DOI:10.20944/preprints202602.0361.v1","u":"https://doi.org/10.20944/preprints202602.0361.v1","t":"","x":"vitamin D3","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":1,"n":0,"y":2026,"r":"positive","s":"Vitamin D3 vs control in paediatric PASC: lower symptom scores and cytokines","v":1,"st":[]},{"i":"DOI:10.21203/rs.3.rs-2676572/v1","u":"https://doi.org/10.21203/rs.3.rs-2676572/v1","t":"","x":"CelWel natural supplement","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":15,"y":2023,"r":"positive","s":"CelWel supplement 14 days, quasi-experimental: lower fatigue and C19-YRS scores and cytokines","v":1,"st":[]},{"i":"ISRCTN12368131","u":"https://www.isrctn.com/ISRCTN12368131","t":"APRIL","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"RCT-unspecified","b":0,"n":105,"y":2022,"r":"unreported-after-completion","s":"Registry record only; no results read; outputs listed on registry","v":0,"st":[]},{"i":"ISRCTN12595520","u":"https://doi.org/10.1038/s41591-024-03384-x","t":"","x":"remote weight management (diet)","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":0,"n":234,"y":2025,"r":"positive","s":"ReDIRECT remote weight management vs wait list in overweight long COVID (n=234): small improvement in most troublesome symptom","v":1,"st":[]},{"i":"ISRCTN13270662","u":"https://doi.org/10.20944/preprints202407.2492.v1","t":"","x":"SPM-enriched marine oil","c":"supplement","p":"long COVID","d":"RCT-active","b":0,"n":0,"y":2024,"r":"mixed","s":"SPM-enriched marine oil at three doses: serum SPMs rose; fatigue and dyspnoea trended better; no dose differences","v":1,"st":[]},{"i":"KCT0008948","u":"https://doi.org/10.3389/fphar.2024.1394810","t":"","x":"Myelophil herbal extract","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":50,"y":2024,"r":"positive","s":"Myelophil open-label 4 weeks (n=50): fatigue and brain fog VAS fell; uncontrolled","v":1,"st":[]},{"i":"KCT0008948 (paper 2)","u":"https://doi.org/10.1186/s12879-025-10984-6","t":"","x":"MYPplus herbal extract","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":50,"y":2025,"r":"positive","s":"MYPplus (Myelophil variant) observational (n=50): fatigue scores fell; uncontrolled","v":1,"st":[]},{"i":"KCT0009410","u":"https://doi.org/10.1016/j.imr.2026.101336","t":"","x":"Kyungok-go (Korean herbal)","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":94,"y":2026,"r":"positive","s":"Kyungok-go herbal medicine, single-arm multicentre (n=94): FSS, VAS and Chalder fatigue fell","v":1,"st":[]},{"i":"NCT04828668","u":"https://clinicaltrials.gov/study/NCT04828668","t":"\"BAC-PAC\"","x":"Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C)","c":"supplement","p":"long COVID","d":"crossover","b":1,"n":32,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-01-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT04846010","u":"https://clinicaltrials.gov/study/NCT04846010","t":"sequelae","x":"herbal/TCM + vagus nerve stimulation","c":"supplement","p":"long COVID","d":"open-label","b":0,"n":2000,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-05-01; no results posted or published abstract found","v":0,"st":[7,8]},{"i":"NCT04924881","u":"https://clinicaltrials.gov/study/NCT04924881","t":"","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":68,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-10-03; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05121766","u":"https://clinicaltrials.gov/study/NCT05121766","t":"","x":"polyphenol/omega-3/anti-inflammatory supplement","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":32,"y":2022,"r":"feasibility-only","s":"Omega-3 vs placebo feasibility pilot (terminated, n=32): only recruitment counts posted","v":1,"st":[6,7]},{"i":"NCT05150782","u":"https://clinicaltrials.gov/study/NCT05150782","t":"","x":"polyphenol/omega-3/anti-inflammatory supplement","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":32,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2022-10-10; no results posted or published abstract found","v":0,"st":[6,7]},{"i":"NCT05311852","u":"https://clinicaltrials.gov/study/NCT05311852","t":"PL-PC19","x":"polyphenol/omega-3/anti-inflammatory supplement","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":34,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2022-02-15; no results posted or published abstract found","v":0,"st":[6,7]},{"i":"NCT05356936","u":"https://clinicaltrials.gov/study/NCT05356936","t":"","x":"vitamins/minerals","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":0,"n":151,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2024-04-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05371288","u":"https://clinicaltrials.gov/study/NCT05371288","t":"","x":"N-acetylcysteine","c":"supplement","p":"long COVID","d":"RCT-active","b":1,"n":0,"y":2025,"r":"withdrawn","s":"Withdrawn before enrolment","v":0,"st":[6]},{"i":"NCT05531019","u":"https://clinicaltrials.gov/study/NCT05531019","t":"","x":"diet","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":54,"y":2021,"r":"positive","s":"Sea urchin egg extract (EchA Marine) vs placebo (n=46): better EQ-5D pain and mobility; small, industry-linked","v":1,"st":[]},{"i":"NCT05618574","u":"https://clinicaltrials.gov/study/NCT05618574","t":"","x":"dietary nitrate","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":17,"y":2023,"r":"null","s":"Dietary nitrate (beetroot) vs placebo (n=17): no change in fatigability (p=0.95) or walking efficiency","v":1,"st":[4,5]},{"i":"NCT05630339","u":"https://clinicaltrials.gov/study/NCT05630339","t":"","x":"magnesium + vitamins/minerals","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":150,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-05-01; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05633472","u":"https://clinicaltrials.gov/study/NCT05633472","t":"","x":"vitamins/minerals","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":33,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2024-08-23; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05684952","u":"https://clinicaltrials.gov/study/NCT05684952","t":"","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":152,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-01-15; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05705648","u":"https://clinicaltrials.gov/study/NCT05705648","t":"","x":"diet","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":103,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT05798221","u":"https://clinicaltrials.gov/study/NCT05798221","t":"NASH-POCO","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":1,"n":86,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-03-25; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT05874089","u":"https://clinicaltrials.gov/study/NCT05874089","t":"DELong#3","x":"VSL#3®","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":96,"y":2022,"r":"positive","s":"VSL#3 probiotic vs placebo (DELong#3, n=48 completers): fatigue improved (Chalder -24% vs -6%, p=0.037), responders 68% vs 36%","v":1,"st":[]},{"i":"NCT05890534","u":"https://clinicaltrials.gov/study/NCT05890534","t":"PYCNOVID","x":"polyphenol/omega-3/anti-inflammatory supplement","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":153,"y":2023,"r":"null","s":"PYCNOVID: Pycnogenol 200 mg vs placebo (n=153): no difference in EQ-VAS; both groups improved","v":1,"st":[6,7]},{"i":"NCT05977179","u":"https://clinicaltrials.gov/study/NCT05977179","t":"Long-COVIDiet","x":"diet","c":"supplement","p":"long COVID","d":"RCT-active","b":0,"n":56,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06013072","u":"https://clinicaltrials.gov/study/NCT06013072","t":"STOPPFATIQUE","x":"diet","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":32,"y":2022,"r":"mixed","s":"Synbiotic vs placebo, 3 months (n=32): fatigue fell in both arms; interaction effects on tissue metabolism favoured synbiotic","v":1,"st":[]},{"i":"NCT06042777","u":"https://clinicaltrials.gov/study/NCT06042777","t":"","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":1,"n":100,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-05-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06054438","u":"https://clinicaltrials.gov/study/NCT06054438","t":"","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"crossover","b":0,"n":110,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2024-03-31; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06095258","u":"https://clinicaltrials.gov/study/NCT06095258","t":"","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"RCT-active","b":1,"n":162,"y":2023,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06214455","u":"https://clinicaltrials.gov/study/NCT06214455","t":"","x":"diet","c":"supplement","p":"long COVID","d":"crossover","b":1,"n":58,"y":2022,"r":"mixed","s":"Intermittent fasting vs time-restricted eating (n=58): larger LC-score drop with fasting (-10.2 vs -2.8); significance not posted","v":1,"st":[]},{"i":"NCT06419712","u":"https://clinicaltrials.gov/study/NCT06419712","t":"VITDPOSTCOVID","x":"vitamins/minerals","c":"supplement","p":"long COVID","d":"RCT-active","b":1,"n":54,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-04-20; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06437210","u":"https://clinicaltrials.gov/study/NCT06437210","t":"","x":"Viusid Oral Solution","c":"supplement","p":"long COVID","d":"single-arm","b":1,"n":200,"y":2022,"r":"unreported-after-completion","s":"Primary completion 2023-12-15; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT06522750","u":"https://clinicaltrials.gov/study/NCT06522750","t":"FASTCOV-P","x":"diet","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06535165","u":"https://clinicaltrials.gov/study/NCT06535165","t":"","x":"dietary nitrate","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":31,"y":2021,"r":"null","s":"Red beetroot juice vs placebo 14 d (n=31): no improvement in functional outcomes; gut microbiota and inflammatory changes","v":1,"st":[4,5]},{"i":"NCT06879925","u":"https://clinicaltrials.gov/study/NCT06879925","t":"QG-PASC","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"crossover","b":0,"n":80,"y":2024,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06967428","u":"https://clinicaltrials.gov/study/NCT06967428","t":"ViTAL-SCAN19","x":"vitamins/minerals","c":"supplement","p":"long COVID","d":"RCT-active","b":1,"n":100,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT06974058","u":"https://clinicaltrials.gov/study/NCT06974058","t":"","x":"polyphenol/omega-3/anti-inflammatory supplement","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":15,"y":2025,"r":"positive","s":"Quercetin-curcumin open-label (n=15): lower symptom burden and fatigue; uncontrolled","v":1,"st":[6,7]},{"i":"NCT06980636","u":"https://clinicaltrials.gov/study/NCT06980636","t":"Shengmai LOFT","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":100,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07418567","u":"https://clinicaltrials.gov/study/NCT07418567","t":"","x":"diet","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":25,"y":2025,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07429903","u":"https://clinicaltrials.gov/study/NCT07429903","t":"","x":"diet","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":1,"n":31,"y":2023,"r":"unreported-after-completion","s":"Primary completion 2025-01-24; no results posted or published abstract found","v":0,"st":[]},{"i":"NCT07544186","u":"https://clinicaltrials.gov/study/NCT07544186","t":"","x":"L-arginine/citrulline","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":0,"n":43,"y":2020,"r":"unreported-after-completion","s":"Primary completion 2022-11-11; no results posted or published abstract found","v":0,"st":[4,5]},{"i":"NCT07627815","u":"https://clinicaltrials.gov/study/NCT07627815","t":"","x":"diet","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":0,"n":82,"y":2026,"r":"pending","s":"No results yet","v":0,"st":[]},{"i":"NCT07722000","u":"https://clinicaltrials.gov/study/NCT07722000","t":"","x":"herbal/TCM","c":"supplement","p":"long COVID","d":"RCT-active","b":0,"n":90,"y":2021,"r":"unreported-after-completion","s":"Primary completion 2023-12-01; no results posted or published abstract found","v":0,"st":[]},{"i":"PMID:35337143","u":"https://doi.org/10.3390/ph15030345","t":"","x":"ADAPT-232 adaptogen herbal","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":100,"y":2022,"r":"mixed","s":"Adaptogens (Chisan/ADAPT-232) vs placebo: better physical performance and shorter fatigue duration reported; most outcomes not different","v":1,"st":[]},{"i":"PMID:35416437","u":"https://doi.org/10.1111/jebm.12465","t":"","x":"Qingjin Yiqi granules (TCM)","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":0,"n":388,"y":2022,"r":"mixed","s":"Qingjin Yiqi granules vs control (n=388, PCC): breathlessness (mMRC, Borg) improved; overall symptom score not different","v":1,"st":[]},{"i":"PMID:36156538","u":"https://doi.org/10.12659/ajcr.937094","t":"","x":"Ginkgo biloba extract EGb 761","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2022,"r":"positive","s":"Ginkgo extract EGb 761, case series: cognitive deficits improved or resolved","v":1,"st":[]},{"i":"PMID:36455453","u":"https://doi.org/10.1016/j.clinph.2022.10.017","t":"","x":"palmitoylethanolamide + luteolin","c":"supplement","p":"long COVID","d":"RCT-placebo","b":0,"n":0,"y":2023,"r":"mixed","s":"PEA-luteolin vs placebo: restored cortical GABA-B activity and plasticity; neurophysiology endpoint only","v":1,"st":[6,7]},{"i":"PMID:36501014","u":"https://doi.org/10.3390/nu14234984","t":"","x":"L-arginine/citrulline + vitamins/minerals","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":46,"y":2022,"r":"positive","s":"L-arginine + vitamin C vs placebo (n=46): better walking, handgrip, flow-mediated dilation; fatigue 9% vs 80%","v":1,"st":[4,5]},{"i":"PMID:38024352","u":"https://doi.org/10.3389/fnut.2023.1195270","t":"","x":"long-term fasting","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":0,"y":2023,"r":"positive","s":"Long-term fasting case series: symptoms improved in most","v":1,"st":[]},{"i":"PMID:38675423","u":"https://doi.org/10.3390/ph17040463","t":"","x":"polyphenol/vitamin food supplement","c":"supplement","p":"long COVID","d":"crossover","b":1,"n":0,"y":2024,"r":"positive","s":"Oral food supplement vs placebo, crossover in long COVID: lower inflammatory ratios, less fatigue, better QoL","v":1,"st":[6,7]},{"i":"PMID:38834234","u":"https://doi.org/10.1136/spcare-2023-004595","t":"","x":"Astragalus root extract","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2025,"r":"positive","s":"Astragalus root extract vs placebo in nurses with post-COVID chronic fatigue: lower chronic-fatigue prevalence","v":1,"st":[]},{"i":"PMID:39072958","u":"https://doi.org/10.1111/pcn.13716","t":"","x":"vitamin D3","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"positive","s":"High-dose vitamin D vs placebo 8 weeks: lower Chalder fatigue, anxiety and better cognition (ACE)","v":1,"st":[]},{"i":"PMID:39076533","u":"https://doi.org/10.1183/23120541.00031-2024","t":"","x":"lactoferrin","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":72,"y":2024,"r":"null","s":"Lactoferrin vs placebo (n=72): no benefit for fatigue or function","v":1,"st":[]},{"i":"PMID:39124710","u":"https://doi.org/10.3390/jcm13154444","t":"","x":"polyphenol/omega-3/anti-inflammatory supplement + microbiome therapy","c":"supplement","p":"long COVID","d":"open-label","b":0,"n":44,"y":2024,"r":"positive","s":"PIRV-F20 supplement (lactoferrin, probiotics, resveratrol), observational (n=44): 6MWD +40 m vs +10 m","v":1,"st":[1,6,7]},{"i":"PMID:39328557","u":"https://doi.org/10.1016/j.heliyon.2024.e37920","t":"","x":"Korean herbal medicines","c":"supplement","p":"long COVID","d":"RCT-active","b":0,"n":45,"y":2024,"r":"feasibility-only","s":"Three herbal medicines (Bojungikgi-tang etc.) pilot: fatigue success 47-80%; no placebo","v":1,"st":[]},{"i":"PMID:39840178","u":"https://doi.org/10.7759/cureus.76148","t":"","x":"omega-3 fatty acids","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2024,"r":"null","s":"Omega-3 vs placebo pilot in healthcare workers: feasible; no symptom improvement","v":1,"st":[6,7]},{"i":"PMID:39861434","u":"https://doi.org/10.3390/nu17020304","t":"","x":"vitamin K2 + D3","c":"supplement","p":"long COVID","d":"RCT-usual-care","b":0,"n":151,"y":2025,"r":"positive","s":"Vitamins K2 + D3 vs standard care (n=151): improved RECOVER LC index, symptom count and gut/inflammatory markers","v":1,"st":[]},{"i":"PMID:40004921","u":"https://doi.org/10.3390/jcm14041391","t":"","x":"hochuekkito (Kampo)","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":20,"y":2025,"r":"positive","s":"Hochuekkito (Kampo) pilot (n=20): trend to less fatigue; uncontrolled","v":1,"st":[]},{"i":"PMID:40429727","u":"https://doi.org/10.3390/ijms26104582","t":"","x":"vitamin D","c":"supplement","p":"long COVID","d":"open-label","b":0,"n":0,"y":2025,"r":"null","s":"Vitamin D supplementation regimens, observational: lower IL-6 and anxiety/depression; no improvement in fatigue","v":1,"st":[]},{"i":"PMID:40761857","u":"https://doi.org/10.3389/fmed.2025.1609812","t":"","x":"kamikihito + saikokeishito (Kampo)","c":"supplement","p":"long COVID","d":"single-arm","b":0,"n":112,"y":2025,"r":"positive","s":"Kamikihito + saikokeishito, prospective observational (n=112): HRQoL improved at 3 months; uncontrolled","v":1,"st":[]},{"i":"PMID:42280350","u":"https://doi.org/10.3390/nu18111706","t":"","x":"L-citrulline","c":"supplement","p":"long COVID","d":"RCT-placebo","b":0,"n":43,"y":2026,"r":"positive","s":"L-citrulline vs placebo 3 months (n=43): lower ICAM-1 and longer 6MWT","v":1,"st":[4,5]},{"i":"PMID:42708315","u":"https://doi.org/10.2174/0118715265475872260417063451","t":"","x":"Viusid (nutritional supplement)","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":0,"y":2026,"r":"positive","s":"Viusid vs placebo: improved brain fog and other symptoms; small","v":1,"st":[]},{"i":"TCTR20230131004","u":"https://doi.org/10.1016/j.ctim.2024.103107","t":"","x":"combined plant extracts","c":"supplement","p":"long COVID","d":"RCT-placebo","b":1,"n":66,"y":2024,"r":"mixed","s":"Combined plant extracts vs placebo (n=66): CRP not reduced; fatigue and PEM appeared improved","v":1,"st":[]}]